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ABSTRACT 
Mycoplasma hyopneumoniae causes swine enzootic pneumonia, an important disease in the 
swine industry. Adherence of M. hyopneumoniae to the cilia of the tracheal epithelial cells is 
required to establish infection. Previous studies have identified a 97-kDa protein (P97) as the 
putative ciliary adhesin. To further characterize the P97 protein, the gene has been cloned, its 
DNA sequence analyzed, and the fvmction of the P97 protein expressed in Escherichia coli 
studied. These results demonstrated that recombinant P97 has swine ciliary adherence activity. 
Further analysis revealed that the P97 gene was translated as a 124.9-kilodalton (kDa) protein 
and subjected to proteolytic cleavage at amino acid 195, resulting in a protein with a predicted 
molecular weight of 102 kDa. The translated P97 protein showed a high degree of 
hydrophilicity and contained no cysteine residues or acylation sites, confirming previous 
findings that P97 was not an integral membrane protein. Two repeat sequences, R1 and R2, 
were identified at the carboxy end of P97. The R1 sequence contained 15 repeats of 
AAKP(V/E) and was shown to function as the P97 ciliary binding motif. The adherence-
blocking monoclonal antibody F1B6 antigenic epitope was also mapped to the 5' end of the R1 
sequence. Analysis of different Af. hyopneumoniae isolates displaying variation in cilia binding 
activity, showed that the variation was not due to expression of P97, the number of R1 copies, 
or changes in the AAKP(V/E) repeat sequence. Thus, another mechanism must be ftmctioning 
to control cilium binding activity in M. hyopneumoniae. The R2 sequence contained four 
repeats of NQGKK(S/A)EG(A/T)P and showed a high degree of homology to ribosome 
binding proteins. Analysis of the P97 contig region showed that the P97 gene was the first of a 
two gene operon, designated the P97 operon. The second open reading frame coded for a 
possible membrane protein with a predicted molecular weight of 102 kDa. It had no sequence 
homology with any known sequence. Hybridization studies showed that the P97 operon 
sequence existed as multiple copies in the Af. hyopneumoniae chromosome. These findings 
support the hypothesis that P97 is involved in ciliary adherence of M. hyopneumoniae. 
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INTRODUCTION 
Rationale and Hypothesis 
Mycoplasma hyopneimoniae is the causative agent of porcine enzootic pneumonia, a 
significant and growing threat to the swine industry. In spite of years of work to develop 
effective vaccines against M. hyopneumoniae, no truly effective vaccine is available. This 
failure could be attributed to our lack of knowledge regarding the pathogenic mechanisms of 
mycoplasmas in general and to M. hyopneumoniae specifically. Little information is available 
concerning the adherence mechanisms and the specific Af. hyopneumoniae proteins involved 
although previous studies by Ross and co-workers indicated that a surface protein called P97 
plays an important role in the adherence of M. hyopneumoniae to swine cilia (264). The 
hypothesis addressed by this research was that P97 is a swine cilium binding protein. In order 
to address this hypothesis, a genetic approach was taken through cloning and analysis of the 
cloned product in Escherichia coli. The direct approach of obtaining mutants and using 
complementation to confirm the phenotype is not available in this system because of the 
inability to transform M. hyopneumoniae. The hypothesis was addressed by completing the 
following specific aims: 
• to clone, sequence and analyze the P97 gene from M. hyopneumoniae; 
• to map the cilia binding site of P97 to a specific DNA sequence; and 
• to map the F1B6 monoclonal antibody (Mab) epitope in similar fashion. 
Cloning and sequence analysis of the P97 gene would add significantly to our 
understanding of the mechanisms utilized by Af. hyopneumoniae to adhere to swine tracheal 
epithelial cells and make progress in developing an effective vaccine for enzootic pneumonia. 
The approaches taken for the first goal involved screening a M. hyopneumoniae Lambda ZAP® 
n expression library using the cytadherence inhibiting Mab, F1B6. Screening of the expression 
library was enhanced by using an E. coli strain, ISM612, specifically developed for use with 
mycoplasmal genes (211). The resulting plasmid clones were subjected to TnlOOO mutagenesis 
to locate the gene and to facilitate DNA sequencing. The TnlOOO inserts were also used to map 
the cilia binding site and the Mab binding epitope of P97. Hybridization studies with P97 
operon-specific probes were used to determine the copy number of P97 and its surrounding 
sequences in the M. hyopneumoniae chromosome. Additional studies were also performed by 
Contour-clamped Homogeneous Electric Field (CHEF) pulse-field gel electrophoresis to map 
the P97 gene to the published physical map of M. hyopneumoniae. 
2 
Dissertation Organization 
This dissertation is organized in a standard format consisting of five chapters: an 
Introduction, Literature Review, Materials and Methods, Results, and Discussion. Following 
the discussion are the references which follow the convention of the American Society for 
Microbiology. 
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LITERATURE REVIEW 
Bacterial Pathogenesis 
Bacterial pathogenicity is a complex, multi-factorial property that enables the pathogens to 
infect mucosa surfaces, sometimes invade the tissue through these surfaces, spread and 
multiply, cause tissue damage, and interact with the host defense system. The molecular basis 
of these factors are the determinants of pathogenicity sometimes referred to as virulence factors 
(25,47, 59,95, 212-214). Successful infection requires the pathogen to express various 
virulence factors in a coordinated and timely manner in vivo. The pathogens first gain access to 
the mucosal surface through contact transmission or through aerosol droplet transmission. 
Pathogens then adhere to epithelial cells through the interaction of bacterial adhesins with host 
cell receptors. Some pathogens grow and multiply on the epithelial cell surface without tissue 
invasion. Tissue damage results upon release of bacterial toxins or as a consequence of an 
inflammatory response by the host. Invasive pathogens express virulence factors that induce 
phagocytosis by epithelial cells or prevent killing by phagocytes. Some pathogens invade 
through lymphoid tissue such as M-cells in Peyer's patches. Some pathogens pass between 
epithelial cells into the underlying submucosa. The subsequent growth of these bacteria often 
results in the death of host cells and in an inflammatory response. Damaged tissue allows the 
pathogens to enter the blood stream (sepsis) and spread to other organ tissues causing 
systematic infection. Certain bacteria express surface adhesins that bind to phagocytes and 
induce lectin-mediated phagocytosis. Concomitant expression of virulence factors allows the 
bacteria to resist the killing mechanisms of phagocytes after being ingested, resulting in growth 
inside the phagocytes. The intracellular growth of these pathogens protects them firom the host 
immune defense system. Systemic infection often is the result of tissue tropism of the 
pathogens, which may be due to the expression of bacterial adhesin molecules that recognize 
specific receptor molecules on the surface of organ tissues. The invasion of tissues allows the 
pathogens to spread and multiply in immune privileged sites where the immune system does 
not function to full capacity such as in the brain. During infections, bacterial components called 
modulins are able to interact and modulate the host immune functions. Bacterial modulins 
stimulate the secretion of cytokines from a variety of host tissues. The combined effects of 
cytokine release are inflammatory responses, anti-inflammatory responses, or inmiune 
suppression depending upon the type of cytokines released. These bacterial components are 
considered a novel class of virulence factors (88). 
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Adherence as a Determinant of Pathogenesis 
Buccal, respiratory, and urogenital tract epithelium are the major sites for pathogenic 
bacterial attachment and entry. These sites are normally covered with commensual flora which 
have reached a state of balance with host clearing mechanisms. These mechanisms include 
desquamation of epithelial cells, the respiratory mucociliary escalator, flushing of the urogenital 
tract by urine, and bowel movement (peristalsis). Normal flora fimction as an integral part of 
the host defense to help prevent infection. Normal flora compete with pathogens for available 
nutrients and attachment sites. In some mstances, normal flora secrete antimicrobial 
bacteriocins that are harmful to pathogens. Therefore, tissue adherence is a prerequisite for 
colonization of pathogens, but there also needs to be a close association established with the 
epithelial cells where bacteria can grow and multiply. 
Mammalian Epithelial Cell Surface: Extracellular Matrix 
The surface structure of mammalian cells is complex. Bacteria bind to integral components 
of epithelial cell membranes or components of the extracellular matrix. Membrane glycolipids 
extend outward to the extracellular milieu with a complex carbohydrate structure. 
Glycoproteins also contain complex carbohydrate stmctures and function as a second class of 
receptor molecules. The normal fimction of these glycoconjugates in the host include cell-to-
cell communication and hormone receptors (77,165). These membrane glycoconjugates 
usually form a network through connections with cytoplasmic cytoskeletal components 
providing a conduit for the transduction of extracellular signals into the cell. These 
glycoconjugates also fiinction as receptors for the binding of inraiune cells (165). 
The surface of epithelial cells is normally covered with a layer of viscous components 
derived from the secreted products of the cell. This viscous layer is called mucus or 
extracellular matrix (ECM). It contains a variety of molecules including polysaccharides such 
as collagen, heparin sulfate, hyaluronic acid, and glycoproteins such as flbronectin and laminin 
(58). The ECM has been shown to be actively involved in mediating adherence of bacteria. 
Some extracellular matrix proteins were recently proposed as a unique class of molecules 
which mediate adherence of gram-positive bacteria to host tissue (167,245). 
When pathogens contact the epithelial surface, they first interact with the extracellular 
mauix. The mucus and its components may function as receptors for the bacteria to attach and 
multiply. In vivo multiplication of pathogens in the mucus layer may be a prerequisite for 
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subsequent adherence to epithelial cells. In some instances, the bacteria bind to mucus 
components and become restrained in the mucus layer and fail to adhere to underlining target 
cells due to the titration effects of available adhesins. 
Bacterial Adherence 
Because of the complexity of the surface structure of epithelial cells, it has become accepted 
that bacterial adhesion is a multi-phasic process involving multiple factors of bacterial and host 
origin. The first phase of bacterial adhesion involves nonspecific interaction between the 
surface components of bacterial and epithelial cells. In this phase, ionic interaction, hydrogen 
bonding, Van der Waal forces, and surface hydrophobicity may play important roles in 
determining the subsequent interaction. The second phase of bacterial adhesion involves 
specific reversible binding between surface components of bacterial and epithelial cells. As 
bacteria and epithelial ceUs are drawn closer together, specific and nonreversible binding occurs 
between bacterial adhesins and receptors on the surface of epithelial cells. The bacteria become 
firmly bound to the host epithelial cells. It is this adhesion that prevents clearance of the 
bacteria by the host's innate clearance mechanisms. 
Pathogens, such as enterotoxigenic Escherichia coli (ETEC), enteropathogenic E. coli 
(EPEC) Vibrio cholerae, and Campylobacter jejuni adhere to host tissues but lack invasive 
mechanisms while pathogens such as enteroinvasive E. coli (EEC), Listeria monocytogenes, 
and Salmonella spp. mvade following cytadherence. The ability of bacteria to adhere to the host 
tissue is mediated by specialized bacterial surface components called adhesins. Receptor 
specificity was first recognized by Dugid and Gillies as the agglutination by some bacteria of 
red blood cells and its inhibition by mannose (mannose sensitive) (55). Not all 
hemagglutination activities of bacteria were sensitive to mannose; some were insensitive or 
mannose resistant. Bacterial adhesins are normally categorized according to their location, 
morphology, and receptor specificities. Bacterial adhesins can also be divided into two groups 
according to their association with fimbriae. The first group consists of fimbriated adhesins. 
These adhesins are protein molecules located either at the tip of the fimbriae or scattered 
throughout the whole fimbriae structure. The second group consists of adhesins not associated 
with fimbriae. These adhesins can be found scattering throughout the entire bacterial surface or 
concentrating at a specialized structure at one end of the bacteria as exemplified by the 
Mycoplasma pneumoniae PI adhesin. 
Classification of adhesins based on their binding specificity results in two classes. One 
class contains adhesins with carbohydrate binding specificities similar to plant lectins. The 
interaction between lectin-like adhesins and their receptors can be inhibited by polysaccharides 
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with similar structure. The other class of bacterial adhesins is defined by non lectin-like 
interactions. This class specificity is determined by the ability of the adhesin to recognize and 
bind to amino acid sequences in the receptor proteins or bind to other surface molecules such as 
sulfated glycolipids, etc. 
Gram-positive bacteria posses lectin-like adhesins either as a component of fimbriae, as 
fibrial structures on the surface, or as non-fimbrial adhesins. Many gram-positive bacteria lack 
fimbriae and lectin-like adhesins, but nevertheless retain the ability to bind to host tissues 
through specific binding to ECM components. Bacterial surface components such as 
lipotechoic acid, peptidoglycan, and surface proteins can function as adhesins and bind to ECM 
components such as fibronectin and collagen. Selected bacterial adhesins that illustrate the 
scope of complexity from gram-negative and gram-positive bacteria as well as mycoplasmas 
will be reviewed in detail. 
E. coli Type 1 Fimbriae 
Most gram-negative bacteria posses fimbriae, surface extrusions consisting of protein 
subunits assembled into rod-shaped organelles about 7-11 imi in diameter and 0.5 to 10 jim 
long. The most common classification of bacterial adhesins is according to "type". Type 1 
refers to fimbriae that are rigid and exhibit maimose-sensitive hemagglutination. Type 2 are 
morphologically related to type 1 but do not cause hemagglutination. Type 3 are flexible 
fimbriae with maimose-resistant hemagglutination common in the Enterobacteriaceae. Type 4 
refers to fimbriae with the major subunit containing N-methylphenylalanine at the amino-
terminal end. Type 5 are mannose-sensitive, but are thinner than type 1. As more and more 
fimbrial adhesins are identified, adhesins are discovered that cannot be classified according to 
any established scheme. The latest classification scheme was proposed by Orskov and Orskov 
(162). Most E. coli strains express more than one type of fimbriae with different receptor 
specificities at any particular time during infection (131). 
Type 1 fimbriae are present in most E. coli strains. Studies have shown that type 1 fimbriae 
are associated with clinical isolates of acute urinary tract infection, chronic prostitis, 
pyelonephritis, sepsis, and meningitis of human and other animals (205). Identification of the 
type 1 fimbriae in clinical isolates was achieved by mannose-sensitive hemagglutination (234), 
serotyping (270), immunofluorescence (53), or hybridization with specific DNA probes (163, 
210). 
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Epidemiology 
Epidemiological studies failed to correlate the roles of type 1 fimbriae in bacterial infection 
in association with other types of fimbriae or virulence factors (50, 199,235). However, 
studies using animal models infected with fimbriated E. coli have suggested a critical role of 
type 1 fimbriae in infection. Jayappa et al. (99) showed that anti-fimbriae serum protected 
newborn pigs from developing colibacillosis after challenge with E. coli expressing type 1 
fimbriae. Another study using chickens experimentally infected with clinical isolates expressing 
either type 1 fimbriae or P fimbriae or both showed that type 1 fimbriae was involved in the 
early stages of development of cohsepticemia by promoting the association of fimbriated 
bacteria with the trachea and air sacs (53). Nonetheless, conflicting results have been reported 
for the exact role of type 1 fimbriae in infection (171,232). 
Genetics 
Genes coding for the assembly machinery of type 1 fimbriae have been cloned and 
characterized (131). The^m operon contains six genes that are major or minor components of 
type 1 fimbriae. Its organization is similar to operons coding for other types of fimbriae 
suggesting the presence of a conmion ancestor gene. Type 1 fimbriae is composed of 17 
kilodalton (kDa) subunits, the product offimA, assembled right-handed as a tubule with a 
diameter of 7 run and length of 10 ^im. There are about 10(X) major subunit proteins per 
fimbriae. The FimA protein does not contain mannose-specific binding activity, however, but 
appears to play only a structural role. This was demonstrated in an experiment with 
recombinant E. coli strains that failed to produce type 1 fimbriae due to a fimA deletion. These 
strains retained binding ability to mannose-coated beads (109). FimC was suggested to play a 
role in the assembly of fimbriae since mutations mfimC abolished fimbrial synthesis (107). Its 
protein sequence was highly homologous to papD, a member of the periplasmic chaperone 
superfamily. The activity of PapD can complement FimC in vitro as well as in vivo (101). 
FimD is found in the outer membrane and appears to function as an anchor for the fimbriae 
structure (108). FimF and FimG are minor proteins with molecular weights of 16 and 14 kDa, 
respectively. Functional analysis offimF and fimG mutants suggested that these two proteins 
are not associated with the fimbriae but are responsible for initiation and termination of fimbriae 
assembly (191). FimH, a 30-kDa minor protein, is the adhesin protein responsible for 
mannose-specific binding. It is located at the tip and the side of the fimbriae (117, 118). 
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Regulation 
The promoter of they?m operon is located upstream of fimA. The expression of the operon 
is regulated by temperature and DNA superhelicity. Expression of the fim operon of type 1 
fimbriae is controlled by the products of two regulatory genes located upstream (22, 106). 
FimB and FimE are basic proteins belonging to the integrase family that recognize and mediate 
inversion of an invertible 314 basepair (bp) segment containing a promoter upstream of FimA 
(56). The inversion of this segment results in an on/off phenotype of the promoter activity. The 
frequency of phase variation from off to on was measured at 10'^ per cell per generation, and 
was mediated by FimB, while phase switching from off to on was measured at 10"^ per cell per 
generation and was mediated by both FimB and FimE (140). Other factors affecting the 
regulation of phase variation of type 1 fimbriae included temperature, media (66), growth 
conditions (93,201), presence of leucine-response regulatory protein (21), integration host 
factor (IHF), and H-NS nucleoid protein (51, 161). 
Phase variants and various type 1 fimbriae mutants with modified phenotypes were used 
for studying the role of type 1 fimbriae in infection in tissue cultures and animal models. Alkan 
et al. demonstrated that phase variation occurred in vivo, and type 1 fimbriae conferred the 
advantage for the growth of E. coli in the peritoneal cavity, at least in early stages of infection 
in mice (2). Bloch et al. found that fimA mutations correlated with the loss of intestinal 
colonization in rats, while blood stream invasion was not affected (20). E. coli F-18, a human 
fecal isolate, produced type 1 fimbriae and colonized streptomycin-treated mouse large intestine 
(119, 141). E. coli strains carrying a plasmid over-expressing FimB proteins resulted in 
locking the phase in the "on" phenotype and became poor colonizers as compared to the 
parental strain (142). 
Receptors 
In general, glycoproteins and glycolipids at the surface of epithelial cells act as receptors for 
type 1 fimbrial adhesins. The sugar moieties on these glycoconjugates function as the binding 
site for the adhesins and determine the binding specificity. Type 1 fimbrial adhesins have been 
shown to mediate the agglutination of erythrocytes and yeast, the attachment of bacteria to 
buccal, respiratory, urogenital epithelial cells and leukocytes in a mannose-specific manner. 
Bacterial adherence to human colonic epithelial cells was inhibited by a-methyl marmoside 
(258). The bacteria bound to epithelial cells directly or were loosely associated with the cell 
surface. Attachment to guinea pig intestinal epithelial cells was inhibited by mannosides. 
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especially aromatic a-mamiosides. 4-methylumbelliferyl a-mannoside and p-nitro-o-
chlorophenyl a-mannoside inhibited adherence 1000 times stronger than did a-methyl 
mannoside (60). 
Bacterial agglutination of yeast, erythrocytes, and human sperm also displayed a similar 
inhibition pattern (60,149). Uropathogenic E. coli with type 1 fimbriae adhered to excised 
human ureter and bladder epithelia in a mannose-specific manner (64). Mannose-containing 
glycoproteins of tracheal epithelial cells have been suggested to be the receptor for type 1 
fimbriae (38). A 65-kDa glycoprotein in a Triton X-100 fraction of guinea pig erythrocyte 
membranes was isolated and characterized as the receptor for type 1 fimbriae adhesin. Type 1 
fimbriae inhibited the binding of fimbriated E. coli to purified glycoprotein receptors. This 65-
kDa receptor bound to concanavaUn A and type 1 fimbriae, and inhibited bacterial 
hemagglutination of guinea pig erythrocytes. The binding of receptors to adhesins was reduced 
when the glycoprotein was treated with sodium metaperiodate, endoglycosidase H, trypsin, 
and V8 protease (73). Leukocyte integrin CDl I/ODIS complex has been demonstrated as a 
receptor for type 1 fimbriae which might result in lectinophagocytosis (68). Binding of type 1 
fimbriae to leukoc5^e integrin was inhibited by methyl a-mannose and Mabs specific to 
CDl la, CDl lb, or CD 18 (69). Other leukocyte membrane glycoproteins have also been 
identified to function as receptors for type 1 fimbriae, though the consequence of these 
interactions is not fiilly understood (184, 197,198). Integral membrane glycoproteins, 
extracellular glycoproteins, or glycoproteins loosely associated with the outer membrane of 
host cells can function as receptors for type 1 fimbriae. Laminin of the extracellular matrix 
acted as receptor molecules for type 1 fimbriae (120). A rabbit intestinal mucus glycoprotein 
was identified as a receptor for type 1 fimbriae, suggesting that the mucus layer constituted a 
site for bacteria to multiply prior to colonization of epithelial cells (206). A 118-kDa 
glycoprotein of rat intestinal mucin functioned as a receptor for type 1 fimbriae and acted as the 
intermediate link between bacteria and epithelial cells (193,194). Secretory IgA has been 
proposed as a receptor for type 1 fimbriae. Secretory IgA and IgA myeloma proteins, 
especially those of IgA2 subclass, contained carbohydrate moieties for type 1 fimbriae binding 
which resulted in agglutination of fimbriated bacteria regardless of the specificity of the 
antibody molecules (257). 
Interaction with the immune system 
Immunogenicitv 
Immunization of Peyer's patches of rats with E. coli carrying type 1 fimbriae was used to 
study antibody production and homing of secretory antibodies against funbriae and bacterial 
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surface antigens. The primary immune response produced antibodies (IgA, IgG, IgM) to 
fimbriae in milk at a concentration 5 times higher than in bile (36). Repeated antigen stimulation 
resulted in the antibodies predominantly in the bile (37). In another smdy, aerosol 
immunization with fimbriated E. coli resulted in the detection of IgA in bile, but not in 
bronchoalveolar lavage. IgG were not detected in semm either (247). Similar results were also 
obtained in another study (155). 
Modulation of the immune system 
E. coli type 1 fimbriae binding to phagocytic cells via lectin-carbohydrate interactions often 
resulted in activation and degranulation of the phagocytes, and uptake and killing of the 
bacteria, a phenomenon called lectinophagocytosis (17, 23). Protein kinase C was believed to 
be involved in the activation of phagocytes (70). Preincubation of purified E. coli type 1 
fimbriae with human neutrophils augmented subsequent activation by concanavalin A, 
opsonized zymozan, or type 1 fimbriae-coated latex particles (74). Fimbriated E. coli phase 
variants stimulated phagocyte oxidative metabolism more efficiendy than non-fimbriated phase 
variants (75). Further more, type 1 fimbriated E. coli treated with specific Mab to form bundles 
of fimbriae on the cell surface activated neutrophils more effectively than did nonfimbriated E. 
coli or fimbriated E. coli without bundles (170). Differential degranulation was observed when 
neutrophils were activated with E. coli expressing type 1 fimbriae; a significant quantity of 
protease-myeloperoxidase and N-acetyl-P-D-glucosaminidase (the primary and tertiary granule 
marker, respectively) was released as compared to the release of vitamin B 12-binding protein 
(the secondary granule marker)(215, 216). Purified FimH, the minor subunit of type 1 
fimbriae responsible for the mannose-specific adherence, was a potent activator of human 
neutrophils and mast cells. This stimulation was suspected to play an important role in host 
defense against infection (134-136, 231). 
Bordetella pertussis 
Bordetella pertussis, the causative agent of whooping cough, has been the subject of 
intense study in order to better understand the mechanisms of bacteria adhesion to host 
epithelial cells. B. pertussis utilizes multiple mechanisms to adhere to tissue culture cells 
including the filamentous hemagglutinin (FHA), funbriae (agglutinogens), pertactins, and 
pertussis toxin. Fimbriae and pertactin are cell surface proteins, pertussis toxin is secreted, and 
FHA is found to be a cell surface-associated secretory protein. 
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Filamentous hemagglutinin 
The filamentous hemagglutinin mediates the adherence of B. pertussis to human respiratory 
tract epithelial cells and agglutination of red blood cells. Its structural gene,/Fia, has been 
cloned and sequenced (180). The filamentous hemagglutinin is synthesized intracellularly as a 
367-kDa preprotein and subsequently processed into a mature 220-kDa protein. Processing and 
transportation to the cell surface is required for the adherence of B. pertussis to eucaryotic cells 
(4). The FHA contains multiple domains which have unique fimctions. Rebnan et al. found 
that an arginine-glycine-aspartic acid (RGD) domain in the FHA sequence might be involved 
in adherence since a B. pertussis mutant with a FHA gene devoid of the RGD domain lost the 
ability to bind to ciliated epithelial cells (180). Arico et al. demonstrated that this RGD domain 
mediated the binding of bacteria to Chinese hamster ovary (CHO) cells (4). Another study by 
Leininger et al. indicated that an RGD-containing peptide derived firom the FHA sequence had 
no effect on the attachment of FHA to epithelial cells, prompting further studies to determine 
the function of the RGD domain in FHA molecules (125). The FHA interacted with 
macrophage galactose-containing glycoconjugates and the integrin CR3 (aMp2, 
GDI ip/CD18). The interaction between CR3 and FHA involved the RGD sequence according 
to Relman et al. (179). Ishibashi et al. demonstrated that the RGD domain promoted B. 
pertussis binding to monocytes, and this enhancement was blocked by antibodies directed 
against CR3 (96). Prasad et al. identified a carbohydrate recognition domain (CRD) located at 
the FHA amino acid sequence 1141 to 1279 that mediated the binding of FHA to 
lactosylceramide (174). In general, this region was believed to be critical for bacterial 
adherence to ciliated cells (129,174). A third domain distinct from the RGD and CRD domains 
exhibited heparin-inhibitable lectin activity. Menozzi et al. proposed that this domain might be 
important to the interaction of B. pertussis with epithelial cells or the extracellular matrix (129, 
145). Binding of B. pertussis to cultured epithelial cells was reduced by the sulfated 
polysaccharide heparin, dextran and purified FHA. Residual adherence activity of a B. 
pertussis mutant lacking FHA was not affected by the sulfated polysaccharides (145). The 
structure of FHA has also been determined. It formed monomeric rigid rods with a length of 50 
nm and had the shape of a horseshoe nail, a globular head, a 35 nm long shaft and a small 
flexible tail (133). The structure contained two regions of tandem 19 residual pseudo-repeats 
that formed P-sheets separated by P-turas. Functional domains were also mapped to the FHA 
molecule. The RGD domain was assigned to the tail region, and the putative hemagglutination 
domain was assigned to the head (133). 
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Pertactin 
Robert et al. demonstrated that a 69-kDa immunogenic surface protein of B. pertussis, P69 
or pertactin (pm), played a role in mediating adherence to HEp2 cells. This was shown by a 
double mutant,^ and pm, that was significantly less adhesive than a fha single mutant. 
However, there was no discernible difference in the binding ability between a pm mutant and 
the wild type strain (183). The P69 protein has been purified and shown to attach to CHO cells 
(126). The attachment was inhibited by an RGD-containing peptide with homology to a region 
in the P69 protein. A mutant lacking P69 exhibited a reduced adherence to CHO and HEp2 
cells. Leininger et al. first used the term pertactin to refer to the P69 protein (126). Over-
expression of pertactin didn't seem to have an effect on the binding of B. pertussis to cultured 
cells (130). The stmcture of pertactin was determined by X-ray crystallographic studies (57). 
Pertactin appeared to contain a 16-stranded parallel (3 helix with a V-shaped cross-section. 
Several putative functional domains were also identified in the same study. 
Pertussis toxin 
Pertussis toxin (PTX) secreted from B. pertussis not only functioned as the major 
pathogenic determinant in damaging host epithelial cells through ADP-ribosyltransferase 
activity of the SI subunit, but also mediated bacterial adhesion to ciliated epithelial cells and 
macrophages (237,238). The binding domains of PTX were localized to the B oligomer. The 
subunits 82 and S3 of the B oligomer of PTX, but not S1 or S4 subunits, participated in the 
adherence of B. pertussis to human macrophages (241). The S2 subunit recognized ciliary 
lactosylceramides, and the S3 subunit recognized leukocyte gangliosides (196). 
Fimbriae 
B. pertussis produces several serotype-specific agglutinins. Serotype 2 and serotype 3 
epitopes have been located on the fimbriae by use of type-specific Mabs in an immunoelectron 
microscopic study (9). Each type of agglutinin associated with fimbriae individually or 
simultaneously. These agglutinins constituted the major subunits of the fimbriae. A third 
serotype, X, was characterized as a silent fimbrial subunit gene. The genes coding for these 
agglutinins, y?m2,yi/ni, and fimX, have been cloned and sequenced (127, 151, 168) Willems 
et al. identified three additional fimbrial genes m a gene cluster located directly downstream of 
the fha gene (249,250). One of these genes, fimB, was homologous to chaperone-like fimbrial 
proteins. jzmC was homologous to a class of outer membrane proteins involved in 
transportation and anchorage of fimbrial subunits. FimD was suggested to be the fimbrial 
adhesin based on high homology to MarK, a fimbrial adhesin from Klebsiella pneumoniae 
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(249). Interestingly, an in-frame deletion in fimD totally abolished FimD expression and also 
affected the expression of Fim2 and FimS. 
The role B. pertussis fimbriae play in pathogenesis is not well defined although it has been 
incorporated in different types of subcellular vaccines as an active component (102). Mooi et 
al. demonstrated that FHA played a more crucial role than fimbriae in the colonization of the 
mouse upper respiratory tract, while the persistence of B. pertussis in the lung was not affected 
by fimbriae expression (150). Funnell et al. showed that a Jim negative mutant of B. pertussis 
adhered less well to the tracheal ring of Papio snubis than to Vero cells. The authors suggested 
that B. pertussis fimbriae might be important in the initial stages of colonization (65). Pertactin, 
FHA, and fimbriae mediated the binding of B. pertussis to monocytes. Mutant strains of B. 
pertussis lacking fimbriae bound less efficientiy to monocytes (86). Fimbriae bound to 
monocytes through the surface interaction of FimD with Very Late Antigen-5 (VLA-5) (87). 
The interaction between FimD and VLA-5 also activated CR3 which resulted in an enhanced 
binding of B. pertussis to monocytes (87). Recentiy, Geuijen et al. demonstrated that fimbrial 
binding to sulfated sugars and HEp2 cells was mediated by the major subunit of fimbriae. The 
binding was not dependent on the minor fimbrial subunit. However, both FHA and fimbriae 
were required for this binding (72). 
Streptococcus pyogenes 
The lack of genetic systems has deterred the smdies of adhesion mechanisms of gram-
positive bacteria until recentiy. Nevertheless, a great deal of progress has been made (245). 
Surface components of some important Gram positive pathogens have been smdied in detail for 
their possible roles in bacterial adhesion to host cells (166). These components include mucin 
(polysaccharide), capsule (usually hyaluronic acid), techoic acid (TA, polyribotol phosphate), 
lipoteichoic acid (LTA, poly glycerol phosphate), and surface proteins such as M protein and F 
protein. It is generally believed that multiple mechanisms are involved in adhesion of gram-
positive bacteria to host tissues. 
S. pyogenes colonizes pharyngeal epithelial cells and causes pharyngitis by releasing toxins 
which may result serious complications, and by causing host inflammatory responses. 5. 
pyogenes binds to various host-derived proteins including albumin, fibronectin, a2-
macroglobulin, immunoglobulin G, laminin, plasmin, collagen type FV, salivary glycoproteins, 
mucins, basement membrane proteins, and haptoglobin. Some of these proteins have been 
studied in detail and proven to be critical in S. pyogenes cytadherence, the remaining proteins 
merit more investigation. 
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Lipoteichoic acid 
Lipoteichoic acid is the major adhesin of S. pyogenes mediating attachment to buccal, and 
pharyngeal, and phagocytic cells (28,35,239). Preparations of LTA inhibited the adherence of 
5. pyogenes to epithelial cells and was shown to protect against S. pyogenes challenge in a 
mouse study (39). Antibodies against the polyglycerol phosphate backbone of LTA also 
inhibited the cytadherence activity (15). Immunoelectron microscopic and ultrastructural studies 
of 5. pyogenes established that LTA was located on the outer cell surface (192). In a study 
using protoplasted S. pyogenes, Mattingly et al. revealed that LTA of S. pyogenes was 
released into the envirormient The released LTA became anchored in the bacterial membrane. 
The exposed hydrophobic domain (glycolipid) of LTA interacted with epithelial cell surface. 
Deacylated LTA preparations had no effect on this interaction (138). 
The receptor for LTA has been identified as fibronectin deposited on the mucosal epithelial 
cell surface (13). Binding sites on fibronectin for LTA from S. pyogenes were located in a 28-
kDa fragment of the N-terminal region. In contrast, LTA from Staphylococcus aureus reacted 
with the 28-kDa fragment, a 23-kDa fragment and other high molecular fragments, suggesting 
that different bacteria may interact with different fibronectin domains (13,14,209). 
M protein 
The M protein is secreted by S. pyogenes and becomes associated with the bacterial cell 
wall. It displays antiphagocytic activity by binding to serum factor H resulting in inactivation of 
the C3b complex (169). Other studies, however, suggested a role of M protein in adherence of 
S. pyogenes to epithelial cells. Expression of M protein correlated with the ability of S. 
pyogenes to adhere to epithelial cells after high in vitro passage of clinical isolates (221). 
Secretory IgA directed against M protein also blocked the adherence of S. pyogenes to nasal 
mucosal cells (121), but isogenic S. pyogenes strains lacking the ability to express M protein 
adhered to buccal, pharyngeal, or tonsillar epithelial cells. This suggested that M protein was 
not the primary adhesin although M protein promoted the aggregation of S. pyogenes to 
tonsillar epithelial cells (27, 35). In contrast, M protein-expressing strain of S. pyogenes 
bound to HEp-2 cells and mouse oral epithelial cells more effectively than did isogenic strains 
lacking M protein. The binding was inhibited by M protein treated with pepsin (33, 35,243). 
The Ugands on the HEp-2 cell surface were identified as two glycoproteins of 97 and 205 kDa 
which differed from fibronectin. These two glycoproteins were sensitive to trypsin, 
chymotiypsin, and heat (243). Binding of M protein to HEp-2 cells was inhibited by several 
fucose-containing oligosaccharides which might be present in these two glycoproteins (244). 
M protein mediated the binding of S. pyogenes to keratinocytes represent a possible role of M 
15 
protein in S. pyogenes skin infections (159). A C-repeat domain in M protein was found 
responsible for the adherence to the keratinocyte receptor, CD46 (160). 
Other S. pyogenes surface proteins were found to be involved in bacterial adhesion. 
Protein F, a 74-kDa protein characterized by Hanski et al, binds to fibronectin (82). Its gene 
was cloned, and the recombinant protein F expressed in E. coli showed high affinity binding to 
fibronectin. Mutant S. pyogenes strain lacking protein F expression had a lower binding 
activity to respiratory epithelial cells. Interestingly, expression of protein F was 
environmentally regulated in response to atmospheric oxygen concentration (242). Its role in 5. 
pyogenes pathogenesis was suggested (82, 83, 159). Sequence and functional analysis of the 
protein F gene revealed that there were two repeat domains, RD2 and UR, required for 
maximal fibronectin binding. Functional assays showed that these two domains bound to 
different parts of fibronectin (164). 
Talay et al. also identified a 71-kDa fibronectin binding protein, Sfb, having a high degree 
of homology to Protein F. Sfb protein was also a putative adhesin for S. pyogenes binding to 
epithelial cells (230,240). The Sfb gene was cloned, and recombinant protein made in E. coli 
bound to fibronectin and HEp-2 epithelial cells. A 37 amino acid sequence repeated 4 times 
was found to constitute the binding domain of the Sfb protein. Purified Sfb protein inhibited 
binding of fibronectin to S. pyogenes as well as the adherence of bacteria to epithelial cells. 
This repeat sequence had a high degree of homology to the 38 amino acid D3 repeat of the 
fibronectin binding protein of S. aureus (230). A two-step model for the adhesion of S. 
pyogenes to epithelial cells has been proposed in which the binding of LTA (anchored to the 
membrane LTA binding protein) to fibronectin preceded a secondary binding of another 
bacterial adhesin to a host receptor (85, 156,208). A 54-kDa protein exhibited binding activity 
to fibronectin and fibrinogen was also cloned by Courtoey et al. (34). This protein was 
suggested to participate in the adhesion of S. pyogenes to host cells. 
Mycoplasmas 
Mycoplasmas constitute a unique group of bacteria which are believed to have evolved 
from Gram positive bacteria. These bacteria lack the peptidoglycan cell wall and outer 
membranes that are characteristic to gram-positive and gram-negative bacteria, respectively. 
Mycoplasmas contain only a single membrane separating their cytoplasm firom the extracellular 
environment. They are classified in the class Mollicutes with more than 1(X) recognized 
species. The class Mollicutes includes four orders: order Mycoplasmatales containing the 
family Mycoplasmataceae; order Entomoplasmatales containing the families 
Entomoplasmataceae and Spiroplasmataceae; oxdsx Acholeplasmatales containing a single 
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family Acholeplasmataceae, and oxdex Anaeroplasmatales containing a single family 
Anaeroplasmataceae (236). The class Mollicutes also includes several uncultivated or 
unclassified mycoplasma like organisms sometimes referred to as MLOs. The generic term 
mollicutes will be used throughout this dissertation to refer to all members of the class 
Mollicutes in a general way. The term mycoplasma will be used to refer only to the members of 
the family Mycoplasmataceae, genera Mycoplasma and Ureaplasma. The term acholeplasma 
will be used to refer to the members of the family Acholeplasmatales. 
Mycoplasmas represent the smallest living organisms known. They are approximately 0.3 
in diameter and can range up to nearly 100 jun in length for some spiroplasmas. Because 
of their small size and pleomorphic structure, mollicutes were once thought to be viruses 
because they can pass through filters. Mycoplasmas also have the smallest known genome 
ranging in size from 580 to 1,700 kb with a low G+C content ranging from 23 to 41%. Codon 
usage for most mycoplasmas, except the acholeplasmas, differ from that of other eubacteria. 
The codon UGA codes for tryptophan in mycoplasmas rather than functioning as a stop codon 
as in other organisms. The small genome of mycoplasmas suggests that there is limited coding 
capacity for protein synthesis. Therefore, they lack the biosynthetic capacity of other bacteria, 
requiring complex media with serum in vitro or are noncultivable. Most mollicutes are parasitic 
to human, animals, insects, or plants. Pathogenic mycoplasmas colonize respiratory and 
urogenital tracts of humans and animals where they form a close association with host epithelial 
cells. This close association is believed to allow mycoplasmas to extract nutrients directly from 
epithelial cells. Exchange of membrane components between mycoplasmas and host cell 
membranes has been documented (253). Surrounded by an amorphous layer of polysaccharide 
capsule, mycoplasmas lack any recognizable appendages such as flagella or fimbriae. 
However, some species of mycoplasmas including M. pneumoniae, M. gallisepticum, M. 
pulmonis, and M. genitalium exhibit a flask-shaped polarity of the cell body (176). 
Cytadherence and gliding motility have been demonstrated to be associated with the flask-shape 
organelle of mycoplasmas (24). 
Mycoplasma pneumoniae 
Since mycoplasmas lack cell walls, they have often been chosen as models to smdy 
membrane structure and fiinction. Mycoplasmal membranes are made of a diverse group of 
lipids including neutral lipids, glycolipids, and phospholipids which are the most abundant. 
Unlike other eubacterial membranes, mycoplasmas contain sterols, in most instances 
cholesterol, as a major component of the membrane. Cholesterol is required for the normal 
growth of mycoplasmas which can be supplied exogenously or obtained from the in vivo 
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environment, possibly the host's cell membrane. To effectively derive cholesterols and other 
nutrients from the host, mycoplasmas need to adhere closely to epithelial cells. 
Ei 
Most studies of mycoplasma cytadherence have been performed with M. pneumoniae, a 
human pathogen that causes atypical pneumonia (walking pneumonia) in children (>3 years) or 
young adults (10, 111, 176,181). Powell et al. examined the attachment of radiolabeled M. 
pneumoniae to hamster tracheal ring organ cultures. Virulent M. pneumoniae was found to 
attach to the luminal surface of epithelial cells, while avirulent Af. pneumoniae failed to interact 
with the epithelial cells (173). The pretreatment of tracheal rings with neuraminidase or sodium 
periodate significant reduced cytadherence. Electron microscopic studies by Wilson et al. 
revealed that Af. pneumoniae adhered to non-ciliated epithelial cells of tracheal ring organ 
cultures using its differentiated tip structure sometimes referred to as the attachment organelle 
(252). This study also revealed that the attachment organelle had a dense central rod 
surrounded by a translucent space. Close association between M. pneumoniae and human 
RBCs was also demonstrated by scanning electron microscopy (175). M. pneumoniae attached 
to the RBC surface which resulted in an indentation at the site of attachment. The use of Mabs 
specific to the attachment organelle also confirmed its involvement in cytadherence. Adherence 
to erythrocytes in vitro could be inhibited by Mabs specific for the attachment organelle. 
Pretreating virulent M. pneumoniae with these Mabs significanUy reduced the lung lesions in 
hamster (26). 
The nature of the M. pneumoniae adhesin(s) has been studied by Razin et al. (177). 
Trypsin treatment of M. pneumoniae cells abolished the ability to attach to human RBCs 
suggesting a protein nature of the adhesins. Hu et al. identified a surface protein, PI, with an 
estimated molecular weight (MW) of 179 kDa as the major adhesin of M. pneumoniae (II, 90, 
91). Monoclonal antibodies against PI reacted with a region of the attachment organelle 
covered with peplomer-like particles and inhibited the attachment of M. pneumoniae to host 
cells (90). The PI gene has been cloned using an oligonucleotide probe derived from the N-
terminal amino acid sequence of purified PI protein (227). Sequence analysis revealed that the 
gene contained a 4,881 bp open reading frame (ORF) encoding a protein with a predicted 
molecular weight (MW) of 176 kDa. Secondary processing of the 176-kDa protein by cleavage 
at the putative proteolytic recognition site resulted in a mature protein with a predicted MW of 
169.8 kDa (227). Southern hybridization of Af. pneumoniae genomic DNA using an internal 
PI probe established that the PI structural gene or gene sequence existed as multiple copies 
(225). Southern hybridization and restriction fragment length polymorphism (RFLP) analysis 
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of the PI gene was used to the classify M. pneumoniae clinical isolates into two distinct groups 
(43,226). Cross-hybridization between adhesin genes of M pneumoniae, M. genitalium, and 
M. gallisepticum was observed under low stringency conditions indicating the existence of a 
family of adhesin-related genes among pathogenic mycoplasmas (40). The relationship of 
cytadhesins from different mycoplasmal species was also investigated by the cross-reactivity in 
immunoblot analysis (153). Infection with virulent strains of M. pneumoniae stimulated 
humoral responses in guinea pigs (97). Immunizing guinea pigs with purified M. pneumoniae 
PI protein stimulated systemic and local humoral antibody responses along with the production 
of cytadherence inhibiting antibodies. In the same study, however, the immune response was 
not protective against subsequent challenge with Af. pneumoniae and actually accentuated 
disease (98). 
Little is known about the receptors for the PI adhesin, but cytadherence studies of M. 
pneumoniae have produced some important results. Krivan et ai. investigated the binding 
specificities of radiolabeled Af. pneumoniae to various types of glycolipids and glycoproteins 
(115, 116,182). M. pneumoniae bound strongly to sulfatide and sulfated glycolipids such as 
seminolipid and lactosylsulfatide all of which contain a terminal Gal (3S04)Pl linkage. Only 
metabolically active M. pneumoniae cells bound to sulfatide. Dextran sulfate inhibited binding 
of M pneumoniae to purified sulfatides. Dextran sulfate also partially inhibited the binding of 
M pneumoniae to cultured human colon adenocarcinoma cells (WiDr) (115). Af. pneumoniae 
also bound to glycoproteins including laminin, fetuin, and human chorionic gonadotropin in a 
dose-dependent and saturable manner. Adhesion was energy dependent since no attachment 
occurred in media without glucose. The presence of a terminal neuraminic acid cx2,3-pi,4-N-
acetylglucosamine linkage was required for binding since soluble laminan, asparagine-linked 
sialyloligosaccharides fi-om fetuin, and 3'-sialyllactose, but not 6'-sialyllactose, inhibited 
attachment of M. pneumoniae to laminin. Dextran sulfate and 3'-sialyllactose did not inhibit 
attachment to lamdnin and sulfatide, respectively, suggesting two distinct receptor specificities 
for the Af. pneumoniae adhesion. Both 3'-sialyllactose and dextran sulfate partially inhibited 
binding of Af. pneumoniae to WiDr cells; the combination of the two glycoconjugates inhibited 
binding by 90% (182). 
The PI operon contains the PI gene flanked by two ORFs 4 and 6 with a coding capacity 
for 28-kDa and 130-kDa proteins, respectively (94). The latter protein is processed into two 
proteins of 40 and 90 kDa both of which are membrane-associated (122). Spontaneous mutants 
of M. pneumoniae lacking the 40- and 90-kDa proteins exhibited reduced adherence to host 
cells suggesting the participation of these two proteins in Af. pneumoniae cytadherence. This 
was confirmed by nearest-neighbor analysis in which the homobivalent, thio-cleavable, and 
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nonmembrane-permeating cross-linking reagent 3,3' dithiobis (sulfosuccinimidylpropionate) 
was used to treat Af. pneumoniae. The resulting cross-linked protein complex was 
immunoprecipitated with antibody against PI, 40-kDa, or 90-kDa proteins. Immunoblot 
analysis indicated that PI, the 40- and 90-kDa proteins, and an unidentified 30-kDa protein 
were positioned at a maximal distance of 1.2 nm on the attachment organelle of M pneumoniae 
(123). Southern hybridization and DNA sequence analysis has demonstrated that the ORF6 
sequence existed as multiple copies in the M pneumoniae genome (190). 
P30 
Another M. pneumoniae surface protein involved in cytadherent activity has been identified 
and characterized. P30 was first observed as a 32-kDa trypsin-resistant protein associated with 
hemadsorption activity. Hemadsorption negative strains of Af. pneumoniae were avirulent and 
noncytadherent (113). Immunoelectron microscopic studies using colloidal gold-labeled 
antibody revealed that P30 proteins were clustered at the attachment tip (12). The P30 gene has 
been cloned and sequenced. It consists of an ORF of 825 nucleotides with a coding capacity 
for a protein of predicted MW of 29.7 kDa (42). Three types of proline-rich 6-amino-acid 
repeat sequences (PGMAPR, 7 repeats; PGMPPH, 3 repeats; PGFPPQ, 3 repeats) were 
identified at the carboxyl end of P30. These repeat sequences exhibited a significant degree of 
homology to the PI adhesin protein. The importance of proline-rich repeat sequences of P30 in 
cytadherence was demonstrated by the identification of spontaneous hemadsorption negative 
mutants carrying a deletion in the P30 gene resulting in the expression of a 25-kDa protein 
lacking 8 of the 13 proline-rich 6-amino-acid repeat sequences (11,12,44, 113). Involvement 
of proteins other than the PI and P30 adhesins in cytadherence of Af. pneumoniae was also 
proposed by these studies. 
HMW cytadherence accessory proteins 
M. pneumoniae undergoes phase variation in its cytadherence phenotype with concomitant 
loss or reacquisition of several high molecular weight proteins. These proteins, HMWl 
through HMW5, range in molecular weight from 140 to 340 kDa by SDS-PAGE gel analysis 
(11, 12, 113, 218). Peptide mapping and Triton-Xl 14 partitioning demonstrated that HMWl 
and HMW4 were stracturally related membrane proteins associated with the detergent-insoluble 
cytoskeleton-like triton shell of the M. pneumoniae attachment organelle (219). Subsequent 
studies, however, showed that HMW4 was a modified product of HMWl arising during 
sample preparation for gel electrophoresis (78). Immunogold labeling of Triton-extracted Af. 
pneumoniae localized HMW3 to the triton shell of the attachment organelle, but HMW3 did not 
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appear to be membrane associated (220). HMW5 was identified as a very high molecular 
weight protein (>340 kDa in nonreducing gel) that was absent in the noncytadherent phase 
variant of M. pneumoniae. In nonreducing-reducing two dimensional gel electrophoresis, 
HMW5 dissociated into a single peptide of molecular weight at 190 kDa that co-migrated with 
HMW2 (218). 
Cloning and physical mapping of cytadherence related genes revealed the existence of three 
distinct loci in the Af. pneumoniae genome. The PI operon has already been discussed. The 
second locus contained HMW2 as the second gene of a four gene operon (cr/ operon, 
cytadherence regulatory locus). The HMW2 gene was flanked by an upstream P65 gene and 
two downstream genes coding for P24 and P41 (111). The third locus, the hmw gene cluster, 
included genes coding for P30, HMWl, HMW3, and five unknown ORFs (48, 112, 157, 
158). Sequence analysis of hmw3 revealed an ORF with a coding capacity of molecular weight 
of 73.7 kDa. This was in disagreement with the 140 kDa size of HMW3 obtained by SDS-
PAGE analysis. The authors suggested that it was due to the presence of an unusual 
distribution of charged residues, a high degree of hydrophilicity, and a high proline content in 
HMW3, the combined effects of which resulted in anomalous migration in SDS-PAGE gel 
electrophoresis (158). 
Mycoplasma hyopneumoniae 
M. hyopneumoniae, originally named M. suipneumoniae, causes Enzootic Pneumonia of 
Pigs (EPP), a chronic pneumonia characterized by a persistent and nonproductive cough (228). 
Af. hyopneumoniae infection is a worldwide phenomenon and leads to a reduction in the 
weight gain/feed ratio which results in great economic loss (172,185, 186). Af. 
hyopneumoniae infects pigs older than 5 to 7 weeks with an incubation period of 10 days to 3 
weeks or longer prior to the appearance of clinical signs, a sporadic nonproductive cough that 
persists for 6 weeks or longer. Gross lesions in the lung can be detected 7 to 10 days after 
infection. These lesions develop fully in 20 to 30 days and gradually resolve (186,246). Other 
mycoplasma species isolated from swine include Af. hyorhinis, Af. hyosynoviae, and Af. 
flocculare. The roles these mycoplasmas play in EPP are not clearly defined except that Af. 
hyosynoviae is known to cause nonsuppurative arthritis without polyserositis in pigs (31). 
Most studies of Af. hyopneumoniae has been limited to diagnosis of EPP and detection of 
the infectious agent. Diagnostic techniques based on antibody production include complement 
fixation (152), hemagglutination (61,260), enzyme-Unked inmiunosorbent assays (ELISA) 
(49, 124), immunofluorescent assays (2(X)), and indirect inraiunoperoxidase assays (52) have 
been developed and evaluated (16,188). Specific DNA sequences identified in the Af. 
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hyopneumoniae genome have been developed as diagnostic tools for identification purposes by 
DNA hybridization (1, 100,217). DNA probes labeled with "P, or '^'l have been used to 
detect 10 pg of mycoplasma DNA (equivalent to 10* organisms)(217). Recent developments in 
PCR techniques have greatly improved the detection and diagnosis of M. hyopneumoniae 
infections. Several PCR protocols based on specific M. hyopneumoniae genomic DNA 
sequences have been developed (5, 6, 84, 139). 
Attempts to eradicate the disease or confine the spread of infection have been 
unsatisfactory, due to the difficulty in detecting the infection early and the lack of effective 
antimicrobial agents to treat the disease (54,76). Administration of antimycoplasmal antibiotics 
in feed has been demonstrated to have some benefits in improving the weight gain and feed-
conversion, but failed to eradicate or prevent the infection (32, 80, 81, 187). Higher cost 
incurred by the use of antibiotics with limited benefits has prompted the development of 
effective vaccines for swine mycoplasmal pneumonia. 
M. hyopneumoniae infection stimulates both cell-mediated and humoral immune responses 
in natural infected and experimentally-challenged swine (114,147,262). Sheldrake showed 
that in experimentally-challenged animals, antibodies were detected 10 days after infection and 
continued to rise for another 50 days. In a field study by the same authors, 97.7% of animals 
sero-converted during the period from 86 to 144 days of life (202). Antibodies found in the 
lung were of the IgG class, whereas in the tracheal lamina propria, the majority of the 
antibodies were of the IgA class (147,204). M. hyopneumoniae infection stimulates alveolar 
macrophage phagocytic fimctions, but suppresses the macrophage responses to secondary 
pathogens (29). Sodium azide-inactivated M. hyopneumoniae had immunosuppressive effects, 
reducing PHA-induced lymphocyte activation (105). Membrane preparations of Af. 
hyopneumoniae had moderate nonspecific stimulatory effects on porcine lymphocytes (146). 
Dextran sulfate, however, appeared to enhance the immune response to immunization with M. 
hyopneumoniae (104). Co-incubation of peripheral blood neutrophils with M. hyopneumoniae 
resulted in an increased intracellular calcium concentration suggesting an altered signal 
transduction in neutrophils (46). M. hyopneumoniae infection also caused increased levels of 
IL-1, IL-6, TNFa, and prostaglandin E2 in bronchoalveolar lavage fluids which may be 
associated with the development of lung lesions (7,8). Antisera to M. hyopneumoniae antigens 
have been used to identify mycoplasmal antigens potentially useful for effective vaccine 
development. Young et al. recognized five M. hyopneumoniae antigens of molecular weights 
110,64,50,41, and 36 kDa with hyperimmune sera (261). Some of these antigens cross-
reacted with sera from animals immunized with M. flocculare and M. hyorhinis. Wise et al. 
identified four Af. hyopneumoniae surface antigens including p65, p50, p44, and p41 (254). 
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The same authors also established that p65, p50, and p41 are hydrophobic membrane 
lipoproteins (103,255). A species-specific 36-kDa inmiunodominant protein from M. 
hyopneumoniae was identified, and its gene has been cloned. Sequence analysis revealed that 
the gene coded for the lactate dehydrogenase of Af. hyopneumoniae (79,222). An ELISA 
assay based on lactate dehydrogenase of M. hyopneumoniae was developed for diagnostic 
purposes (62). 
Several vaccines have been developed to help prevent M. hyopneumoniae infection (110, 
128,154,189,203). Ross et al. demonstrated that whole cell vaccines containing 10' CCUs 
were partially protective against the development of pneumonia, whereas freeze-thaw-saline 
solution extracts were inconsistent in protective activity, and in some instances, enhanced 
lesion development (189). M. hyopneumoniae membrane preparations were partially protective 
and enhanced elimination of Af. hyopneumoniae from the respiratory tract of piglets (110). 
Formalin-treated M. hyopneumoniae vaccines appeared to reduce lung lesion scores when 
administered intraperitoneally (203). 
Since bacterial adherence to epithelial cells is a prerequisite for pathogen colonization, 
interference with bacterial adherence by the immune response would most likely prevent 
infection. Therefore, studies to identify and characterize M. hyopneumoniae adhesins has 
become increasingly important to better understand adherent mechanisms and to assist in the 
development of more effective vaccines. 
Electron microscopic studies of the respiratory tract of pigs experimentally-infected with Af. 
hyopneumoniae have revealed gross lesions in the lung tissue, mild lesions in the trachea and 
bronchia with epithelial hyperplasia, and infiltration of the lamina propria by inflammatory 
cells. Af. hyopneumoniae covered the tufts of cilia of ciliated epithelial cells in the mid trachea 
and bronchi during infection. Association of M. hyopneumoniae and cilia was predominantly at 
the top of the cilia. Evenmally the infection resulted in loss of cilia and desquamation of 
epithelial cells (19, 143,229). M. hyopneumoniae cytadherence has been studied in several in 
vitro systems including cultured swine tracheal rings (45,251), lung fibroblasts (71), 
respiratory tract ciliated epithelial cells (267), and kidney cells and human lung fibroblasts 
(269). These studies reinforced the cytopathic effects observed in animals infected with M. 
hyopneumoniae. 
Preincubation of Af. hyopneumoniae with dextran sulfate, ammonium sulfate, magnesium 
sulfate, and methionine reduced attachment (267). Treatment of the mycoplasmas with 
periodate, trypsin, and formaldehyde reduced the adherence to cultured monolayer cells (269). 
Convalescent serum or lung lavage fluids from swine with pneumonia inhibited the attachment 
of Af. hyopneumoniae to isolated ciliated epithelial cells (267,269). These results suggested an 
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adhesin-receptor interaction mediating the adherence of Af. hyopneumoniae. A microtiter plate 
adherence assay (MPAA) has been developed by Zhang et al. Af. hyopneumoniae bound 
specifically to microtiter plates coated with purified swine tracheal cilia which contained the 
receptors for M. hyopneumoniae (266). The binding was dependent on the concentration of 
cilia and the number of mycoplasmas. Dextran sulfate, heparin, chondroitin sulfate, laminin, 
mucin, and fiicoidan significantly inhibited the binding of mycoplasmas. Pretreatment of cilia 
with metaperiodate decreased binding suggesting the glycoconjugate nature of the receptors 
(266). Thin layer chromatography of lipid extracts from cilia over layered with radiolabeled M. 
hyopneumoniae led to the identification of three putative ciliary glycolipid receptors (La, Lb, 
and Lc) (263). These glycolipids appeared to be sulfated glycolipids as determined by laminin 
binding and staining with azure A. Binding of M. hyopneumoniae to these three lipids was 
blocked by dextran sulfate, heparin, chondroitin sulfate, mucin, and fiicoidan. These 
glycolipids also blocked the adherence of M. hyopneumoniae to cilia and ciliated epithelial cells 
(263). A putative adhesin protein of M. hyopneumoniae was identified and characterized 
biochemically (264). Two Mabs, F2G5 and F1B6, were isolated which inhibited the adherence 
of M. hyopneumoniae to cilia. The Mabs reacted with multiple proteins in immunoblot analysis 
of M. hyopneumoniae antigen preparations. The dominant protein had a molecular weight of 
97 kDa (designated as P97). Affinity chromatography with immobilized Mab F2G5 was used 
to partially purify the P97 protein. P97 protein bound to cilia and blocked the adherence of M. 
hyopneumoniae to cilia. Immunoelectron microscopy localized P97 to the surface of M. 
hyopneumoniae. These results suggested that P97 was a M. hyopneumoniae adhesin mediating 
the adherence of mycoplasma to cilia of swine tracheal ciliated epithelial cells (264). 
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MATERIALS AND METHODS 
Bacterial Strains and Plasmids 
Bacterial strains and plasmids included in this study are listed in Table 1. E. coli strains 
were grown in LB medium (195). X was grown on E. coli using LB phage agar and soft agar 
overlays as described (195). All Af. hyopnewnoniae strains were a gift of Dr. R. F. Ross 
(Iowa State University). M. hyopneumoniae was grown in modified Friis medium (63). The 
medium contained (per liter) 15.625 ml solution A (160 g NaCl-8 g KCl-2 g MgSO^ 7'H20-2 
g MgClj 6«H2C)-2.8 g CaClj per liter), 15.625 ml solution B (3 g Na2HP04 per liter), 5.125 g 
Brain Heart Infiision (Difco Laboratories, Detroit, Mich.), 5.435 g PPLO w/o CV (Difco), 
1.125 ml phenol red (1% in 50% ethanol), 10 ml Cefobid (2.5 mg per ml in 50% ethanol), 
37.5 ml fresh yeast extract, 206.25 ml acid-adjusted porcine serum (20% final concentration) 
and tissue culture grade water to bring the final volume to 1 liter. The medium was mixed and 
then passed sequentially through 3.0,0.8,0.45, and 0.2 |im cellulose nitrate membrane filters 
(Cat. No. 7188 004, Whatman Limited, Maidstone, UK) in Nalgene reusable filter holders 
(Cat. No. 300, Nalgene Nunc International, Milwaukee, Wis.). The final filtrate was sterilized 
by filtration through 0.2 |xm Falcon 7111 bottle-top filters (Becton Dickinson & Company, 
Lincoln Park, NJ). Friis plates were prepared by mixing filter-sterilized 2X concentrated Friis 
medium with an equal volume of 2% molten sterile noble agar (Difco). All cultures were 
maintained at -70°C. Plasmids were stored at -20°C. M. hyopneumoniae specific primers (6) 
were used to confirm the M. hyopneumoniae strains. 
Reagents and Buffers 
Chemicals, porcine serum, ampiciUin were purchased from Sigma Chemical Co. (St. 
Louis, Mo.). Restriction enzymes, T4 DNA ligase, DNA polymerase Klenow fragment, Taq 
DNA polymerase, calf intestinal alkaline phosphatase, and ribonuclease A were purchased 
from Promega Corporation (Madison, Wis.), GDBCO BRL (Gaithersburg, Md.), and New 
England Biolabs (Beverly, Ma.). Agarose was purchase from Bio-Rad Laboratories (Hercules, 
Calif.). Isopropyl thiogalactoside (IPTG) and X-gal were obtained from Gold Biotechnology, 
Inc. (St. Louis, Mo.). Alkaline phosphatase-conjugated, affinity-purified antibodies to mouse 
immunoglobulins was obtained from Organon Teknika Corp. (West Chester, Pa.). ^^P-
Deoxyribonucleotides were purchased from ICN Biomedicals (Irvine, Calif.). Mab F1B6 and 
swine cilia were the gift of Dr. R.F. Ross (Iowa State University). Buffers used in this study 
are listed in Table 2. 
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Table 1. Bacterial strains and plasmids 
Bacterial strain or 
Dlasmid Genotype or ohenotvpe* Source 
Af. hyopneumoniae 
J Avirulent nonadherent strain R.F. Ross 
232A Virulent adherent strain R.F. Ross 
144L Virulent field isolate R.F. Ross 
232A.H High adherent clonal isolate of 232A, 232A91 P3 R.F. Ross 
232A.M Medium adherent clonal isolate of 232A, 232A20 PIO R.F. Ross 
232A.L Low adherent clonal isolate of 232A, 232A61 P3 R.F. Ross 
E. coli 
DH5a 
LE392 
XLl-BlueMRF' 
SOLR 
BW22 
DPWC 
ISM612 
Plasmid 
pMOB 
pMOB::TniaW 
pSK(-) 
pKS(-) 
pISM1136 
pISMllS? 
pISM1138 
pISM1161 
pISM1165 
pISM1168 
pISM1169 
(j)80d/acZDMi5 endl recAl fisdRl? supE44-l gyrA 
relAl F MlacZYA argF)U169 
F hsd514{Tk\ mk") lacY supE44 supF58 galK2 galT22 
trpR55 metBl X' 
MjmcrA) AimcrCB-hsdSMR-mrr)173 endAl supE44 
thi-1 recAl gyrA96 relAl lac F' 
el4~(mcrA) k(jncrCB-hsdSMR-mrf)171 sbcC recB 
recJ uvrC lac gyr96 relAl thi-1 
endAl A, \]B'proAB lacfiZDlS] Su' (nonsuppressing) 
FKan'' 
supE43 ArecA (Sstl-EcoRI) srl::TnlO(te^) F 
LE392 (pISM3001) Cm'" 
pMOB with TnlOOO insert 
pSK- with a 5.3 kb M. hyopneumoniae chromosomal 
fragment, pISM2136A+ 
pSK- with a 5.3 kb M. hyopneumoniae chromosomal 
fragment, pISM2136A+ 
pSK- with a 7.1 kb M. hyopneumoniae chromosomal 
fragment, pISM2136A+ 
pSK- with 3.3 kb £coRI fragment from P97 region 
pSK- with a 6.6 kb M. hyopneumoniae chromosomal 
fragment, pISM2136C+ 
pSK- with a 5.5 kb M. hyopneumoniae chromosomal 
fragment, pISM2136C+ 
pSK- with a 5.9 kb M. hyopneumoniae chromosomal 
fragment, pISM2136C+ 
Stratagene 
Stratagene 
Gold 
Biotechnologies 
Gold 
Biotechnologies 
(211) 
Gold 
Biotechnologies 
this smdy 
(3) 
(3) 
this study 
this study 
this study 
this study 
this study 
this study 
this study 
* pISM2136A, clone identified using the entire 615 bp insert of pISM2136; pISM2136C, 
clone identified using the 415 bp SaK-Pstl fragment of pISM2136; plus, identified using the 
indicated probe. 
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Table 1. (continued). 
pISMinO 
pISM1172 
pISM1174 
pISM1176 
pISMI210 
pISM1212 
pISM1213 
pISM1214 
pISM1217 
pISM1228 
pISM1232 
pISM1233 
pISM2121 
pISM2136 
pISM2139 
pISM2155 
pISM2167 
pISM2I68 
pISM2169 
pISM2170 
pISM2171 
pISM2172 
pISM2173 
pISM2159 
pSK- with a 6.1 kb M. hyopneumoniae chromosomal this study 
fragment, pISM2136C+ 
pSK- with a 6.5 kb M. hyopneumoniae chromosomal this study 
fragment, pISM2136C+ 
pSK- with a 6.0 kb M. hyopneumoniae chromosomal this study 
fragment, pISM2136C+ 
pSK- with a 7.7 kb M. hyopneumoniae chromosomal this study 
fragment, pISM2136C+ 
pSK- with a 8.2 kb M. hyopneumoniae chromosomal this study 
fragment, pISM1161+ 
pSK- with a 5.4 kb M. hyopneumoniae chromosomal this study 
fragment, pISMl 161+ 
pSK- with a 5.4 kb M. hyopneumoniae chromosomal this study 
fragment, pISM1161+ 
pSK- with a 5.5 kb Af. hyopneumoniae chromosomal this study 
fragment, pISMl 161+ 
pSK- with a 8.8 kb Af. hyopneumoniae chromosomal this study 
fragment, pISMl 161+ 
4.2 kb PstUNcil fragment from pISM2159 cloned into this study 
pKS-
pSK- with 3.8 kb EcoRl fragment of M. this study 
hyopneumoniae chromosomal DNA containing second 
copy of PI02 
pSK- with 4,2 kb fcoRI fragment of M. this study 
hyopneumoniae chromosomal DNA containing second 
copy of P102 
pSK- with a 7.2 kb fragment derived from pISM2139 this study 
andpISM2159 
pSK- with a 0.6 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 5.5 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.1 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.3 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.5 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.2 kb fragment of M. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.2 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 5.6 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 6.6 kb fragment of M. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 5.1 kb fragment of Af. hyopneumoniae this study 
chromosomal DNA, Mab F1B6+ 
pSK- with a 5.2 kb fragment of M. hyopneumoniae this smdy 
chromosomal DNA, Mab F1B6+ 
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Table 2. Buffers 
Buffer Component Usage 
PBS 
SM 
TS-Tween 
Electrode Buffer 
TAE (SOX) 
TE 
TNE 
TNE 
SSC (lOX) 
Denhardt's reagent 
(50X) 
Denaturing buffer 
Renaturation buffer 
Prehyb/Hyb solution 
washing solution (2X) 
washing solution 
(0.2X) 
TES-1 
AES 
CaClj (lOX) 
TES-2 
Blocking buffer 
Coating buffer 
10 mM NajHPO^-lSO mM NaCl, pH 7.4 
5.8 g NaCl- 2 g MgS04-7H20- 50 ml 1 M 
TriS'Cl (pH 7.5)-5 ml 2% gelatin 
0.01 M Tris-0.140 NaCl-0.01 % Tween 20 
25 mM Tris-192 mM glycine-20% methanol 
vol/vol; pH 8.3 
242 g Tris-100 ml 0.5 M EDTA (pH 8.0)-
57.1 ml glacial acetic acid 
10 mM Tris-1 mM EDTA, pH 8.0 
20 mM Tris-10 mM NaQ-l mM EDTA, pH 
8.0 
10 mM Tris-140 mM NaCl-1 mM EDTA, 
pH 8.0 
1.5 M NaCl-150 mM sodium citrate, pH 7.0 
5 g Ficoll-5 g polyvinyIpyrrolidone-5 g 
bovine serum dbumin per 500 ml 
0.5 N NaOH-1.5 M NaCl 
1.0 M Tris-1.5 M NaCl, pH 8.0 
5X SSC-5X Denhardt's reagent-0.1 g/ml 
denatured salmon sperm DNA-0.1% SDS 
2X SSC-0.1% SDS 
0.2X SSC-0.1% SDS 
20 mM Tris-HCl-10 mM EDTA-125mM 
sucrose, pH 7.2 
80 mM sodium Acetate-10 mM EDTA-125 
mM sucrose, pH 6.8 
200 mM CaClj 
50 mM Tris-HQ-IOmM EDTA-10 % 
sucrose, pH8.0 
1% gelatin in RPMI1640 
O.IM Sodium Carbonate. pH 9.3 
X maintenance and 
dilution buffer 
Immunoblot washing 
buffer 
Protein transfer buffer 
Electrophoresis 
DNA buffer 
Mycoplasmal DNA 
isolation (Basic protocol) 
Mycoplasmal DNA 
isolation (Alternative 
protocol) 
DNA hybridization 
DNA hybridization 
DNA hybridization 
DNA hybridization 
DNA hybridization 
DNA hybridization 
DNA hybridization 
Cilia isolation 
Cilia isolation 
Cilia isolation 
E. coli lysate preparation 
MPAA 
MPAA 
DNA Primers 
Sequencing and PCR primers were designed using the Oligo Primer Analysis Software 
(National Biosciences, Inc., Plymouth, Minn.). DNA synthesis was performed in a 
DNA/RNA Synthesizer (Model 399, Applied Biosystems, Perkin-Elmer Corporation, 
Morwalk, Conn.) at the DNA Instrumentation Facility, Iowa State University. Table 3 lists the 
PCR and sequencing primers used in this study. 
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Table 3. Primers 
Primer Sequence (5'-3') Specificity 
PCR Primers 
TH120 
TH121 
AAGGTAAAAGAGAAGAAGTAG 
TTGTAAGTGAAAAGCCAGTAT 
P97 first repeat 
TH122 
TH123 
AGCGAGTATGAAGAACAAGAA 
rmTACCTAAGTCAGGAAGG 
P97 second repeat 
Mhp3 
Mhp4 
AAGTTCATTCGCGCTAGCCC 
GCTCCTACTCCATATTGCCC 
Af. hyopneumoniae 
TH127 
TH128 
TATrCGCl'l'l'lTGTATnTCA 
GCAGCTAAAACTAGTAAGTITGAA 
pISM2136 sequence 
position No. 550 - 569 
pISM2136 sequence 
position No. 30 - 53 
Sequencing 
primers 
G186 ATATAAACAACGAATTATCTCC Tn7W0 3'end 
G188 TAAGTTATACCATAAACG Tn7W05'end 
TH125 
Universal 
T3 
Reverse 
T7 
GCGGCTGCTAAACTAAGACTA 
TGTAAAACGACGGCCAGT 
ATTAACCCTCACTAAAG 
CAGGAAACAGCTATGACC 
AATACGACrCACTATAG 
pISM1232-specific 
Bluescript plasmid 
DNA Preparation 
M. hyopneumoniae chromosomal DNA was prepared as follows. Fifty to 500 ml of M. 
hyopneumoniae culture was serially amplified in Friis medium to early stationary phase (color 
of the medium changed to orange and cloudiness of culture became apparent). The culture was 
centrifuged at 8,000 x g for 15 minutes to collect the bacterial cell pellet. The milky-white 
appearance of the pellet indicated that the culture was healthy which was critical for the 
isolation of high quality chromosomal DNA. The pellet was washed once with phosphate 
buffered saline (PBS, Table 2), centrifiiged, and suspended in 7.5 ml of TNE buffer (Table 2). 
Cells were lysed by adding an equal volume of TNE buffer plus 1% sodium dodecyl sulfate 
(SDS) and 2(X) mg per ml proteinase K final concentration (Fisher). The mixture was incubated 
in a water bath at 50°C overnight. The lysate was extracted with an equal volume of 
phenolxhloroform: isoamyl alcohol mixture (24:24:1) overnight in a 250 ml polypropylene 
centrifuge tube rotated slowly at 4°C. The upper layer containing the DNA sample was 
decanted into a 40 ml oakridge tube and centrifuged at 12,000 x g for 15 minutes to separate 
•> 
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the phases and remove protein contaminants. The clear supernatant fraction was pipetted into a 
new tube and precipitated with 0.1 vol of 3M sodiimi acetate (pH 4.8) and 2 vol of 100% 
ethanol in a large petri dish. The DNA precipitated as threads which were collected using a 
sterile pasteur pipette with a sealed tip. The DNA was rinsed with 70% ethanol, air-dried, and 
dissolved in 2 ml of TE buffer after incubation for at least two days at 4°C. The extraction 
procedure was repeated once more beginning with proteinase K and SDS treatment, and the 
extracted DNA was dissolved in 50 to 250 pi of TE at 4°C. 
Plasmid DNA was isolated from E. coli according to the method of Bimboim (18). This 
DNA was of adequate purity for general purposes such as restriction digestion, labeling, and 
cloning. For DNA sequencing, plasmid DNAs were prepared using a QIAGEN plasmid 
purification kit (QIAGEN Inc., Chatsworth, Calif.) per manufacturer's instructions. DNA 
precipitated with isopropanol was centrifiaged in eppendorf tubes in a microfiige. Air-dried 
pellets were dissolved in sterile Hp or Tris buffer (10 mM Tris-HCl; pH 8.0). All agarose gel 
electrophoresis was conducted using 0.4 to 1.5% agarose in IX TAE buffer (Table 2). 
Library Construction 
The construction of the Af. hyopneumoniae chromosomal DNA genomic library in Lambda 
ZAP® n using 75p5091 partially digested DNA has been described (148). Briefly, Af. 
hyopneumoniae chromosomal DNA was partially digested with restriction enzyme Tsp5091 
(New England Biolabs, Inc., Beverly, Maine), and 5 to 10 kb fragments were isolated from 
agarose gels using glassmilk (BIO 101, La Jolla, Calif.). The fragments were ligated into 
£coRI-digested Lambda ZAP® II DNA (Stratagene), and the recombinant phage were packaged 
using the Packagene Lambda DNA packaging system (Promega, Madison, Wis.). The 
recombinant phage were grown on E. coli LE392, and single plaques were picked, individually 
amplified and stored in 96-well microtiter plates as described previously (148). The remaining 
recombinant phages were amplified using standard techniques (195). 
Screening of M. hyopneumoniae Genomic Libraries 
Screening of the M. hyopneumoniae genomic library was performed as follows. In the 
primary screening, an amplified Lambda ZAP® n library was grown as single plaques on E. 
coli LE392 or XL-1 Blue at a concentration of 5(X)-1,000 plaques per 85 mm plate. Plaques 
were lifted onto nitrocellulose membranes taking care to precool the plates prior to overlaying 
the membranes and carefully marking the plates and membranes prior to removal from the 
plate. The membranes were then treated with denaturation buffer (Table 2) followed by 
treatment with renaturation buffer (Table 2). The membranes were baked in a 80°C oven for 
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1.5 to 2 hour to fix the DNA to the membranes. Prehybridization and hybridization were 
conducted as described for the DNA hybridization experiments. Putative positive plaques were 
picked using sterile pasteur pipettes by stabbing the pipette into the center of the plaque and 
dispensing the agar into 1 ml of SM (Table 2). The phage were eluted overnight at 4°C. 
Secondary screening was performed by growing the eluted phage at a concentration of 20-100 
plaques per plate and repeating the plaque lift and hybridization procedure described above. 
Positive plaques were used for M13 phage growth and subsequent excision of cloned genomic 
DNA inserts into Bluescript plasmids as described (207). 
Plasmid Constructions 
DNA cloning was performed according to established methods (195). Plasmid pISM2121 
was constructed by joining the Pstl-BamlQ. fragment from pISM2139 with the BamHi-Pstl 
fragment from pISM2159 and cloning into plasmid pMOB (223). The Pstl site was within the 
vector's multiple cloning site. This provided a single continuous 7.4 kb chromosomal DNA 
fragment from M. hyopnewnoniae which was then analyzed for P97 gene expression using 
TnlOOO mutagenesis, immunoblot analysis and cilia binding assays. Plasmid pISM2159 was 
excised from a recombinant Lambda ZAP® n clone by M13 rescue (207). It carries a 5.2 kb 
insert of M. hyopneumoniae genomic DNA in the pSK- vector (Stratagene). Plasmid 
pISM1228 was constructed by cloning the Neil - Pstl fragment from pISM2159 into Pstl -
Smal digested pKS- vector DNA. Following digestion with Neil, the site was filled-in using 
the Klenow fragment of DNA polymerase (5 mM dCTP, 5 mM dGTP and 0.1 U of Klenow, 
30 minutes at 30°C), and then the Klenow fragment was inactivated by treatment at 70°C for 15 
minutes. The DNA was then precipitated with ethanol and subsequently digested with Pstl. 
The Ncil-Pstl fragments were purified from agarose gels (QIAEX Gel Extraction Kit, 
QIAGEN, Inc. Chatsworth, Calif.) and ligated to agarose purified Smal-Pstl digested pKS- n 
vector DNA. The structure of the resulting recombinant plasmid was confirmed by restriction 
digestion. This cloning strategy maintained the reading frame and direction of (3-galactosidase 
promoter activity as found in the original plasmid, but deleted all but two base pairs 
downstream of the P97 structural gene. 
Transformation of E. coli 
Transformation of plasmid DNA into E. coli was performed by electroporation using an 
Electro Cell Manipulator (Model ECM 600, BTX, San Diego, Calif.). The parameters of 
electroporation included 2 consecutive pulses at 8 kV and 129 Ohms in a 0.2 cm 
electroporation cuvette. The time constant was maintained at about 5.5 msec. E. coli was 
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prepared for electroporation in the following way. E. coli stock cultures were inoculated into 3 
to 5 ml of LB broth supplemented with the proper antibiotics followed by overnight growth 
under vigorous shaking. A 1:1000 dilution of the cultures were made into 200 to 500 ml of 2X 
LB broth without antibiotics. The growth of the cultures was monitored by optical density at 
600 nm until the density reached approximately 1.0. From this point, the cells were maintained 
at 4°C on ice water. The cultures were centrifuged at 9,000 x g at 4°C, and cell pellets were 
washed twice with an equal volume of pre-chilled distilled water followed by a final wash in 20 
ml of pre-chilled 10% glycerol in water. The pellets were suspended in 3 to 5 ml of 10% 
glycerol and dispensed in 50 pJ aliquots in 0.5 ml eppendorf tubes. The aliquots of cells were 
snap-frozen in a dry ice-ethanol bath prior to storage at -70°C. E. coli competent cells thus 
prepared and stored at -70°C have a transformation frequency of approximately 2 - 5 x 10' 
transformants per |J.g of plasmid DNA for 3 to 6 months. For E. coli ISM612, superbroth (32 
g of tryptone (Difco)-20 g yeast extract (Difco)-5 g glucose per liter) was used for growth 
instead of LB broth. The transformation frequency for ISM612 was significantly (10 - ICX) 
times) lower than for other E. coli strains used in this study. 
Forty microliter of £. coli competent cells was used in each transformation with 5-50 ng 
plasmid DNA. The cell mixtures were diluted into 1 to 1.5 ml of SOC media (20 g Tryptone 
(Difco)-5 g yeast exfract (Difco)-2.03 g MgCl2*6H20-2.46 g MgSO4-7H20 -3.6 g glucose per 
liter) and then incubated at 37°C for 30 minutes prior to plating the transformation mixture on 
selective media. 
TnlOOO Mutagenesis 
TnlOOO mutagenesis was performed by conjugal mating in the following way. Briefly, 
plasmids to be mutagenized were first transformed into E. coli DPWC. The resulting strains 
which carried both F and the recombinant plasmid were used as donor strains for conjugation 
with kanamycin resistant recipient E. coli BW22. One hundred microliters of overnight donor 
and recipient cultures were mixed and diluted into 2 mis of LB and grown for 3 hours at 37°C 
(shaking). Different amounts of the mating mixtures (1-100 |il) were then plated onto 2X LB 
agar supplemented with 100 p.g per ml ampicillin and 50 ^ig per ml kanamycin. The resulting 
ampicillin and kanamycin resistant colonies contained recombinant plasmids with TnlOOO 
randomly inserted. The location of the TnlOOO inserts were determined by restriction digestion 
of the isolated plasmid with Sail and £coRV. 
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DNA Sequencing and Polymerase Chain Reaction 
DNA sequencing was performed by the Iowa State University DNA facility using cycle 
sequencing protocols and an automated DNA Sequencer (Model 373 or 377, Applied 
Biosystems, The Perkin-Elmer Corporation, Norwalk, Conn.). DNA sequence analysis was 
performed with MacVector software (Eastem Kodak Company, Rochester, N. Y.). 
All polymerase chain reaction (PCR) amplifications were performed using a TwinBlock 
System (model EZ cycler, Ericomp Inc., San Diego, Calif.). The annealmg temperature was 
determined by Oligo primer analysis software (National Biosciences, Inc., Plymouth, Minn.). 
The basic PCR reaction mixture contained 2 mM MgClj, 25 pmol each primer, 1-50 ng 
template DNA, 0.25 U Tag DNA polymerase in 50 pi IX manufacturer's reaction buffer. PCR 
products were analyzed by agarose electrophoresis. 
Clamped Homogeneous Electrical Field Electrophoresis 
Preparation of intact M. hyopnewnoniae genomic DNA and restriction digestion were 
performed according to the method described by Mahairas and Minion (132). M. 
hyopneumoniae cells were pelleted by centrifugation and resuspended in 50 pJ of TNE buffer 
(Table 2). The tube was equilibrated to 37°C and then an equal volume of 2% low-temperature 
melting agarose (Seaplaque, FMC Corp., Rocklane, Maine) in TNE was added. The 
suspension was placed in a plug mold and allowed to harden. The plugs were then transferred 
to 12 X 75 mm snap cap tubes at which time 100 ^il of lysis buffer (2 mg per ml protease K, 
1% Sarkosyl, 0.5 M EDTA, and 10 mM Tris-HCl; pH 9.5) was added. The tube was then 
incubated at 50°C for 12 hours, and then dialyzed against 1 ml volumes of TE at least four 
times for 1 h. Dialyzed agarose blocks were stored in TE buffer at 4°C. The concentration of 
cells was determined empirically by assessing the DNA isolated from different dilutions of cells 
by CHEF. 
DNA digestions were performed in 1 ml of IX digestion buffer containing 30 - 40 U of 
each enzyme at 37°C for 12 hours. Prior to electrophoresis, the blocks were equilibrated in 
0.5X Tris-Borate electrophoresis buffer (45 mM Tris base, 45 mM boric acid, 1 mM EDTA) 
for at least 1 hour. Electrophoresis was performed according to the manufacturer's mstructions 
with a Bio-Rad CHEF-DR n pulse field electrophoresis system, Pulsewave 760 switcher, and 
a Model 2(X)/2.0 power supply. Digested DNA was electrophoresed in a 5-10 mm thick, 1.5% 
agarose gel using lambda DNA as size markers (CHEF DNA size standards. Cat. No. 170-
3635, Bio-Rad Laboratories, Hercules, CA.). The electrophoresis was carried out at 200 V for 
20 hours at 14°C with ramping from 2 to 14 seconds. Transfer of the DNA to nylon 
membranes was performed according to protocol described elsewhere in this thesis. 
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Radiolabeling 
Oligonucleotides were end labeled as described (195). The labeling solution contained 50 
pmole of oligonucleotide, 150 mCi y^^P-ATP, and 20 U T4 kinase in 50 |xl of IX Taq 
polymerase buffer (New England Biolabs). Labeling mixtures were incubated at 37°C for 30 
minutes. Labeled oligonucleotides were purified from unincorporated "P-ATP using the 
Mermaid kit (BIO 101, Inc., La JoUa, Calif.). 
DNA probes were labeled with a ^^P-dCTP using the Multiprime DNA labeling system 
(Amersham Intemational pic., Amersham, UK) according to the manufacturer's instructions. 
Unincorporated a '^P-dCTP was separated from radiolabeled probes by passing labeling 
reaction mixtures through MicroSpin S-300 HR columns (Pharmacia Biotech Inc., Piscataway, 
N.J.). 
Hybridization 
DNA digested with restriction enzymes was electrophoresed in agarose gels (0.4% to 
1.0%) to separate the fragments. Agarose gels were treated with 0.25 N HCl for 10 minutes, 
rinsed with distilled HjO, and the DNA was denatured by incubating the gels in denaturing 
buffer (Table 2) for 30 minutes to 1 hour. The DNA was renatured by directly transferring the 
gel into renaturation buffer (Table 2) and incubating for 30 minutes to I hour. The DNA was 
then transferred to nylon membranes (Biodyne Plus, Pall Corporation, New York, N.Y.) by 
capillary transfer overnight with lOX SSC buffer. 
The DNA was fixed to the nylon membranes by baking in a vacuum oven for 1 to 1.5 
hours at 80°C. Membranes were prehybridized in Prehyb/Hyb solution (Table 2) at 65°C for at 
least 1 hour. Hybridization was then carried out overnight with ^^P radiolabeled probe at 65°C 
in Prehyb/Hyb solution. After hybridization, the Prehyb/Hyb solution was discarded or stored 
at -70°C for further use. The membranes were washed with 2X washing solution (Table 2) 
twice at 25°C, and 0.2X washing solution twice at 65°C unless indicated otherwise. 
Autoradiography was performed with membranes placed on wet (with 2X washing solution) 
3M filter paper wrapped in saran wrap to prevent non-reversible cross-linking of probes to the 
membranes and exposed to X-ray film (BioMax MR Film, Eastern Kodak Company, 
Rochester, N.Y.). 
Immunoblot Analysis 
Immunoblotting was performed according to Towbin (233). Proteins resolved by SDS-
PAGE were transferred to nitrocellulose membranes (Midwest Scientific, St. Louis, Mo.). A 
Transphor Electrophoresis Unit (TE series, Hoefer Scientific Instrument, Piscataway, N.J.) 
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was used with Electrode buffer (Table 2), and transfer was conducted for at least 2 hours at 1 
mA or overnight at 0.5 mA at 4°C. After electroblotting, membranes were blocked with TS-
Tween buffer (0.01 M Tris-0.140 NaCl-0.01 % Tween 20) plus 5% powdered milk for I 
hour and washed 3 times with TS-Tween for 15 minutes each. The blots were incubated with 
Mab FIB6 (diluted 1: lOCX) in TS-Tween buffer) overnight at room temperature. Membranes 
were washed as described above. Alkaline phosphate conjugate diluted in TS-Tween was 
incubated with the membranes for 2 hours. After washing, the blots were developed with AP 
substrate (Naphthol 0.03 g-Fast red 0.06 g in 2 mM Tris»HCl; pH 7.4). The reaction was 
halted by rinsing membranes with a large amount of KJD and air dried. 
Adherence Assay 
Ten to 20 ml of log to stationary phase M. hyopnewnoniae culture was centrifiiged at 8,000 
X g for 15 minutes. The cells were washed by suspending them in 1 ml of PBS, transferring to 
an eppendorf tube, and centrifuging in a microfiage at full speed for 1 minute. The pellet was 
resuspended in 100 |il of PBS. Thirty to 40 ml of overnight E. coli ISM612 cultures were 
induced with 2.5 mM isopropyl thiogalactopyranside (IPTG) for 5 to 6 hours. The E. coli 
pellets were resuspended in 5 ml of TES-2 buffer (Table 2) and centrifiiged again. The final E. 
coli pellets were suspended in 2 ml of TES-2 buffer. Cells were lysed by sonication in a 13 ml 
centrifuge tube (Cat. No. 62.515.006, Sarstedt, Inc., Newton, NC) with a sonicator (Cell 
disrupter, model W225R, Heat systems-ultrasonics. Inc., Plainview, N.Y.) set at 70 % 
maximum output and 50% duty cycle using a microtip probe. Each cell suspension was kept on 
wet ice and received 20 pulses with a 20 second break between pulses. Lysates were collected 
after centrifiigation at 12,0(X) x g for 20 minutes. Protein concentration was determined by 
standard Bio-Rad protein assay (Bio-Rad Laboratories, Richmond, CA) using 5 to 20 jil of 
sample. Bovine serum albumin was used to determine the standard curve. 
Swine cilia were prepared in the following way. Swine trachea were aseptically removed 
from pigs and immersed in HBSS (Cat. No. 14185, Life Technology Inc., Gaithersburg, 
Md.). The epithelium was scraped from trachea using a laboratory spatula into 25 ml TES-1 
buffer (Table 2) in a conical centrifiige tube. This cell suspension was then centrifiiged at 288 x 
g for 10 minutes. The pellet was washed with TES-1 buffer and centrifiiged once more, 
resuspended in 6 ml of AES buffer (Table 2), mixed, and 6 ml of 20 mM CaCIj was added. 
The mixture was vortexed vigorously for 10 minutes prior to passage through an 18G needle 
once and a 22G needle twice. The mixture was brought to 40 ml with TES-1 buffer and 
centtifuged at 472 x g for 5 minutes twice to remove cell debris. The supernatant was 
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transferred to a clean centrifuge tube followed by a 20 minute centrifiigation step at 20,000 x g. 
The pellet containing the cilia was washed with PBS prior to centrifiigation again. The final 
pellet was resuspended in 1 ml of PBS, aliquoted and stored at -70°C. 
For coating microtiter plates, cilia were removed from the -70°C freezer and diluted with 
PBS to 1 mg protein per ml. One fourth volume of a 5 mg per ml SDS solution was added to 
the cilia suspension and the tube was incubated at 37°C for 45 minutes. The cilia preparation 
was then diluted with coating buffer in which the cilia final concentration was 10 mg per ml. 
Immulon 4 microtiter plates ODynatech Industries, Inc., McLean, Va.) were coated with 
solubilized cilia at 1 mg per well overnight at room temperature. The plate was either used for a 
MPAA assay immediately or was stored at -70°C freezer until use. Incubation at 37°C was 
sometimes used to shorten the time required to coat the plate. 
For most MPAA assays, cilia-coated Immulon 4 plates were taken from -70°C freezer and 
thawed at 25°C. The plate was washed 4 times with PBS and blocked with blocking buffer 
(1% gelatin (Sigma) in RPMI1640) for 2 hours at 37°C. Without washing the plate, antigen in 
100 ^l blocking buffer was added to each well. The plate was incubated at 37°C for 1 hour. 
After 4 washes with PBS, 100 jxl of primary antibody F1B6 diluted 1:100 in blocking buffer 
was added to each well and incubation was continued for 90 minutes at 37 °C. This was 
followed by 4 washes with PBS and incubation for 1 hour at 37°C with alkaline phosphate-
labeled goat anti-mouse immunoglobulins conjugate (Cappel, Cat. No. 59294, Organon 
Teknika Corp., West Chester, Pa.) diluted to 1:200 in blocking buffer. After 4 washes with 
PBS, 100 ml of alkaline phosphate substrate (Sigma 104) was added to each well. The plate 
was developed at 37°C, and the absorbance was read in a Microplate Autoreader (Model 
EL310, BIO-TEK Instruments Inc., Winooski, Vt.) at an optical density of 405 nm. Negative 
controls included wells with negative control antigens or wells with blocking buffer. All 
experiments were performed in triplicate with freshly prepared antigens and experiments were 
repeated at least twice. 
The MPAA inhibition assay was performed with three inhibitors, heparin, fucoidan, and 
mucin. Each of these materials have been shown to inhibit binding of M. hyopneumoniae to 
cilia (266). To examine the ability of these chemicals to inhibit the binding of recombinant P97 
in £. coli lysates to cilia, inhibitors and antigens dissolved in blocking buffer were added to 
eppendorf tubes containing antigens and then immediately added to microtiter plates without 
any further incubation. The assay was then completed according to the protocol described 
above. Control wells contained no inhibitor. 
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RESULTS 
Analysis of Mab F1B6-Reactive Lambda ZAP*" n Clones 
A total of 1,920 individually picked clones from the M. hyopneumoniae genomic library in 
Lambda ZAP® II had been screened previously in this laboratory with Mab F1B6. Four 
positive clones were identified and rescued into pSK- by excision from Lambda ZAP® H. The 
resulting plasmids, pISM2136, pISM2139, pISM2155 and pISM2159, were isolated and 
restriction mapped. According to the restriction map, the inserts of plasmids pISM2139, 
pISM2155, and pISM2159 appeared to overlap a single region of the M. hyopneumoniae 
chromosome (Figure 1). Therefore, it appeared that this region was likely to contain the P97 
adhesin gene. This hypothesis was supported by subsequent isolation of additional clones from 
the amplified M. hyopneumoniae genomic library using Mab F1B6 (Figure 1). To increase the 
opportunity of successfully deriving the complete P97 gene sequence, the plasmid pISM2121 
was constructed by ligating inserts from pISM2139 and pISM2159 at the BamHI site and 
cloning the combined fragment into pMOB, a vector designed to facilitate TnlOOO mutagenesis 
(Materials and Methods). Interestingly, of the four Mab reactive clones, pISM2136 contained 
an insert of 6(X) bp in length and contained a single SaK site, a restriction site (GTCGAC) 
rarely observed in mycoplasma DNA because of the high A+T content. The presence of the 
Sail site suggested that the cloned fragment in pISM2136 was derived from the same 
chromosomal region of P97 which also contained a Sail site (Figure 1), but DNA sequence 
analysis of both pISM2136 and pISM2121 failed to identify the source of the pISM2136 
fragment. 
Immunoblot Analysis 
To locate the P97 gene in pISM2121, TnlOOO mutagenesis was performed as described in 
Materials and Methods. pISM2121::Tn70(?0 plasmids were isolated and restriction mapped to 
determine the site of the TnlOOO insertion. A series of pISM2121::Tni000 plasmids with 
transposon inserts spanning the entire pISM2121 insert were examined for P97 expression by 
immunoblot analysis with Mab F1B6 (Figure 2). Each of these plasmids was transformed into 
E. coli ISM612, a strain constructed to enhance the expression of mycoplasma genes by 
suppressing opal stop codons (211). Each of the ISM612 (pISM2121: TnlOOO) derivatives 
were cultivated under IPTG induction, and whole cell proteins were prepared and separated in 
10% SDS-PAGE gels. The proteins were transferred to nitrocellulose membranes and analyzed 
for the expression of Mab FlB6-reactive antigens. The results of one experiment are shown in 
Figure 2. TnlOOO insertions (1-3, 1-15,26-14, and 1-14) within a 2.0 kb region of pISM2121 
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Figure 1. Restriction map of the P97 region of the M. hyopneumoniae chromosome and 
overlapping fragments from cloned sequences. The location and direction of transcription of 
P97 is shown by the large arrow. Selected recombinant clones (designated as plasmid 
numbers) expressing the P97 epitope are mapped to the chromosomal region. The small arrows 
(POal) indicate the direction of transcription in each plasmid due to lac promoter activity from 
vector sequences. Plasmids pISM2121 and pISM1228 constructed from clones pISM2139 and 
pISM2159 are marked with asterisks. Also shown (A) are selected TnlOOO insertion sites in 
pISM2121 used in immunoblot analysis to identify the P97 coding region. Sizes of the cloned 
fragments are given in kilobases. B = BamHl; E = EcoRI; EV = EcoRV; H = //mdlll; N = 
Neil; P = Pstl; S = Sail. NA = not applicable. The Pstl site is part of the cloning vector's 
multiple cloning site. 
38 
abolished the production of Mab FlB6-reactive antigens, while inserts outside this region 
failed to abolish antigen production (Figure 2). It was concluded that the P97 coding sequence 
was located in the region between inserts 1.14 and 1.3 (Figure 1). Interestingly, our results 
indicated that £ coli produced a major antigen of approximately 126 kDa which was 
significantly larger in size than the 97 kDa protein observed in M hyopneumoniae. This 
suggested that the coding region was larger than expected or that E. coli was improperly 
initiating transcription of the structural gene. Also, E. coli ISM612 (pISM2121::Tni000 16-13) 
produced a dominant protein with a reduced size of approximately 98 kDa (Figure 2, lane 7). 
1 2 3 4 5 6 7 8 9 10 11 12 13 
Figure 2. Western blot analysis of selected InlOOO insertions in pISM2121. Protein antigens 
were prepared from IPTG-induced cultures as described in the Materials and Methods, 
separated on a 10% SDS-PAGE mini-gel, and blotted to nitrocellulose. The blots were 
developed with Mab F1B6 as described. Lane 1 contained M. hyopneumoniae antigen, and the 
remaining lanes contained protein preparations from IPTG-induced ISM612 with pSK- (lane 
2); pISM2121 (lane 3); pISM2121 derivatives containing TnlOOO insert l.l (lane 4); 1.2 (lane 
5); 1.4 (lane 6); 16.13 (lane 7); 1.14 (lane 8); 26.14 (lane 9); 1.15 (lane 10); 1.3 (lane 11); 
16.12 (lane 12); and 1.12 (lane 13). Apparent molecular masses, in kilodaltons, are indicated 
on the left. The blot was digitized using a Cohu model 4900 high performance charge-coupled 
device camera (Cohu, Inc., San Diego, Calif.) and a Macintosh Ilci equipped with a Scion 
Corporation (Frederick, Md.) video board. The resulting TIFF file was cropped and assembled 
in Adobe Photoshop and labeled in Aldus FreeHand. 
Construction of pISM2159:;TniOOO Insertion Mutants 
Since plasmid pISM2159 seemed to include the entire P97 gene sequence (Figure 1), it was 
chosen to sequence. Plasmid pISM2159 was mutagenized with TnlOOO, and pISM2159:; 
TnlOOO plasmids were isolated and restriction-mapped to determine the location of each insert 
(Figure 3). A series of pISM2159::Tni000 plasmids representing TnlOOO inserts distributed 
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throughout the pISM2159 insert sequence was analyzed by immunoblot with Mab F1B6 as 
described above, and a similar result to Figure 2 was obtained (data not shown). The TtilOOO 
series was then used to derive the DNA sequence of pISM2159 using TnlOOO -specific 
sequencing primers. 
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Figure 3. The location of TniOOO insertions within the cloned insert of plasmid pISM2159. 
Each flag represents one individual pISM2159::Tni000 isolate. The orientation of each 
transposon correlates with the direction of the flag which is pointing towards the 3' end of the 
transposon. The scale is shown in kilobases. The numbers are insert designations. The arrow 
indicates the position and direction of transcription of P97. B, 5amHI restriction site. 
Sequence analysis of P97 Gene and Translated Protein Product 
The DNA sequence of pISM2159 was analyzed with Mac Vector software. A 3,324 base 
pair (bp) open reading frame (ORF) was identified with a coding capacity for a protein with a 
predicted molecule weight of 124.9 kDa. This has been designated the stmctural gene for P97 
(Figure 4). The translated protein had a predicted pi of 8.71. A putative promoter region was 
identified 145 bp upstream of this ORF P97 structural gene. The -10 sequence (TATAAT) and 
-35 sequence (TTGCAA) was separated by a stretch of 17 adenine residues including the two 
within the -35 sequence. A putative Shine-Dalgamo sequence (GAGGT) was identified 7 bp 
upstream of the ATG start site. No termination signal could be identified immediately 
downstream of the P97 stmctural gene, but an uninterrupted ORF was identified which could 
constitute a second gene of an operon. 
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-10 
-35 
ATAAAAAAATTTCCAAACiTm'i'CfriGCAAfeAAAA 
AAAAAAAAAAG TATAAI ITrAATTGTACAAGTTMATAAATTTlTCACTTATCTTTTTTTATTITGCAAAACTTTrAAAAA 
iUVTTACy^ATCTAAATTATATTATATGATTGflGAAAATGAAAAATTTATTTCCTAGAACCAAGM'AATTGAGGTTTAAAAT 
M S K K S K T F K I G L T A G I V G L G V F G L T V G  
ATGAGTAAAAAATCAAAAACATTTMAATTGGTTTGACTGCCGGAATTGTTGGTCTTGGAGTTTTTGGTCTAACTGTCGGA 81 
L S S L A K Y R S E S P R K I A N D F A A K V S T L A  
CTTAGCAGCTTGGCAAAATACAGATCAGAAAGTCCACGAAAGATTGCAAATGATTTTGCCGCAAAAGTTTCAACATTAGCT 162 
(1,3) 
F S  P Y A F E T D S D Y K I V K R W L V D S XN N N I R  
TTTAGTCCTTATGCTTTTGAGACTGATTCTGATTATAAAATAGTCAAAAGGTGACTAGTTGArrCTAATAACAATATTAGA 243 
N K E K V I D S F S F F T K N G D Q L E K I N F Q D P  
AATAAAGAAAAAGTTATTGArrCCrrTTCCTTTTTTACTAAAAACGGTGATCAGTTAGAAAAflATTAATTTTCflAGATCCT 324 
E Y T K A K I T F E I L E I I P D D V N Q N F K V K F  
GAATATACCAAGGCGAAGATAACmTGAGATTCTTGAAATTATCCCTGATGATGTCAATCAflAATTTTAAGGTAflAATTT 405 
Q A L Q K L H N G D I A K S D I Y E Q T V A F A K Q S  
CAGGCATTACAAAAACTTCATAATGGTGATATTGCQiAflTCTGATATTTM'GAGCAAACAGTTGCTTTTGCCAflACAGTCA 486 
N L L V A E F N F S L K K I T E K L N Q Q I E N L S T  
AATCTTTTAGTTGCCGAATTTAATTTTTCGCTTAAAAAAATTACCGAAAAATTAAATCAACAAATTGAAAATTTATCAACA 567 T 
K I T N F A D E K T S S Q K D P S T L R A I D F Q Y D  
AAAATTACAAATTTTGCTGATGAAAAAACMGCAGCCAAAAAGATCCCTCAACTCTAAGAGCTATTGACTTCCAATACGAT 64 8 
L N T A R N P E D L D I K L A N Y F P V L K N L I N R  
TTAAATACAGCGCGAAATCCTGAGGATTTAGATATAAAGCTTGCTAATTATTTTCCAGTACTTAAAAATTTAATAAACAGA 729 
L N N A P E N K L P N N L G N I F E F S F A K D S S T  
CTAAATAATGCTCCTGAGAATAAATTACCTAATAATTTGGGTAATATTTTTGAATTTAGCTTTGCflAAAGATAGTTCAACT 810 
N Q Y V S I Q N Q I P S L  F L K A D L S Q S A R E I L  
AATCAATATGTAAGTATCCAGAACCflAATTCCTTCGCTGTTTTTAAAAGCAGATCTTAGTCAAAGTGCCCGTGAAATnTA 891 
A S P D E V Q P V I N I L R L M K K D N S S Y F L N F  
GCTAGCCCAGATGAAGTTCAGCCAGTTATTMCATTTTAAGATTAATGAAAAAAGATAATTCTTCTTATTTTCTAAATTTT 972 
E D F V N N L T L K N M Q K E D L N A K G Q N L S A Y  
GAGGATTTTGTTAATAATTTAACACTGAAAAATATGCAAAAAGAAGATTTAAATGCAAAGGGTCAAAATCTTTCTGCCTAT 1053 
E F L A D I K S G F F P G D K R S S H T K A E I S N L  
GAATTTCTAGCAGATATTAAATCTGGATTTTTCCCTGGflGACAAGAGATCCAGTCATACCAAGGCAGAAATTAGTflATCrT 1134 
(1,15) 
L N K K i E N I Y D F G K Y N G K F N D R L N S P N L E  
TTAAATAAAAAAGAAAATATTTATGACTTTGGTAAATACAATGGAAAATTCAACGACCGTCTTAACTCGCCAAATTTAGAA 1215 
Y S L D A A S A S L D K K D K S I V L I P Y R L E I K  
TATAGCCTAGATGCAGCAAGCGCAAGTCTTGATAAAAAAGATAAATCAATAGTTTTAATTCCCTACCGCCTTGAAATTAAA 1296 
D K F F A D D L Y P D T K D N I L V K E G I L K L T G  
GATAAATTTTTTGCCGATGATTTATArCCAGATACflAAAGATAATATTCTCGTAAAAGAAGGGATTCTTAAATTAACTGGA 1377 
F K K G S K I D L P N I N Q Q I F K T E Y L P F F E K  
TTTAAAAAAGGCTCAAAAATTGATCTCCCTAATATCAATCAGCAAATTTTTAAAACCGAATATTTACCATTTTTTGAAAAA 1458 
Figure 4. Nucleotide and amino acid sequence of P97 of M. hyopneumoniae strain 232A. The 
putative -35 and -10 sequences are boxed. The repeating motifs are indicated by a single 
underline for the AAKP(V/E) motif or double underline for the NQGKK(S/A)EG(A/r)P motif. 
Plus (+) indicates the beginning of each repeating motif. Base numbering begins with the start 
codon of P97. The posttranslational cleavage site is indicated by (T). Arrows pointing 
downward indicate TnlOOO insertion site; the insertion number is given above the arrow. UGA 
codons are boldface. 
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G K E E Q A K L D Y G N I L N P Y N T Q L A K V E V E  
GGTAAAGAAGAACAAGCAAAATTAGACTATGGTAATATCTTAAATCCATATAATACTCAACTrGCCAAAGTTQAAGTTGAA 1539 
A L F K G N K N Q E I Y Q A L D G N Y A Y E F G A F K  
GCTCTTTTTAAAGGGAATAAAAACCAAGAAATCTATCFLAGCACTTGATGGAAATTATGCCTATGAATTCGGGGCCTTTAAA 1620 
(26,14) 
S V L N S W T G K I Q H P E K A I X LI Q R F T R H L E Q  
TCCGTGCTTAATTCCrcaACftGGAAAAATTCAGCaTCCTGAAAAAGCTGATATCCaAAGATTTACAAGACATTTAGAACAA 1701 
V K I G S N S V L N Q P Q T T K E Q V I S S L K S N N  
GTTAAAATTGGTTCTAATTC3VGTTTrAAATCAACCACAAACAACRAAAGAACAAGTAATTTCAAGTCTTAAAAGTAATAAC 1782 
F F K N G H Q V A S Y F Q D L L T K D K L T I L E T L  
TTTTTTAAAAATGGACATCAAGTTGCAAGTTATTTCCAGGATTTACTCACCAAGGACAAATTAACAATTTTAGAGACTCTT 18 63 
Y D L A K K W G L E T N R A Q F P K G V F Q Y T K D I  
TATGATCTAGCAAAAAAATGGGGACTAGAAACTAACAGAGCACAATTCCCFLAAAGGGGTTTTCCAATATACAAAAGATATT 1944 
F A E A D K L K F L E L K K K D P Y N Q I K E I H Q L  
TTTGCAGAAGCAGATAAATTAAAATTTTTGGAATTGAAGAAAAAGGATCCrTACAATCAGATAAAAGAAATTCACCAACTT 2025 
S F N I L A R N D V I K S D G F Y G V L L L P Q S V K  
TCCTTTAATATTTTAGCCCGTAACGATGTAATAAAATCTGATGGATTTTACGGAGTTTTATTATTGCCCCAAAGTGTAAAA 2106 (1.14) 
T E I L E G K N E A Q I F E A L K K Y S L I E N S A F K  
ACTGAATTAGAAGGCAAAAATGAGGCGCFTAATTTTTGAAGCGCTTAAAAAGTATTCTTTAATTGAGAACTCGGCTTTTAAA 2187 
T T I L D K N L L E G T D F K T F G D F L K A F F L K  
ACTACTATTTTAGATAAAAATTTACTTGAAGGGACTGATTTTAAAACCTTCGGTGATTTTTTAAAAGCATTTTTCCTTAAA 2268 
A A Q F N N F A P W A K L D D N L Q Y S F E A I K K G  
GCAGCCCAATTTAATAATTTTGCTCCTTGRGCAAAATTAGACGATAATCTTCAGTATTCATTTGAAGCTATCAAAAAAGGG 2349 
E T T K E G K R E E V D K K V K E L D N K I K G I L P  
GAAACTACAAAAGAAGGTAAAAGAGAAGAAGTAGATAAAAAAGTTAAGGAATTGGATAATAAAATAAAAGGTATATTGCCT 2430 
+ + + + + 
Q P P A A K P E A A K P V A A K P E T T K P V A A K P  
CAGCCCCCAR,FFLGCFTFLFTFTCCFLAY^SCFT«3WTF\CMGTFTGCGCTFLFTFTCCAGW^G^CAFLFLFTCMSTFICCFTGCTAAFTCCT 2511 
+ + + + + + 
E A A K P E A A K P V A A K P E A A K P V A A K P E A  
GAAr^r^AAACCTGAAGCAGCAAAACCAGTARCnGOTAAACrAGAAGnAGrAAAACCAGTAGCGGCTAAArr.AmAGr.A 2592 
+ + + + 
A K P V A A K P E A A K P V A A K P E A A K P V A T N  
GCAAAARRAC7RAGCR^AARCRAGFLAC^GCAAAACA«7RAGRCGRTAAARRAGAAGRAGR.AAAACCAGTTGCTACTAAT 2673 
T G F S L T N K P K E D Y F P M A F S Y K L E Y T D E  
ACTGGCTTTTCACTTACAAATAAACCAAAAGAAGACTATTTCCCAATGGCTTTTAGTTATAAATTAGAATATACTGACGAA 2754 
N K L S L K T P E I N V F L E L V H Q S E Y E E Q E I  
AATAAATTAAGCCTAAAAACACCGGAAATTAATGTATTTTTAGAACTAGTTCATCAAAGCGAGTATGAAGAACAAGAAATA 2835 
I K E L D K T V L N L Q Y Q F Q E V K V T S  D Q Y Q K  
ATAAAGGAACTAGATAAAACTGTTTTAAATCTTCAATATCAATTCCAGGAAGTCAAGGTAACTAGTGACCAATATCAGAAA 2916 
+ + 
L S H P M M T E G S S N Q G K K S E G T P N Q G K K A  
CTTAGCCACCCAATGATGACCGAAGGATCTTCAAATCAAGGTAAAAAAAGCGAAGGAACTCCTAACCAAGGTAAAAAAGCA 2997 
+ (16.13) -F 
E G A P N IQ G K K A E G T P N Q G K K A E G A P S Q Q  
GAAGGCGCGCCTAACCAAGGTAAAAAAGCCGflAGGflACTCCTAACCAAGGGflAAAAAGCAGAGGGAGCACCTAGTCaACAA 3078 
S P T T E L T N Y L P D L G K K I D E I I K K Q G K N  
AGCCCAACTACCGAATTAACTAATTACCTT CCTGACTTAGGTAAAAAAATTGACGFTAATCATTAAAAAACAAGGTAAAAAT 3159 
W K T E V E L I E D N I A G D A K L L Y F I L R D D S  
TGRAAAACAGAGGTTGAACTAATCGAGGATAATATCGCTGGAGATGCTAAATTGCTATACTTTATCCTAAGGGATGATTCA 3240 
K S G D P K K S S L K V K I T V K Q S N N N Q E P E S  
AAATCCGGTGATCCTAAAAAATCAAGTCTAAAAGTTAAAATAACAGTAAAACAAAGTAATAATAATCAGGAACCAGAATCT 3321 
K 
AAATAAAACCCGGAGGTATTrATCCTATGAAGTTAGCftAAATTACTTAAAAflACCTTTTTGATTAATAACAACAATTGCCG 
GAATTAGTCTTAGTTTATCAGCCGCrGTTGGTACAGTTGTCGGAATTAATTCTTATAATAAATCATATTATTCTTATCTAA 
ATCAGATCCCGAGTCAGCTAAAAGTACCAAAAAATGCTAAAA 
Figure 4 (Continued). 
42 
The P97 structural gene was translated using a mycoplasma translation table. The amino 
acid sequence of the predicted P97 protein has been included in Figure 4. The protein displayed 
high hydrophilicity throughout the entire protein that is predicted to be rich in helix structure 
(Figure 5). Two putative overlapping transmembrane helices comprising 17 amino acids 
(numbers 13 to 29) and 20 amino acids (numbers 12 to 31) were identified at the amino 
terminus using TMpred software (89) located at URL: http://ulrec3.unil.ch/software/tmpred_ 
form.html. The two helices have opposite orientations relative to the membrane, In-Out and 
Out-In. A protein kinase ATP-binding region signature was also identified at the amino 
terminus of the protein overlapping the transmembrane domain by the use of MOTIF software 
at URL: http://www. genome.ad.jp/ sit/motif.html. The amino acid composition is shown in 
Table 4. Most notably, the protein contains no cysteine residues. There was no identifiable 
lipoprotein acylation site, such as has been observed in other mycoplasma membrane proteins 
(248, 259). Four UGA codons were found in the P97 DNA sequence at positions 214, 1636, 
2296, and 3160. Expression of proteins terminated at these codons would result in production 
of proteins with predicted MWs at 7.8,62.0, 87.5, and 118.7 kDa assuming that translation 
begins at the normal ATG start codon. Two proline-rich repeated sequences, R1 and R2, were 
identified near the carboxy terminus. Rl comprises 15 repeats of the 5 amino acid consensus 
sequence of AAKP(V/E), and R2 consists of 4 repeats of the 10 amino acid consensus 
sequence of NQGKK(S/A)EG(A/r)P. The amino terminal amino acid sequence of P97 has 
been obtained (264). This sequence, ADXKTDSDKDPSTLRAIDEQ, aligned to the predicted 
amino acid sequence of P97 beginning at position 195, indicating that P97 in M. 
hyopnewnoniae was produced as a 124.9-kDa precursor and then processed to 102.9 kDa by 
proteolytic cleavage at that position. 
Table 4. Amino acid composition of the translated P97 sequence. 
No. Percent No. Percent 
Non-polar: A 89 8.03 Polar: G 49 4.42 
V 46 4.15 S 71 6.41 
L 105 9.48 T 55 4.96 
I 64 5.78 C 0 0 
P 55 4.96 Y 36 3.25 
M 6 0.54 N 84 7.58 
F 65 5.87 Q 57 5.14 
W 5 0.45 
Basic: Acidic: 
K 146 13.18 D 65 5.87 
R 18 1.62 E 84 7.58 
H 8 1.72 
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Figure 5. Predicted hydrophilicity and structural properties of the translated sequence of 
P97. The scale at the bottom of the figure indicates the amino acid residue number. The type of 
analyses are indicated on the left. Positive numbers indicate high probability for hydrophilic 
regions, surface exposure and antigenicity. Shown in the bottom panel are the regions of 
secondary structure that agree using the Chou-Fasman (Cf) (30) and Robson-Gamier (Rg) (67) 
methods. Hlx, a-helix; Sht, P-sheet; Tm, mm. 
Functional Analysis of P97 Protein Expressed in E. coli 
Previous studies had suggested a role for P97 in the binding of Af. hyopneumoniae to 
swine cilia (264). Iirmiunoblot analysis of ISM612 clones containing pISM2121 or pISM2159 
indicated that proteins related to P97 were being expressed, but additional studies were needed 
to confirm the role of P97 in ciliary adherence. To demonstrate that pISM2121 coded for a 
swine ciliary adhesin, MPAA analysis was performed. This was accomplished by transforming 
pISM2121 and pISM2121::Tni000 derivatives into E. coli ISM612, preparing lysates and 
examining the lysates for cilia binding activity in the MPAA assay. Figure 6 shows the results 
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Figure 6. Binding of M. hyopneumoniae and recombinant P97 preparations to swine cilia. A: 
Data represent the means of triplicate wells from two experiments (solid and shaded bars). The 
E. coli strains are indicated as 2121 (the positive control) or by the number of the TnlOOO 
insert. Not shown are the values for M. hyopneumoniae antigen which were greater than 2.0 in 
both experiments. B: Data are from two representative experiments (solid and shaded bars) 
with M. hyopneumoniae (first four sets of bars) or E. coli (pISM2121) preparations (second 
four sets of bars), with or without an inhibitor. Values in both panels are given in mean optical 
density units ± standard deviation of triplicate wells. Zero values indicate 0 or lower values 
after background (pMOB::Tn7000) subtraction. Mhyo, M. hyopneumoniae antigen; HS, 
heparin sulfate; 2121, £. coli lysate containing recombinant P97 produced by plasmid 
pISM2121. 
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of these assays. Lysates containing control plasmids, pMOB or pMOB::Tn7000 failed to show 
binding activity. M. hyopneumoniae antigen or E. coli lysates from strains containing 
pISM2121 bound to cilia and gave positive optical density responses (Figure 7). To map the 
ciliary binding activity and correlate it with the immunoreactivity on immunoblots, TnlOOO 
inserts in pISM2121 were also examined. TnlOOO insertions outside the P97 ORF retained cilia 
binding activity and were immunoblot positive whereas TnlOOO inserts within the P97 ORF 
abolished cilia binding activity and immunoreactivity (Figure 2). Interestingly, insertion 
pISM2121::Tni000 16-13, previously shown to produce a dominant Mab FlB6-reactive 
protein with reduced size, retained cilia binding activity (Figure 6). 
Previous studies by Zhang et al. demonstrated that M. hyopneumoniae adherence to cilia 
was inhibited by heparin, fiicoidan, and mucin (266). These polysaccharide inhibitors were 
also examined for their ability to inhibit ciliary binding of ISM612 (pISM2121) lysate as 
compared to that of Af. hyopneumoniae whole cells. Heparin, fucoidan, and mucin inhibited 
the ciliary binding of E. coli ISM612 (pISM2121) lysate and M. hyopneumoniae whole cell 
antigens in a similar manner (Figvire 6). 
In order to rule out the possibility that sequences downstream of the P97 gene were 
involved in cilia binding, these sequences were removed by cloning the Neil - Pstl fragment 
from pISM2159 into Pstl - Smal digested pKS as described in the Materials and Methods. The 
resulting plasmid, pISM1228, was transformed into ISM612 and lysates prepared for 
immunoblot and MPAA assays. Figure 7 shows the results of these studies. Lysates from 
ISM612 containing pISM2121, pISM2159 and pISM1228 gave similar immunoblot banding 
patterns (Figure 7, panel A). This was also true for the ciliary binding activities (Panel B). 
These results demonstrate that the P97 gene, but not downstream sequences, were producing 
the ciliary binding activity. 
Construction of the P97 Operon Restriction Map 
Since other mycoplasmal adhesins are within multigene operons, it was important to 
determine if this was also true for Af. hyopneumoniae. The first step was to obtain as many 
clones as possible containing P97 gene sequences. This was accomplished by screening the M. 
hyopneumoniae genomic Lambda ZAP® n library with a radiolabeled probe derived from the 
3.3 kb £coRI fragment of pISMl 161 spanning the upstream region and the 5' end of the P97 
gene. Five recombinant phage were subsequently identified and the DNA inserts rescued into 
pSK- plasmids. These plasmids were isolated and restriction mapped (Figure 8). The 
alignment of some of these plasmids were confirmed by Southern analysis with the same probe 
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Figure 7. Immunoblot and cilia binding analysis of E. coli lysates from strains containing 
pISM2121, pISM2159 and pISM1228. A. Immunoblot analysis with Mab F1B6. Lanes 
contain lysates from ISM612 with plasmids pISM2121 (lane 1); pISM2159 (lane 2); 
pISM1228 (lane 3); or pMOB::TniOOO Oane 4). Molecular masses are given in kDa on the 
right. B. Optical density of cilia binding assay. Data represent the means of triplicate wells of 
two identical experiments (white and shaded bars). pMOBtn, pMOB::Tn7000. 
(data not shown). These plasmids overlapped a 16 kb region (designated as the P97 contig) 
including the two largest plasmids, pISM1210 and pISM1217 corresponding to the up and 
downstream regions of the P97 gene, respectively. 
Sequence and Structure Analysis of the P97 Operon 
TnlOOO mutagenesis was performed on plasmids pISM1210 and pISM1217 to facilitate 
DNA sequencing of this region as described in Material and Methods. The location of each 
TaJOOO insert was restriction mapped, and a series of TnlOOO inserts were chosen to use as 
template DNAs for sequencing reactions based upon their location in the operon and their 
usefulness in adding to the DNA sequence information upstream and downstream of the P97 
sequence already obtained. A total of 9,455 bp of DNA sequence was subsequently obtained 
including the sequence of the P97 gene. The remaining portion of this sequence is shown in 
Figure 9 except for the P97 gene sequence which is given in Figure 4. 
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Figure 8. Restriction map of the P97 contig and overlapping clones obtained by DNA 
hybridization with the cloned fragment from pISMl 161. The restriction maps of the five clones 
from the Af. hyopneumoniae library obtained by DNA hybridization are shown along with their 
insert size in parentheses. Also shown are the positions of the P97 and PI02 structural genes, 
the direction of their transcription (arrow), and the region of DNA sequence analysis (double 
headed arrow). The sizes are given in kilobases. Restriction sites: B, BamHli E, £coRI; EV, 
EcoRV; S, Sail. 
A total of 6 ORFs were identified in this 9,455 bp sequence using MacVector software 
(Figure 10). P97 appeared to be first gene of a two gene operon, the P97 operon. The second 
structural gene in the P97 operon, initiated 20 bp downstream of the P97 structural gene, and 
was preceded by a putative Shine Dalgamo sequence (GGAGGT) 10 bp upstream of the ATG 
start codon (Figure 9). The ORF was 2,712 bp in length with a coding capacity for a 102.3-
kDa protein. This protein was designated as PI02, had a calculated pi of 9.28, and lacked 
cysteine (Table 5). The protein was highly hydrophilic with a putative 25 amino acid 
membrane-spanning domain at its amino terminus (amino acids 10 to 34). Searching the 
database for homology with P102 revealed no significant match to any known sequence, 
including adhesin genes from other eubacteria. The protein predictions for PI02 are shown in 
Figure 11. The P97 operon is flanked upstream and downstream, respectively, by ORF 1 and 
ORF 5 which are transcribed in the reverse direction to P97. The ORF 1 translated sequence is 
highly homologous to the ribosomal protein S10 from other eubacteria. ORF 5 codes for a 
26.3-kDa protein whose sequence is homologous to proteins of unknown function from other 
bacteria. ORF 6 has a high homology to alaS which codes for alanyl-tRNA synthase. 
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< S V E I E I W V G A P L Q S R S I K E T V L  
GlTriTGATTTGTAG(?rAAAACrrTTaiAAATTACAAGTCTITrATGTGTTCGACTTTCAAATKXrKaCGTGATTTTrTAT 162 
< K Q N T P L V K L I V L R K H T R S E F Q E R S K K N  
TAATATGCACTGATCTAAGAATTGTATAAATTGCTCTTGAAGTCGGTAGAGGCACAGGCCCCCGAGTTTCTATATTAAGTT 243 
< I H V S R L I T Y I A R S T P r . P V P G R T E I N L E  
CXXX3AGCrAGAAGAATAATTTTTTTAGCaXy«3CaTCX3aTTTQACGATGATaiAATGArrrTAACTTAATrTTAATTGATG 324 
< R A L L I I K K A A A D I Q R H D F S K L K I K I S T  
TTGTATrcATAAAAATATAGTTGAGTIGCrCCTGTTCArAAATTTrGAACGAACTCCACATAAflAACCAATACACGATAAC 405 
< T N M F I Y N L Q E Q E y i K F S S W M  
AACTCACTCTCGCGTACTGCAACCTrATGCATCAOXaTCCTTTAACGGTAAGATTAAATTATACaCAAAAAArAAAAATTC 486 
AATAArX'm'I'fAAAAAAa'mTiTACCCTTGGCflGCTAAAACTAGTAAGTrTGAAAAGTCTGAATATTATTACTATTrTT 567 
CCAAATTTTTTTTAAAAAAAAAAAAAAAAAAAAAATTCTCTAAAAATGATTAAAGGTATTGTAAAAATTCCAAAGAAGAGG 648 
TTCTTAAAGTCATTrATTTATATTATACAGGAAAATATTTAGTTGATCAAGACCAGAAAAGTATAAAATCTGAGATAAAAA 729 
ACGTGATTGTCAGCTTAATATCAAAGGTAAATATCCAAAAACTAGAAAAAAATAATGCCACfl3TAAGCAAAAATCCAGTGG 810 
TTTTGCAAGCTAAATTAAAATCCAAAACTTGTTAATAACAACCAAGTTrTGGATTTTTTGTTGTATAATAATATCAAAATT 891 
• * 
ATTTATAATTTATTATTOSTGATTTTATATGAAAGCTAATTTTTCTTTCTrTrrTTAATTCGATTTTTCGGAGAAAATTACA 972 
M K A N F S F F F N S I F R R K L Q >  
AAAACGCTCAATTTTAGCGCTTATTTTTTGACTAATTlTm'AATAATAATOXnxrTTGTAATTATTGTTGTTCAAAAAAA 1053 
K R S I L A L I F W L I F L I I I A V V I I V V Q K K >  
AGCTTGATATGATGOATCTCCATTTGTGGGCnTITAGCCATCTCXXnrrTCTGCCCTKXSCAGCGTTCTTAGACTrGGATT 1134 
A W y D A I S I C G L L A I S L S A L G S V L R L G I >  
GTTrAGTAGTrTTTCGGITTCTTATCATAAATGAAGAArrAA'rrCCCAGAATAAAATTTrAGAAAAACGGGGATTTAAAAC 1215 
F S S F S V S Y H K W R I N S Q N K I L E K R G F K T >  
AGAAACTCCAAAAATTGACTATGCTTTrATTAAAAAAAAACAGAAAGAACICICACrrTTrACCTATTTTTTTAGGATTTAT 1296 
E T P K I D Y A F I K K K Q K E I i S L L P I F L G F  I >  
TTTTGGATITITACTTTTAATTATTAGTCTTCCTTTTTTAATTCAAAAITAATAAAAAAATATAGAAGAAAATTTCCTAGT 1377 
F G F L L L I I S L P F L I Q N >  
AAAGTTCTAAAATTATTAAAAAAACAGCATTAAAAACTGCTCjm'mTAM'AATCCTAATTrTAATATTGGATTATTrAT 1458 
» 4 
TTAAAJ'TGTTCAAA'i'mTiTATACTAAAATAAftTTATAAAAGAAGACTGATTAGAAArrTAGAACTATTCAAATCTTTCA 1539 
AAAAAGTGGCCTAAAAACAATG 11 P97 Gene Sequence 11 
AAGTCTAAAAGTTAAAATAACAGTAAAACAAflGTAATAATAATCAGGAACCAGAATCTAAATAAAACCCGGAGGTATTTAT 5103 
S L K V K I T V K Q S N N N Q E P E S K >  
Figure 9. Sequence of the P97 operon and adjoining sequences. Most of the P97 structural 
gene sequence has been deleted to conserve space with truncation beginning at the first base of 
Figure 4. The direction of transcription for each ORF is given by < or >. The arrows indicate 
stem loop structures which flank ORF 2. The last ORF is not a complete sequence. 
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CCTATGAAGTTAGCAAAATrAlOTAAAAAACCOTrTTGATTARTAACAACAATTGCCGGAATTAGTCTTAGTTTATCAGCC 5184 
M K L A K L I i K K P F W L I T T I A G I S L S L S A >  
GCTGTTGGTACACnTCTCXSGAATTAATTCTrATAATAAATCATATTATTCTTMCTAAATCAGATCCCGAGTCAGCTAAAA 5265 
A V G T V V G I N S Y N K S Y Y S y L N Q I P S Q L K >  
GTACXAAAAAATGCTAAAATTAGTOVGGAAAAATITCATTCAArTGTTITAAATCTTAAAATTAAAGATAATTTTAAAAAA 5346 
V A K N A K I S Q E K F D S I V L N L K I K D N F K K >  
TGATCGGCAAAAACAGTIOTAACTGCTCCCAiW«STGATCTTrATCGTTATAATCTTGTTTCTGCTTrTGATTTAAC?rGAA 5427 
W S A K T V L T A A K S D L Y R Y N L V S A F D L S E >  
CTAATAW^CAATGATTATTTASTAAGTTTISSATCTTGAAAATGCAGTAGTTGATCAAAATTCAArTAAAAATGTTGTTATT 5508 
L I N N D Y L V S F D L E N A V V D Q N S I K N V V I >  
TATGCAAAATCTGATAAGGATCAAATaACTTATTCAAAACAAATTGTACTTAAAGGCTTTGGftAATACAGAACAAGCTAGA 5589 
Y A K S D K D Q I T Y S K Q I V L K G F G N T E Q A R >  
ACTAATTTTGATTTTAGTCAAATTGMTCAAGCaAGTCTTITGTTGATCrTTCAAGASCAAAICTAACTTTGATGGAATTC 5670 
T N F D F S Q I D S S K S F V D L S R A N L T L M E F >  
CflAATTTTGCITGCCCAAAATTTTC3AAAATGAAA3AGGAAGTAATTGATTTTCACGACITGAAA3AGCTTrGGTTGCA!rCA 5751 
Q I L L A Q N F E N E R G S N W F S R L E R A L V A S >  
AAAGCGaGTCTTrcACTrrATAATTCXTrAGGAGAACCCXSTATTTTTAGGCCCAGATTArcAATTAGACCCAGTTITGGAC 5832 
K A S I . S L Y N S L G E P V F L G P D Y Q L D P V L D >  
CGAAAAAAATTATTAACTTrcTTAAATAAAGATGGAAAATTAGTTCTTGGACTTAATTTAGTGCAAATTTCAACTAAAAAA 5913 
R K K L L T L L N K D G K L V L G L N L V Q I S T K K >  
ACTATGAATTTAAATCTTGAAGTTCGCGGCGCGATTTCAAATCAGGAAAITTCTAAAATTCTAAAATCCTGACTTGAAACA 5994 
T M N L N L E V R G A I S N Q E I S K I L K S W L E T >  
AATCTTCAAGGCyiAATTAAAAACCAAAGATGATTOXaAATGGCaCTAGTAAAAGftTAAAATTAGCCTCTCTGATTATrGA 6075 
N L Q G K L K T K D D L Q M A L V K D K I S L S D Y W >  
TATGGATCTCCGAATTCAAAAGTAMTACATCCCAAAITrTAACAAAAAGTAAAGAAaTrAAAGA.TCTTTTTGATTTflAGT 6156 
Y G S P N S K V N T S Q I L T K S K E F K D L F D L S >  
GAGACaAATTTmTCTTAATACCAAAATCXXiftACTGTCrATTTAAGTATTATTCCCAAACTTTTAGATCCAAGTCAGATT 6237 
E T N F F L N T K I G T V Y L S I I P K L L D P S Q I >  
TCTGTTGTTGATAAGAAAAAACTAGTTGAAAATCAAAAAAIITCGCTTTGAAATTACTGCTTCTTTAAAACGAAAAGCTATT 6318 
S V V D K K K I . V E N Q K I R F E I T A S L K R K A I >  
GATAAAAAATTTATCATCCAGGATCTTCC^GTTTTTCTTGATCTAAAASTrcMTTTAATAAATACCAAGCCGCTGTTGCC 6399 
D K K F I  I Q D L P V F V D L K V D F N K Y Q A A V A >  
CAAATGTTTGGAACGATAAAAGCAGTTAAAGAATrTTCAATGCXrCGAAGATCAAGATGCAAAAACTITATCCTCAAATGAA 6480 
Q M F G T I K A V K E F S M P E D Q D A K T L S S N E >  
ATAAAACAGCGAGTTGATCGACTTTTTGAACTAGCAAAAACAGTGACTAATrTGGAAAATCCAAGTGAAGAAGTTCTTAAA 6561 
I K Q R V D R L F E L A K T V T N L E N P S E E V L K >  
AGCATTTATTTATTAAATACGGGAAAArATTrAGTCGACCAAGACCAGGAAAAAGTAAAACAAGAGCTAAAAACCGTQATT 6642 
S  I Y L L N T G K Y L V D Q D Q E K V K Q E L K T V I >  
GAGGGCTTAAAATCAAAGGCAAATACTCAAAAAACAGAAAAAAATAGCCCCACACAACCGAAAAAACCAGAGGTTTCACTA 6723 
E G L K S K A N T Q K T E K N S P T Q P K K P E V S L >  
Figure 9. (Continued) 
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GCTAAAACAi«:aGAAAATTCAGCAAAAAC7«3TCAAGGTJ«GCACTTTTGCAGAflGAAGCTAAGGGTCAAAGTCAAAGTCfiG 6804 
A K T T E N S A K T V K V S T F A E E A K G Q S Q S Q >  
C^AACaO^CCAGTTTCCJ r^raMCGCCTCAAACTAGTa^U^ATKaCTTCCTAAnCCACAAGCAGCTCJWVTTCTCT 6885 
Q T Q P V S T S S P Q T S Q N S L P N S T S S S N S V >  
TTAGAAMTGAAAAATTTCGGACAAGCATTTGAflCAGCTTTTAATTTCXSCTAM'ATTTArAATCTTGAAAATACAAAAAGC 6966 
L E N E K F G T S I W T A F N F A N i y N L E N T K S >  
GAATAIGAGftTCTCAACTTTAGGAAATAAGCTATTTTTTGATTTTAAATTAGTTGATAAAACTAATCAAAATCTAATTTTG 7047 
E Y E I S T L G N K L P F D F K L V D K T N Q N L I L >  
GCTCaGTCCAAAATTAGTCTTAATAATATTATTAATTCTAATAAATCTGCCTATGM'ATAATTAAGAAATTCAATCCCGAT 7128 
A Q S K I S L N N I  I N S N K S A y D I I K K F N P D >  
GTGTTTTTAGATGGAACAATTAA'ITATCAAAArCAAGGAAAAlSATAAAAAAGAA'm'ATCCTAAAAGATTrAAGTGATAAT 7209 
V F L D G T I N Y Q N Q G K D K K E F I L K D L S D N >  
AAATTAATATrTAAATCAISAAGATGCAATTCAAACrcATCAAGGTTTAGAGCTAAAGAAACCTTTGAAATTACAGTCAAAA 7290 
K L I F K S E D A I Q T D Q G L E L K K P L K L Q S K >  
TaSTCTAATCCAGAAAAASAAATATCAACTTCTTTATATACCGGAGCAATTrATTTAGTTTTTGATGCAAAAAATATTTCC 7371 
S S N P E K E I S T S L Y T G A I Y L V F D A K N I S >  
GATGGTAATTGGATTAATCTTTTAGCCGATAGAAAAGGAAAAGGGCTTGTAATTAAAGTTCAAAATTCAAATAATAATGTA 7452 
D G N W I N L I i A D R K G K G I . V I K V Q N S N N N V >  
CCTAAAACCMAGAAATTCnTGACaMX3GTACCTATTTATATGAAATTCTIXX:TGGC»A3GATTCGATTAAGGTAAATTCT 7533 
P K T K E I V E N G T Y L Y E I L A G K D S  I K V N S >  
TATTTTTITCCAACAAAGTACCCAAAACGTGTAMACCTCTTAAATTCGAGATTAACCCTAAAGACACCTrGCCAAATrTC 7614 
Y F F P T K y P K R V K R L K F E I N P K D T L P N F >  
TTTACmAGAATGATTTCATCTTGATrGGTATCAAATCGGCCCAGGCGAACAAAATAAAAAACCACAACAAAACGCTAAA 7695 
F T L E W F H L D W Y Q I G P G E Q N K K P Q Q N A K >  
AAAGAACCTACAATTATATTAAAAACXSCTGGCAArATTTAATGATAAATCATTTGCAGAGAAAGGAAGTTTAACAAAAAGA 7776 
K E P T I  I L K T L A 1 F N D K S F A E K G S L T K R >  
AGTGAATOAATrrAACGGGTTCATTAGAAACTATGTTAAAAAGTAACGATCAAATTTTTGITAAAAAACAGAATTTAGTAAA 7857 
S E L I N G L I R N Y V K K >  
AGATTTITrATTrAAATTATAAAMGCAAACCCrAATTAAAAGTGGAAAAAATTAGGAAAAASAAGCTATTTTTACTTTTT 8019 
TTTGATTATTTTATAATTTTTTGATAATATTQGTGATATATTArrAAATCTATTTlTTCGTTGAAAAAC3GATGTTrAATAA 8100 
TGCAAATmTATAAAAATTTGCATTTCrAGCaVAAATTAATCnTrTATAC»TTTTGTTAAAAGAAAAATTGCGGCTGTCT 8181 
< D K I C K T L L F  l A A T E  
CA3ATCTAAGAATTCTTTTCCCGAGTCTGATA:nTIX3AAACCCTAATTTTTCIGCTrGTreGATTTCAACATCATCAAACC 8262 
< S R L I R K G L T I S Q F G L K E A Q Q I E V D D F G  
CACCTTCAGQCCCAATAAITATAATTGTATTITQGGQGTTATawSGGATATTTATATTGTTTTTTGCrCITTCAAAACrGA 8343 
< G E P G I  I I I T N Q P N D P I N I N N K A R E F S I  
TTAATnrACTGGAAAATTTTTGGCITGTTCrAAAAGATCCrTATAMTrATAGGTAAArTTATrTPrGGAATCAAATTGC 8424 
< L K V P F N K A Q E I , I , D K Y N I P I , N I K P I I , N R  
GGAAACTTTGTTGGGO^CTATGAAGACAAATTTGTTCTCATCITITGAGTTTTTTTTCMGATCCCCGCTTAGTTTTTGGG 8505 
< F S Q Q A S H t . C I Q E W R K L K K E L D G S L K Q S  
Figure 9. (Continued) 
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i«ACATTITrACTATAAAAAGGTaU\ATTTCATTAACCCaATrTCAACAGCTTTCTGGATTGCAAATTCAAATGATTTTG 8586 
< V N K S Y F P W I E N V G I E V A K Q I A F E F S K T  
TCrTCAAAATTGawnm5AGAACAACmX3TTTm<3GTIXXnTArTCCCCTTMTTTTTTCAATTATTTCTGCTTTGT 8667 
• e K L I A L A L V V K N K P E N N G K I K E I I E A K N  
TTGAATTAGGGACTAATCTCACAAGGTAGAArrCATTTTGATAAACACAAATAAAATTTTaOTTTTAATTCTTACAGTTT 8748 
< S N P V L R V L Y F E N Q Y V C  I F N E N K I R V T K  
TAATATGATTTAAGGITAGATTTGTTAAGATAAASAAATlTrCTTGTTTTTCAirTGACAAAAAAGCGATACAirAATAAAAA 8829 
< I H N L T I . N T I , I P P N E Q K E N V F F R Y M  
TTTTAAAGGAAAATTGATAAACTATTTAAAAAATAGTrTAAAATTATTAAAAAAGAAGGAAAAACTAT<3GAAAAATTATCA 8910 
M E K L S> 
GCAAACGAAATAAGACAACTTTGAATOGATTTTTTTCGaSAAAAAAATCATTTITITATCGAATCAAAACCACTTGTTCCC 8991 
A N E I R Q L W I D F F R E K N H F F I E S K P L V P >  
CAAAATGATGACTC7\CrTCTTTGAATAAATTCAGGAGTTGCCACTITAAAAGATTATTTTACCX3GCAAAAAAATTCCCCCA 9072 
Q N D D S L I i W I N S G V A T L K D Y F T G K K I  P P >  
TC^AAAO^CnCTAAACTCCCAAAAAGCCTrAAGAACAAATGACATTGAAAATCTTGGTCTAflCOTCGCGCCATCACACC 9153 
S K R L V N S Q K A L R T N D I E N V G L T S R H H T >  
TTATTTGAAAOXKrrTGGGAATTTTTCAATTGGTGACTATTTTAAAACAGAiUSCAATTGACTAIGCTTATGAATTTTTAACT 9234 
L F E M L G N P S I G D Y F K T E A I D Y A Y E F L T >  
AAAAAGTTAAAATTAGATCCCAAAAATTTGTTTATTACTTATTATGATGGTGATGATATAACTTTTGAAAAATGAAAAAGT 9315 
K K L K L D P K N L F I T Y Y D G D D I T F E K W K S >  
TTGGGATTTTCTAATGAAAAATTAATAAAAGGCAGO^AAAAAACAAATTTTTGGGATTTAGGTCAGGGGCCTTGTGGTCCT 9396 
L G F S N E K L I K G S K K T N F W D L G Q G P C G P >  
TGTASTGAAATrTATTTTGACCX3CGGGCCAAAAriTGATAC?rCGAGGGAGCGAACTAA 
C S E I Y F D R G P K F D S R G S E ] >  
Figure 9. (Continued) 
Table 5. Amino acid composition of the translated PI02 sequence. 
No. Percent No. Percent 
Non-polar A 45 4.98 Polar: G 33 3.65 
V 52 5.75 S 86 9.51 
L 103 11.39 T 54 5.97 
I 62 6.86 C 0 0 
P 28 3.10 Y 29 3.21 
M 6 0.66 N 74 8.19 
F 44 4.87 Q 47 5.20 
W 9 1.00 
Basic: Acidic: 
K 114 12.61 D 50 5.53 
R 17 1.88 E 50 5.53 
H 1 0.11 
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Figure 10. Analysis of the P97 contig for ORFs and direction of transcription. Bars indicate 
ORFs identified using Mac Vector software and a mycoplasma codon table. The ORF or gene 
designation is given below each bar. Shaded bars indicate transcription of left to right, white 
bars indicate transcription right to left. Sizes are given in kilobases. P97, ORF 3; P102, ORF 
4. Restriction enzymes: A, Accl; B, BaniHl; Bg, Bg/II; C, Clal; E, EcoRI; EV, EcoRV; H, 
//indHI; Hn, HincR; S, Sail. 
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Figure 11. Predicted hydrophilicity and structural properties of the translated sequence of 
P102. The scale at the bottom of the figure indicates the amino acid residue number. The type 
of analyses and regions of secondary structure are as described in Figure 5. 
In the approximately 1 kb region between ORFl and P97 is 0RF2 which is transcribed in 
the same direction as P97.0RF2 is 426 bp long and has a capacity coding for a 16.4-kDa 
protein with a pi of 10.52. The sequence of 0RF2 displays no significant homology to known 
sequences. 340 bp upstream of ORF 2 is a 21 bp polyadenine sequence of unknown function. 
Two stem-loop structures were also identified flanking the ORF 2. The first stem loop, which 
is located 60 bp upstream of ORF 2, consists of 16 bp stem and a loop of 11 nucleotides. The 
second stem loop, which is located 40 bp downstream of ORF 2, consists of an 18 bp stem 
and a loop of 8 nucleotides (data not shown). An 133 bp sequence located 140 bp upstream of 
ORF 2 was found to be highly homologous to a sequence in the PI02 gene (80% identity). 
One explanation for the 600 bp cloned fragment in plasmid pISM2136 is a recombination event 
between these two sequences with a deletion of the intervening sequences (Figure 12). 
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PISM2136 
489-782 
6540-7006 
-AATTTTTTT AAAAAMTTT TTTACCCITG GCAGCTAAAA CTAGTAAGTT 49 
TAATTTTTTT AAAAAATTTT TTTACCCTTG GCAGCTAAAA CTAGTAAGTT 50 
PISM2136 
489-782 
6540-7006 
TGAAAAGTCT GAATATTATT ACTATTTTTC CAAATTTTTT TAAAAAAAAA 99 
TGAAAAGTCT GAATATTATT ACTAITTTrC CAAATTTTTT TTAAAAAAAA 100 
PISM2136 
489-782 
6540-7006 
AAAAAAAAAA AA—TTCTCT AAAAATGATT AAAGGTATTG Ti 
AAAAAAAAAA AAAATTCTCT AAAAATGATT AAAGGTATTG TJ 
'AAAAA3RC( 
'AAAAMTCi 
:c 
:c 
-free 
147 
150 
3 
PISM2136 
489-782 
6540-7006 
AA 
AA 
-AIAAGA; 
A^AAGA; 
AADTSAAGAV 
3TTCTTAAAC 
3TTCTTAAAC; 
3TTCTTAAW. 
TTATTTATTT AT.MTIATACA 
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pISM2136 
489-782 
6540-7006 
TAGT:3?C 
TAGTC3?1 
TAGT:3?|C 
CA AGACAGGM^ A^-(^AAAATC AAPAG 
CA AGAC 
CA AGAC CjG3[;A AI^ACTAAAJC AA3AG 
AA A^AOTGATT 
A|3T;^AAAAIT CRBAG^AA APAIXTTGATT 
:T«AA AAC :S3TGATT 
244 
249 
103 
PISM2136 
489-782 
6540-7006 G^ 
ra^GOGCTTAA 
•AA 
3GCTTAA 
GXI^GCTTA 
/ATCAAAGG: 
TATCAAAGGT 
IIATCAAAGG: 
AAATrCICAA 
AAAT^TCCAA 
AAATRCICAA 
AAAA( LQAGAAA AAAAT 
AAAAT 
AAAA^ 
AA;!CnAGAAA 
AA;ACAGAAA 
-G-CC 
lT^GCCC 
292 
294 
153 
PISM2135 
489-782 
6540-7006 
CACACAACCG AAAAA-CCAG AGTTCACTCT AGCT-AAACA ACAG-AAATT 
CACACAACCG AAAAAACCAG AGGTTTCACT AGCTAAAACA ACAGAAAATT 
339 
294 
203 
PISM2136 
489-782 
6540-7006 
CAGCACAAAC AGTCAAGGTA AGCACTTTTG CAGAAGAAGC TAAGGGTCAA 
CAGCAAAAAC AGTCAAGGTA AGCACTTTTG CAGAAGAAGC TAAGGGTCAA 
389 
294 
253 
Figure 12. Analysis of the overlapping region between pISM2136 and the P97 contig. The 
region of overlap in the P97 contig was determined to be the regions consisting of base pairs 
489-782 and 6540-7006 in the P97 contig DNA sequence. The regions of identity are shown 
by the boxes. The numbers on the right indicate the base pair number of the three regions being 
compared. Dashes indicate mismatched base pairs. 
Mapping of P97 to the M. hyopneumoniae Genome 
As a first step in determining if the P97 gene sequence is found in single or multiple copies in 
the M. hyopneumoniae chromosome, it was decided to map the location of P97 on a physical 
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genome map. This process was simplified by the studies of Huang and Stemke who had 
previously constructed a physical map of M. hyopnewnoniae with the restriction enzymes 
Apal, Snol, dcadAspllZ (92). Following preparation of M. hyopneumoniae chromosomal 
DNA in SeaPlaque low melting temperature agarose blocks, the DNA was digested with Apal 
and ApaLi, an isoschizomer of Snol. Separation of the fragments was then accomplished by 
using CHEF pulsed field gel electrophoresis. After electrophoresis, the DNA was stained with 
ethidium bromide and visualized under UV light. The size of each restriction fragment was 
determined by using GelReader software (NCSA, Urbana-Champaign, EL). Apal digestion 
gave rise to 6 bands in which the smallest 3 bands appeared to be doublets, resulting in a total 
of 9 fragments (Figure 13). ApalA restriction digestion also gave rise to 9 restriction fragments 
in which the largest 2 fragments were doublets. The total calculated genomic size based upon 
ApaLl digests was 1050 kb, which was in good agreement with the published data (92). DNA 
in the pulsed field agarose gels was denatured and transferred to nylon membranes which were 
hybridized with probes derived from the P97 contig. Probe A consisted of the 1.75 kb fcoRV 
fragment of pISM2159. Probe B consisted of the 0.42 kb EcoRI fragment of pISM2139. 
Probe A and B both hybridized to the same ApalA and Apal fragments which we calculated to 
be 186 kDa and 141 kDa in size, respectively (Figure 13). This data mdicates that the P97 
operon is found within a 120-140 kb region of the chromosome based upon the published 
physical map (92). It could not be determined by this analysis if there were more than one copy 
of P97 in this region. 
Screening of M. hyopneumoniae Library with pISM2136-Speciflc Probes 
One possible explanation for the reactivity of Mab F1B6 with multiple bands on 
immunoblots (Figvire 2, (264)) is the expression of modified copies of the P97 gene sequence 
or its Mab binding epitope in M. hyopneumoniae. This is a second explanation for the 615 bp 
insert found in plasmid pISM2136 which produces a polypeptide product that reacts with Mab 
F1B6. The basis for the reactivity of pISM2136 was not obvious once the DNA sequence was 
known, however. Adhesins or adherence-related genes from several mycoplasmas have been 
demonstrated to exist as multiple copies in the genome, which include M. pneumoniae, M. 
genitalium, M. hominis and M. gallisepticum (137, 178, 224, 265). 
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Figure 13. Mapping of the P97 operon sequences ioApal- and ApaLI-digested 
chromosomal DNA of M. hyopneumoniae. Following CHEF electrophoresis of Apal- and 
ApaLI-digested chromosomal DNA of M. hyopneumoniae, the DNA was transferred to nylon 
membranes and hybridized to P97 operon-specific probes. The restriction enzymes are 
indicated above the lanes. Panel 1, probe A: 1.75 kb EcoRV fragment of pISM2159; Panel 2, 
probe B: 0.42 kb £coRI fragment of pISM2139; Panel 3, CHEF gel prior to DNA transfer. 
The fragment sizes are given in kilobases. 
Since pISM2136 contained an internal SaH site which is rare in the M. hyopneumoniae 
chromosome (Minion, unpublished), it was initially placed overlapping the SaK site of the 
restriction map shown in Figure 1. DNA sequence analysis of both pISM2136 and the region 
of the P97 contig containing the Sail site failed to support this idea, but there was substantial 
homology with sequences in this region to a portion of the pISM2136 insert (Figure 11). When 
the insert of pISM2136 was used as hybridization probe to EcoRI-digested M. hyopneumoniae 
chromosomal DNA (designated as pISM2136A in Table 1), three bands of 2.2, 3.3 and 4.2 kb 
were identified (Figure 14). When the insert was divided into two probes by digestion with 
£coRV, Pstl, and SaK resulting in 200 and 415 bp fragments, the hybridization patterns were 
distinctly different. The 200 bp probe recognized a single 3.3 kb band; the 415 bp fragment 
(designated as pISM2136C in Table 1) recognized bands of 2.2 and 4.2 kb strongly and a 3.3 
kb fragment weakly (Figure 14). This was the first positive genetic evidence suggesting that 
the F1B6 Mab epitope might be found in multiple copies in the chromosome. 
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Figure 14. Hybridization analysis of M. hyopnewnoniae EcoRI-digested chromosomal 
DNA with pISM2136-specific probes. M. hyopneumoniae chromosomal DNA was digested 
with fcoRI, separated on 1% agarose gels and blotted to a nylon membrane. The probes used 
to analyze the digests are indicated at the top of the autoradiograms. The molecular weight 
standards (MW) are shown on the left in kb. 
When pISM2136 fragments were used to screen the M. hyopneumoniae genomic library, 
two groups of clones were obtained following rescue and restriction mapping (Figure 15). One 
group represented clones from the P97 contig region while the second group represented a 
distinctly different chromosomal region. None of the group 2 clones were recognized by the 
F1B6 Mab by immunoblot analysis (data not shown). 
The final experiments with pISM2136 sequences to further delineate the origin of 
pISM2136 was PCR analysis of M. hyopneumoniae chromosomal DNA using primers 
designed to amplify an internal 539 bp fragment (TH127 and TH128). These primers failed to 
amplify genomic DNA in two different experiments, but did amplify the positive control DNA 
(pISM2136)(data not shown), suggesting that the genomic structure of the pISM2136 insert 
does not lie within the genome of M. hyopneumoniae. 
Hybridization Analysis of M. hyopneumoniae 232A with P97 Internal Probes 
In order to examine the possibility that multiple copies of P97 might be present in the M. 
hyopneumoniae chromosome, a hybridization smdy was undertaken using probes from various 
regions within the P97 operon. Probes 1 through 5 and probe 5.1 were isolated, radiolabeled 
and used to probe M. hyopneumoniae chromosomal DNA digested with restriction enzymes 
BglQ., £coElI, EcoRV, HincYL, and //indlH (Figure 16). Digested chromosomal DNAs were 
separated on 0.4% agarose gels, transferred to nylon membranes, and hybridized with the ^^P-
radiolabeled probes. Probe 1 hybridized to restriction fragments from EcoRI, EcoRV, and 
Hindin. digestions as predicted by the resttiction map shown in Figure 10. HincU digestion 
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gave rise to a 7.6 kb fragment, presumably resulting from the presence of a HincTl site located 
upstream of P97 gene and outside the cloned region. Fragments hybridizing weakly to probe 1 
were also observed. BglQ. digestion, however, gave rise to two fragments of equal intensity 
with apparent sizes of 10.5 kb and 14 kb (Figure 16). 
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Figure 15. Restriction maps of clones identified with pISM2136-specific probes. A. 
Qones that overlap the P97 contig region (group 1). B. Clones that failed to overlap the P97 
contig region. Plasmid numbers indicate clones that were identified using the 615 bp fragment 
(pISMl 136 - pISMl 138) or the 415 bp probe (plasmid numbers > pISMl 165). Sizes are given 
in kilobases. 
Figure 16. Hybridization analysis of M. hyopneumoniae DNA with P97 operon-specific 
probes. The physical map of the P97 contig region is shown at the top of the figure. Restriction 
enzymes: B, 5amHI; E, £coRI; EV, £coRV; H, //mdlll; He, HincUr, K, Kpril, P, Pstl; S, 
Sail. The probes used in this analysis are shown below the physical map. Each panel 
represents hybridization with a single probe (shown at the top of the panel). Restricted enzyme 
digested chromosomal DNA: lane 1, i/mdlH; lane 2, Hincll\ lane 3, EcoRV; lane 4, £coRI; 
lane 5, BglR. Lane 6 contains 6 ng of control plasmid DNA digested with the enzymes used to 
isolate ±e probe. Probes 1-3 were isolated from EcoKV - HindBl - iViciI-digested pISM 1213 
DNA. Probes 4, 5 and 5.1 were isolated from pISM2139 DNA digested with HincU - Kpnl 
(probe 4), HincU - Neil - Kpnl (probe 5), or HincU - Pstl (probe 5.1). The size of each band 
was determined using GelReader software, and the sizes are indicated in kilobases. 
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Probe 2 also hybridized to fragments of the £coRI-, £coRV-, and HzwcII-digested M. 
hyopneumoniae chromosomal DNA as predicted according to the restriction map (Figure 8). 
Hindni digestion resulted in a 13.5 kb fragment recognized by probe 2, indicating the presence 
of a Hindni downstream of the cloned region. BgUl digestion gave rise to two fragments 
strongly hybridized by probe 2, one of which (3.5 kb fragment), was predicted by the 
restriction map. A weakly hybridizing 10.5 kb fragment was also observed in the Bgfn. lane 
with probe 2 which, according to the restriction map, should be the fragment containing the 5' 
end of P97 gene and its upstream region which overlaps the probe 2 sequence by 
approximately 200 bp (Figure 16). 
Probe 3 hybridized to a 14 kb BglH. fragment, the same size as the larger fragment 
recognized by probes 1 and 2, in addition to the predicted 3.5 kb fig/II fragment. Since probe 3 
did not overlap the 1.75 kb EcoRV fragment within the P97 operon, a fragment containing the 
PI02 gene sequences as well as other downstream sequences was observed. This fragment, 
which was larger than 16 kb, must result from the presence of a downstream EcoRV site 
outside the cloned region (Figure 16). 
Probe 4 hybridized to 0.85 and 3.5 kb BglR fragments as predicted by the restriction 
map of the P97 operon and to the 14 kb fragment which was also recognized by probes 1, 2, 
and 3. However, probe 4 also hybridized to two BglU. fragments of 3.0 and 7.5 kb along with 
several other fragments that were weakly hybridized. In the £coRI digest, probe 4 recognized 
the 0.5, 2.2, and 2.3 kb fragments expected from the restriction map, but it also recognized 
three extra fragments of 3.8, 4.2, and 4.8 kb which was not observed with probes 1,2, and 3. 
Hybridization of probe 4 to EcoKV-, HincJl-, and /fwdlH-digested DNA also revealed extra 
bands that could not be accounted for from the restriction map of the P97 contig (Figure 16). 
Interestingly, when probe 5 was hybridized to BglR -digested DNA, the 14 kb 
fragment was not recognized. Instead, a 7.7 kb fragment was weakly recognized. According to 
the restriction map, probe 5 should recognize two BglS. fragments of 0.9 (weak) and 1.3 kb 
(strong). However, the 0.9 kb fragment hybridized strongly to probe 5, while the 1.3 kb 
fragment showed a weak hybridization. A 2.2 kb £c<?RI fragment was hybridized by probe 5 
as expected based on the restriction map, but a 4.2 kb £coRI fragment was also recognized. 
£coRV and //iwdlU digests had similar hybridization pattems when using probes 4 and 5. A 
5.4 kb £coRV fragment, and 5.2 and 12.1 kb HindSL fragments could not be accounted for by 
the restriction map. HincR digestions gave rise to two fragments (1.8 and 8.2 kb) with probe 
5. The P102 internal probe 5.1 had an identical reaction pattern to probe 5. 
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Hybridization of Chromosomal DNAs of Six M. hyopneumoniae Strains With 
P97 Operon Internal Probes 
Zhang et al. demonstrated variation in the ciliary binding activities of different M. 
hyopneumoniae strains (264). To explain this variation, an examination of the P97 operon 
structure of six M. hyopneumoniae strains was performed. These strains included the wild type 
strain 232A, three 232A clonal isolates that exhibited high (232A.H), medium (232A.M), and 
low (232A.L) ciliary binding activity, an avirulent strain J and a virulent strain 144L. Strain 
144L had previously been shown to express a smaller P97 protein by immunoblot, but it had 
high ciliary binding activity (264). The BgHi- and EcoRI -digested chromosomal DNAs from 
these strains were hybridized to probes 1-5 representing different regions of the P97 contig. 
B /^n-digested genomic DNA from the six M. hyopneumoniae strains gave ahnost 
identical hybridization pattems with probes 1 through 4 (Figure 17). There existed a few 
differences, however. The 14 kb BglQ. fragment in strain 232A hybridized strongly with 
probes 1 through 4, but weakly in clonal strains 232A.H, 232A.M, 232A.L. Hybridization 
with DNA from strains J and 144L demonstrated a higher degree of variability as compared to 
strain 232A. The 10.5 and 14 kb BgHl fragments seen in strain 232A when hybridized with 
probes 1 and 2 were replaced by two smaller fragments of 8 kb and 11.5 kb in strain 144L. 
The major 14 kb BgHl. band observed in 232A DNA by probes 1-4 was weakly recognized in 
all of the 232A clonal isolates and was barely detectable in strains J and 144L. Strain J differed 
from other strains in its hybridization pattems with probes 1 and 2; a 8.2 kb BglR fragment, 
rather than one of 10.5 kb, was recognized. With Bgfll-digested DNAs, strains J and 144L 
had similar hybridization pattems with probes 4 and 5, but J lacked the 7.2 kb BglXL fragment 
observed in other strains with probe 5. 
With EcoRI-digested DNAs, there was a large similarity between the six strains in their 
hybridization pattems except for the following differences (Figure 17). A 5.2 kb EcoRI 
fragment from 232A that was barely detectable with probes 1-3, hybridized more strongly with 
DNA from 232A.H, 232A.M, 232A.L, and was absent in strain J. Probe 4, which contained 
the 5' end of P102, recognized two bands of similar size in J and 144L to those of the 232A 
derivatives, but two other bands were missing and a smaller fragment was present in both 
strains. For probe 5, the hybridization pattern for both J and 144L were similar to each other, 
but completely different from 232A and its clonal siblings. 
Figure 17. Analysis of six Af. hyopenumoniae strains for P97 contig-specific sequences. 
Hybridization was performed on BglU. and EcoRl restricted genomic DNAs from six different 
M. hyopneumoniae strains. Each letter represents two blots developed with a specific probe; A, 
probe 1; B, probe 2; C, probe 3; D, probe 4; E, probe 5; F, R1-specific probe. Each probe was 
hybridized to BgUL- Geft panel) and EcoRI- (right panel) digested DNAs: lane 1,232A (L); 
lane 2,232A (M); lane 3, 232A (H); lane 4,144L; lane 5, J; lane 6,232A; lane C, control 
plasmid DNA (see legend to Figure 16 for a description). Sizes of important fragments are 
given in kilobases. 
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Mapping of the P97 Mab F1B6 Antigenic and Ciliary Binding Epitopes 
Once the P97 gene sequence had been obtained and the role of its product in ciliary binding 
confirmed, studies were performed to map both the Mab F1B6 binding epitope and the cilium 
binding site on the gene sequence. Both analyses were begun by insertional mutagenesis of 
plasmid pISM2159 followed by analysis of the resulting recombinant gene product in E. coli. 
Mutagenized pISM2159 plasmids were isolated, and the TnlOOO insertions were mapped by 
restriction digests. The exact location of the TxdOOO insertion was determined by DNA 
sequencing using TnlOOO end-specific primers. Selected plasmids were transformed into E. 
coli ISM612, the transformants were induced, and the lysates were examined for reactivity 
with Mab F1B6 by immunoblot and for ciliary binding activity. 
Immunoblot analysis with lysates from a series of TniOOO insertions in pISM2159 showed 
thattransposon insertions at or upstream of pISM2159::Tni000.79 (bp 2476 of P97) failed to 
express Mab FlB6-reactive antigens (Figure 18). Plasmids with TnlOOO inserts at or 
downstream of pISM2159::Tni000.133 retained the ability to produce Mab F1B6 reactive 
proteins. These two inserts are separated by 62 bp, which corresponds to amino acids 830 to 
850. Within this amino acid sequence is the AAKP(EAO (Rl) repeated sequence (Figure 19). 
The Mab epitope appears to be within the Rl repeat and requires at least 2.5 repeating units. 
10 70 79 133 90 156 117 76 66 160 147 111 145 
Figure 18. Mapping the P97 F1B6 Mab binding epitope by inraiunoblot using InlOQO 
insertions in pISM2159. Whole cell antigens were prepared from recombinant E. coli as 
described in Materials and Methods. The proteins were resolved on a 10% polyacrylamide (3 
|ig per lane), and the resulting blot was developed with Mab F1B6. The lane numbers indicate 
the number of the TnlOOO insertion (Figure 18; number 10 location is shown in Figure 3). The 
molecular weight markers are shown in adjacent lanes and the sizes are indicated in kDa. 
Figure 19. Location of TniOOO insertions used to identify the Mab epitope and the ciliary 
binding site of P97. The data is given as translated amino acid sequence. Sequence numbers 
are from the P97 DNA sequence given in Figure 4. Arrows indicate transposon insertion 
locations. The transposon insert number is given above each arrow. The underline indicates the 
first repeat (Rl); the hatched underline indicates the second repeat (R2). 
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Microliter plate adherence assays were performed with E. coli lysates to locate the P97 
ciliary binding epitope by using the series oiTnlOOO insertions in pISM2159. Lysates 
prepared from pISM2159::Tni000.70 and pISM2159::Tni000.133 failed to bind to cilia, 
whereas lysates prepared from pISM2159::Tni000.90 and those downstream of 
pISM2159:;Tn7000.90 showed ciliary binding activity (Figure 20). The two inserts 
pISM2159::Tn7000.133 and pISM2159::Tn7000.90 are separated by 75 bp. The 
corresponding amino acid sequence is within the first repeat between repeats 8 and 12 in the 15 
repeat sequence (Figure 19). 
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Figure 20. MPAA analysis of TniOOO insertions in P97. Lysates were prepared from 
ISM612 (pISM2159::Tn7000) strains and tested in the MPAA assay as described in the 
Materials and Methods. The data are represented as mean ± standard error of triplicate wells. 
Numbers refer to the position of the TniOOO insertion in the P97 DNA sequence. The 
transposon number is given in parentheses and corresponds to the number shown in Figure 18. 
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Analysis of M. hyopneumoniae Strains with a Rl-Specific Probe 
Once the P97 Mab FlB6-reactive epitope was mapped to the first repeat region of P97, it 
was of interest to test the hypothesis that other proteins in the M. hyopneumoniae genome had 
the same or similar repeat sequence, thus explaining the complex immunoblot banding pattern 
with Mab F1B6. The two PCR primers TH120 and TH121 were used to prepare a radioactive 
PGR product using M. hyopneumoniae DNA as template, and hybridized to BglR- and EcoRl-
digested genomic DNA from M. hyopneumoniae strains 232A, J, 144L, and the 232A clonal 
derivatives 232A.H, 232A.M, and 232A.L. 
The Rl-specific probe hybridized to the 3.5 kb Bgin. fragment from ail 6 strains of M. 
hyopneumoniae as expected from the restriction map of the P97 operon contig, although the 
hybridization was weak for both J and 144L strains (Figure 17). The R1 probe also hybridized 
to the 14 kb BglR fragment in all strains except for strain J. The signal strength of strain 232A 
was strong compared to those of the 232A clonal isolates although equal amounts of DNA was 
loaded in each lane of the gel. The R1 probe hybridized strongly to the 2.3 kb £coRI fragments 
from strains 232A and its derivatives, but only weakly with those from strains J and 144L. 
Weak hybridization was observed with an EcoRI fragment of approximate 5.2 kb derived from 
strains 144L, 232A.H, 232A.M, and 232A.L, but not with strains 232A and J. 
Analysis of Size Variation in the P97 Repeat Regions by PCR Analysis 
Zhang et al. demonstrated size variation in P97 adhesins among different isolates of M. 
hyopneumoniae (264). The presence of two repeated sequences, R1 and R2, at the carboxy 
end of P97 suggested that there might be a relationship between the size of these repeat regions 
in different strains and the resulting size of the P97 product. To study this, two primer pairs 
(TH120/TH121 for amplification of R1 and TH122/TH123 for amplification of R2, 
respectively) were used. Chromosomal DNA from M. hyopneumoniae 232A, J, and 144L 
strains were isolated and used in PCR amplification with these two primer pairs. Figxire 20 
shows the results of this study. M. hyopneumoniae 232A gave rise to a product of the R1 
region 57 bp larger than that of strain 144L, which in turn was 22 bp larger than that of strain 
J. On the contrary, amplification of R2 from strain J produced a fragment 23 bp larger than that 
from strain 144L which was 7 bp larger than that from strain 232A (Figure 21). 
DNA Sequence Analysis of the P97 Repeat Sequence R1 in Different Strains 
Zhang et al. had previously shown that M. hyopneumoniae exhibited variable ciliary 
binding activity among different strains (264). Analysis of the P97 sequence for the cilia 
binding epitope by transposon mutagenesis indicated that it was located within the central 
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Figure 21. Analysis of size variation in the P97 repeat regions by PCR analysis. The bands 
represent PCR products produced from template DNA from different M. hyopneumoniae 
strains. Lane 1, strain 232A; lane 2, strain J; lane 3, strain 144L, lane C, no template DNA 
control. Rl, repeat region 1 amplified with primer set TH120/TH121; R2, repeat region 2 
amplified with PCR primer set TH122/TH123. 
portion of the first repeat region. None of the strains analyzed above by PCR lacked the Rl 
repeat region and all of the strains seemed to have sufficiently large regions to code for the 
epitope. Another hypothesis was that the repeat sequence was modified to create a missense or 
loss of function mutation. This was addressed by amplifying the region of P97 containing both 
repeat regions of different strain chromosomal DNAs and analyzing the PCR products by DNA 
sequencing. The primers TH120 (upper primer for Rl) and TH123 (lower primer for R2) were 
used for these studies. Following gel purification, the PCR products were sequenced using the 
TH120 primer and the sequences analyzed. The Rl sequences exhibited a high degree of 
sequence homology among the six strains analyzed some of which lacked cilia binding activity 
(J and 232 (L)). All 6 strains retained the AAKP(V/E) Rl repeat sequences. Only 10 and 11 
repeats were observed in strain J and 144L, respectively, while strain 232A and its derivatives 
had 15 repeats (Figure 22). 
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232A P97 AA KGILPQPPAA KPEAAKPVAA KPETTKPVAA KPEAAKPEAA KPVAAKPEAA 50 
232A KGILPQPPAA KPEAAKPVAA KPETTKPVAA KPEAAKPEAA KPVAAKPEAA 50 
232A.H KSILPQPPAA KPEAAKPVAA KPETTKPVAA KPEAAKPEAA KPVAAKPEAA 50 
232A.M KGILPQPPAA KPEAAKPVAA KPETTKPVAA KPEAAKPEAA KPVAAKPEAA 50 
232A.L KSILPQPPAA KPEAAKPVAA KPETTKPVAA KPEAAKPEAA KPVAAKPEAA 50 
J KSILPQPP AA KPEAAKPVAA KPEAAKPETT 30 
144L KGILPQPP AA KPEAAKPVAA KPVAAKPEAA 30 
232A P97 AA KPVAAKPEAA KPVAAKPEAA KPVAAKPEAA KP-VATNTGF SLTNKPKEDY 99 
232A KPVAAKPEAA KPVAAKPEAA KPVAAKPEAA KP-VATNTGF SLTNKPKEDY 99 
232A.H KPVAAKPEAA KPVAAKPEAA KPVAAKPEAA KP-VATNTGF SLTNKPKEDY 99 
232A.M KPVAAKPEAA KPVAAKPEAA KPVAAKPEAA KP-VATNTGF SLTNKPKEDY 99 
232A.L KPVAAKPEAA KPVAAKPEAA KPVAAKPEAA KP-VATNTGF SLTNKPKEDY 99 
J KPVAAKPEAA KPVAAKPVAA KPVATN TNTNTGF SLTNKPKEDY 73 
144L KPVAAKPEAA KPVAAKPEAA KPVAAKPVAT NTNTNTNTGF SLTNKPKEDY 80 
232A P97 AA FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQE IIKELDKTVL 149 
232A FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQE IIKELDKTVL 149 
232A.H FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQE IIKELDKTVL 149 
232A.M FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQE IIKELDKTVL 149 
232A.L FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQE IIKELDDTVL 149 
J FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEEQK IIKELDKTVL 123 
144L FPMAFSYKLE YTDENKLSLK TPEINVFLEL VHQSEYEDQK IIKELDKTVL 130 
232A P97 AA NLQYQFQ 156 
232A NLQYQFQ 156 
232A. ,H NLQYQFQ 156 
232A. M NLQYQFQ 156 
232A. ,L NLQYQFQ 156 
J NLQYQFQ 130 
144L NLQYQFQ 137 
Figure 22. Sequence comparison between the P97 R1-R2 region of six M. hyopneumoniae 
strains. Amino acid sequence alignment between the original strain 232A P97 sequence (Figure 
4) and the PGR products of 232A, its single colony isolates 232A.L, 232A.M, and 232A.H, 
strains J and 144L. The alignment was generated using DNA sequence information obtained 
from PGR products with primers flanking the R1/R2 region of P97. 
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Analysis of Clones Overlapping the Second Chromosomal Copy of P102 
Since tiie hybiidization data indicated that M. hyopneumoniae contained at least one 
additional copy of the P102 gene sequence (Figure 16), the cloning of this region was 
undertaken. £coRI digests of M. hyopneumoniae chromosomal DNA were resolved on 
agarose gels, the regions of the gel representing the 3.8 and 4.2 kb fragments were excised, 
and the DNA was isolated. These fragments were then cloned into pSK- as described in the 
Materials and Methods. Probe number 4, which contained the 5' half of P102 (Figure 16), was 
then used in colony hybridization (195) to identify the appropriate recombinant plasmids 
containing the P102 sequence. Two plasmids, pISM1232 and pISM1233, were identified, 
restriction mapped, and the ends of the cloned fragments were subjected to DNA sequencing. 
A sequencing primer was used to obtain additional sequence information of the 3' end of 
pISM1232. The sequence obtained was then aligned to the P97 contig sequence using 
MacVector software. Figure 22 shows the results of this study. Restriction site mapping of the 
two cloned fragments, 3.8 and 4.2 kb, suggested that these two clones are from the same 
chromosomal region as the five clones identified with the pISM2136 probe (Figure 15). The 
DNA sequence of the 3' end of pISM1232 and the 5' end of pISM1233 aligned perfectly with 
the PI02 sequence, but ended abruptly at the 3' end of the P97 gene sequence. The 5' end of 
pISM1232 showed no homology with the P97 gene or any other known sequence. The 3' end 
of pISM1233 had homology with the heat shock protein Clp. 
Figure 23. Analysis of clones overlapping the second chromosomal copy of P102. The M. 
hyopneumoniae 3.8 and 4.2 kb £coRI fragments identified by probe 4 (Figure 16) were 
cloned, restriction mapped, and the ends of each fragment were sequenced. The physical map 
of the P97 contig is shown as a reference along with the direction of transcription Qarge 
arrow), and the P97 and P102 gene boundaries. The physical maps of clones pISM1232 and 
pISM1233 are shown below the P97 contig map. The 5' and 3' ends of the plasmids are 
relative to the orientation of PI02. The sequence information derived from these two plasmids 
are indicated by the smaller arrows. The boxes above the second P102 copy indicate alignment 
results of the DNA sequence information. The open boxes indicate almost perfect aligiunent 
with P102 sequences, the black boxes indicate no sequence homology with known sequences, 
and the hatched boxes indicate no sequence information available. The actual sequence 
aligrmient is shown at the bottom of the figure. The end of the P97 sequence is indicated as 
well as £coRI sites (E) used for cloning, the NcH site (N) which lies between P97 and PI02 in 
the P97 operon, and the SaK site (S) that has been modified in the second copy of P102. Also 
shown are the £coRV sites (EV). The upper sequence is from the P97 operon. The sequence 
aligrmient is indicated in the lower sequence as follows: capital letters indicate agreement and 
small letters indicate no match in the 3' end of P97, periods indicate perfect alignment with P97 
operon sequences. No sequence information is available for the small 422 bp region between 
the two £coRI sites within the second PI02 copy. 
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GATGCTAAATTGCTATACTTrATCCTAAGGGATGATTCAAAATCCGGTGATCCTAAAAAATCAAGTCTAAAflGTTAAAAT 5040 
agTaCaAAAaaaacAaAaaaaAggtTAtaattTGAaTatAtAagacaaGcaaaTttcccccttttgCagttcaaTAAAAa 
end of P97 Mrir 
AACAGTAAAACAAAGTAATAATAATCAGGAACCAGAATCTAAaTAAMCCCGCAGGTATTTATCCTATGAAGTTAGCAAA 5120 
ActttTtAcAgtAAaTtgccAccAT-AatccCCtc > 
ATTACTTAAAAAACCTTTTTGATTAATAAC <450 bp of identical sequence> 5200 
- > 
EcdBl 
TTITAGTCAAAilTGaVTTCAAGCAAGTL'm'TGTi'GaTCTTTCAAGAGCAAATCTAACmGATcjGAATrcjcAAATTrTGC 5680 
c g c 
TTGCa:AAAATTrTGAAAATGAAAGAGGAAGTAATTGATTTTC»CGACTTGAAAGAGCTTTGGTTGCATCAAAAGCGAGT 5760 
CTTTCACTTrATAATT<XTTAGGAGAACCa3TATTrTTAGGCCCAGAITATCAATTAGACCCAGTITTGGACCGAAAAAA 5840 
ATTATTAACrTTGTTAAATAAAGATGGAAAATTACSTTCTTGGACITAATTTAGTGCAAATTTCAACTAAAAAAACTATGA 5920 
ATrTAAATCTTGAAGTTCXX»XXXXamTCyu\ATa\GGAAATTrCTAAAATTCTAAAATCCTGACTTGAAACAAATCTT 6000 
CAAGGCAAATTAAAAACX:AAAGATGATTTGCAAATGGCACTAGTAAAAGATAAAATTAGCCTCTCTGATTArTGATATGG 6080 
gCORI 
ATCTCC^ Am^ AAAAGTAAATACATCCCAAA.. .<450 h^ ) of identical sequence> 6160 
> 
Sail* 
AAGCATTTATTTATTAAATACXSGGAAAATATTrAllgrCGACfcAAGACCAGGAAAAAGTAAAACaAGAGCTAAAAACCGTGA 6640 
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DISCUSSION 
General Discussion 
M. hyopneumoniae colonization of the swine trachea occurs by attachment directly to the 
cilia of the tracheal epithelial cells (144,268). The attachment is mediated by specific M 
hyopneumoniae surface proteins, adhesins (264). The adhesins appear to bind specifically to 
receptor molecules on the swine cilia and not to the epithelial cell bodies. Non-adherent strains 
of M. hyopneumoniae are avirulent (Ross, R. F., and T. F. Young, unpublished). Therefore, 
the ciliary adhesin(s) appear to be a crucial virulence factor for M. hyopneumoniae 
pathogenesis. Previous studies have suggested that the M. hyopneumoniae surface protein P97 
fimctions as the cilium adhesin (264,267). To examine this hypothesis more thoroughly, this 
study was undertaken. 
In the study reported here, a molecular and functional analysis of the P97 protein 
was performed to further characterize its adhesive properties and potential role in ciliary 
adherence in vivo. To accomplish this, the P97 gene was cloned and expressed in E. 
coli. The recombinant protein (rP97) was then examined for its ability to bind to 
purified swine cilia. The results of this study show that P97 can bind to swine cilia, and 
its binding mimics the binding characteristics of intact M. hyopneumoniae in the 
MPAA. The latter was established by inhibition assays showing that rP97 binding to 
cilia was inhibited by the sulfated polysaccharides heparin, fiicoidan, and mucin in a 
similar maimer to that observed with whole cells of M. hyopneumoniae. This is the first 
reported functional analysis of a cloned mycoplasmal gene in E. coli and represents a 
significant advance in mycoplasmal research. 
These results do not directly link P97 with ciliary adherence of M. 
hyopneumoniae in vivo, however. For instance, it was not possible to explain the 
discrepancy between the lack of ciliary adherence in strains J and 232A.L with either 
the expression of P97 in these strains or with changes in the ciliary binding site as 
defined by these studies. Further analysis will be required to either introduce mutations 
in P97 in M. hyopneumoniae or link other proteins to the ciliary adherence phenotype. 
These results, however, do support the hypothesis that P97 is involved in ciliary 
adherence, possibly as the major adhesin, since rP97 has ciliary adhesive properties. 
The expression of P97 in ISM612 resulted in production of multiple proteins 
recognized by Mab F1B6 in immunoblot analysis. The largest protein had an apparent 
molecular weight of 124.9 kDa which correlated well with the predicted size of P97 
(Figure 2). Other smaller FlB6-reactive proteins are either prematurely truncated P97 
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proteins because of the presence of UGA codons in P97 gene, or are the result of 
aberrant initiation of translation at sites other than the ATG start codon of P97. This 
could be due to the high AT content of mycoplasmal genomic DNA that could serve as 
ribosome binding sites. TrdOOO mutagenesis proved to be the essential genetic tool in 
the molecular characterization of rP97. The minimum coding sequence of P97 in cloned 
fragments was determined, DNA sequencing was facilitated, and the antigenic and cilia 
binding epitopes of P97 were mapped all by the use of TniOOO mutagenesis. 
Sequence analysis of the P97 gene contig region also suggests that P97 belongs 
to a two gene operon, designated the P97 operon. The second gene which lies 
downstream of P97 codes for a putative surface protein with a predicted molecular 
weight of 102 kDa. Screening of a M. hyopneimoniae genomic Lambda ZAP® II 
library with P97 operon-specific internal DNA probes revealed that P97 operon 
sequences are present in no more than two copies in the M. hyopneumoniae 
chromosome. Mutation of P97 gene sequences with TnlOOO followed by immunoblot 
and MPAA analysis of the mutagenized plasmids was used to identify the Mab F1B6 
antigenic and cilia binding epitopes in the rP97 protein. 
Sequence and Functional Analysis of the P97 Adhesin 
Immunoblot analysis ofTalOOO mutagenized pISM2121 plasmids under IPTG induction in 
£. coli ISM612 revealed that transposon insertions in a 2.2 kb region resulted in the loss of 
expression of Mab FlB6-reactive proteins, or as in the case of insert 16.13, resulted in the 
production of a protein with reduced size. Therefore, this 2.2 kb region in pISM2121 
represents the minimum coding sequence of the P97 structural gene. This smdy also suggested 
that the F1B6 antigenic epitope is located in the region between inserts 16.13 and 1.14 (Figure 
2). DNA sequencing of this region using TnlOOO-specific primers revealed a 3.3 kb ORF with 
a protein coding capacity for a 124.9-kDa protein. This study indicated that P97 underwent 
post-translational processing because the amino terminal amino acid sequence of the native P97 
protein was mapped to position 195 of the P97 amino acid sequence. The cleavage of P97 
protein at the putative processing site results in a protein with a predicted molecular weight of 
102 kDa which is in good agreement with the size of the native P97 protein by SDS-PAGE. A 
protein kinase ATP binding domain was also identified in an amino terminal transmembrane 
domain. It is still unknown whether this processing event is required for the translocation of 
the protein to the mycoplasmal surface and if it is dependent on the binding of ATP. 
Analysis of the predicted amino acid sequence of P97 demonstrated that the protein is 
highly hydrophilic, which confirmed the findings by Ross and Young. They found that native 
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P97 partitioned in the aqueous (hydrophilic) phase in Triton X-114 extracts of M. 
hyopneumoniae proteins or was found in the insoluble portion (Ross, R.F., and T. F. Young, 
personal communication). Immunoelectron microscopic studies of M. hyopneumoniae with 
anti-P97 Mabs revealed a translucent space between the gold beads and the mycoplasma 
membrane, suggesting that P97 was not directly associated with the membrane surface, but 
was possibly linked to the membrane by an electron translucent structure such as a glycocalyx. 
This could not occur through cysteine linkages since P97 lacks cysteine residues. P97 would 
fimction as the bridge between M. hyopneumoniae and the host epithelial cells by binding to 
receptors on cilia. Since M. hyopneumoniae lacks the tip organelle observed in other 
mycoplasmas including M. pneumoniae, M. gallisepticum, M. pulmonis, and M. genitalium, 
polarized attachment to cilia would not occur. 
Mapping of the P97 Mab F1B6 Antigenic Epitope and Cilia Binding Site 
The use of repeat sequences to mediate the interaction between adhesins and receptors in 
eucaryotes has been well documented, especially when the interaction involves protein-protein 
interaction such as extracellular matrix proteins which mediate cell-cell recognition. The repeat 
sequences in S. pyogenes F protein and Sfb were proposed to mediate bacterial adherence to 
fibronectin (230, 240). In this study, amino acid sequence analysis of P97 has revealed two 
repeat sequences, R1 and R2, at the carboxy terminus of the protein. The R1 sequence consists 
of 15 repeats of AAKP(V/E) and has been demonstrated in this study to mediate the binding of 
rP97 to cilia (Figures 19 and 20). Insertion ofTnlOOO in the seventh repeat of R1 (insert 
number 133) yielded a protein with negative cilia binding activity when expressed in E. coli 
ISM612, whereas an insertion 5 repeats further downstream (insert number 90) yielded a 
protein with cilia binding activity. It is concluded that the cilia binding activity requires a 
minimum of at least seven repeats of the AAKP(V/E) sequence. 
Sequence analysis of 5 other Af, hyopneumoniae strains that exhibit different degrees of 
cilia binding activity was performed. These studies failed to show a significant difference in the 
number of R1 repeats n these strains, and thus, it was not possible to make a correlation of cilia 
binding with number of R1 repeats. The low adherent strain J had ten R1 repeat sequences, 
and the high adherent strain 144L had eleven R1 repeat sequences. To examine this issue 
further, clonal isolates of 232A exhibiting high, medium and low adherence to swine cilia were 
also studied. These isolates retained the identical sequence and structure in R1 region. 
Therefore, it is concluded that cilia binding activity in Af. hyopneumoniae is subject to 
regiilation from mechanisms other than changes in the R1 region of P97. There is evidence that 
protein conformation may play an important role; a TniOOO insert at location 160 seems to have 
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significantly higher cilia binding activity than those of neighboring locations (Figures 19 and 
20). This suggests that cilia binding activity may require proper folding of the cilia binding 
domain. Alternatively, ciUa binding assays with recombinant proteins may vary significantly 
due to differences in protein expression (Figure 18). Nonetheless, it is clear from these studies 
that transposon insertions in the R1 region result in abolition of cilia binding activity in P97. 
The R2 repeat sequence, four repeats of NQGKK(S/A)EG(A/r)P, revealed a strikingly 
high homology (> 88% identity) to a 180-kDa canine ribosome receptor. Sequencing analysis 
of the cloned ribosome receptor gene revealed that the receptor contains an NQGJCKAEGAP 
sequence that is repeated 54 times without interruption in the N-terminal end of the protein. The 
ribosome receptor protein is an integral membrane protein of the endoplasmic reticulum; the 
repeat sequence functions as a ribosome binding domain mediating the interaction between the 
ribosome and the endoplasmic reticulum. Since the P97 adhesin is suggested to exist as a 
secreted protein associated with membrane components outside the mycoplasma, this 
association may involve interactions with membrane proteins through the R2 repeat sequence in 
P97. Further studies are needed to confirm this. 
The Mab F1B6 antigenic epitope in the P97 protein was mapped to the R1 repeat region 
and demonstrated a minimum of two and a half repeating units for the formation of the epitope. 
The region was defined by the loss of immunoreactivity of pISM2159::Tn7000.79 E. coli 
lysates and and not with pISM2159::Tni000.133 lysates (Figure 18). Both cilia binding 
activity and the antigenic epitope have thus been mapped to the R1 region. The observation that 
Mab binding to P97 requires a smaller R1 region than does cilia binding may explain the fact 
that binding of P97 to cilia does not completely block the ability of the Mab to recognize the 
protein, as shown by the ability to use Mab F1B6 in the MPAA assay. Short synthetic peptides 
comprising the amino acid sequence from this junction region could be used in MPAA 
inhibition assays to determine more precisely the Mab FIB6 antigenic epitope. This may have 
important consequences in designing subunit vaccines. 
Because of the nature of TniOOO mutagenesis which results in the fusion of transposon 
sequences with structural gene sequences, one could argue that changes in the cilia binding 
activity observed in the MPAA may be influenced by extra amino acid sequences derived from 
TniOOO prior to the first stop codon. This could vary depending upon the reading frame of the 
transposon insertion site. The extra amino acid sequence from TnlOOO may help to explain a 
reduction in cilia binding activity through steric hindrance effects on cilia binding domain. To 
test the hypothesis, synthetic peptides consisting of the AAKP(V/E) repeat sequences could be 
examined for the ability to block cilia binding activity of either rP97 or M. hyopneumoniae 
whole cells. A second approach would be to construct a fusion protein consisting of the 
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putative cilia binding domain and an enzymatic domain, i.e. P-galactosidase, the binding of 
which could be easily followed in the MPAA. The sequence and structural analysis of the cilia 
binding domain could then proceed at the molecular level. 
Sequence analysis of the repeat regions R1 and R2 among different strains of M. 
hyopneumoniae indicated a high conservation of DNA sequence (Figure 22). In the six strains 
analyzed, a stretch of 70 amino acids immediately downstream of the R1 sequence were 
identical. This suggests that this domain may be critical in maintaining the structure and 
function of the two repeat sequences. It may be helpful to sequence additional Af. 
hyopneumoniae strains to examine this issue more closely. 
Analysis of the P97 Operon Contig Sequence 
Sequence analysis of the P97 contig has revealed several interesting features. Other 
mycoplasmas encode tissue adhesins within operons, i. e. M. pneumoniae and M. genitalium. 
Thus, it is not surprising to find P97 within an operon as well. The P97 operon contains only 
two ORFs, P97 and P102. The P102 gene codes for a protein with a amino terminal 
transmembrane domain followed by a sequence with high hydrophilicity. Therefore, PI02 
appears to be a membrane-targeted protein. Future studies should focus on mapping the 
location of P102 in the cell and determining whether P102 has a function in ciliary adherence. 
Monospecific, polyclonal antisera could be used in immunoelectron microscopy to determine 
its location and whether the presence of anti-P102 antibodies has an effect on adherence to 
swine cilia. Another approach to determine the function of P102 is by nearest-neighbor 
analysis involving a cross-linking reagent such as 3',3' dithiobis (sulfosuccinimidyl 
propionate) and monospecific antisera. Close association of the PI02 protein and P97 would 
result in a cross-linked product containing both proteins. 
Although there is no direct evidence that P97 is part of a two gene operon, this conclusion 
is based upon the observation that only a single putative promoter sequence has been identified 
145 bp upstream of the P97 gene start codon, there is only 20 bp between the P97 stop codon 
and the PI02 start codon, and that an ORF transcribed in reverse orientation was identified 
downstream of P102. The putative P97 promoter contained a unique feature; the -10 and -35 
sequences were separated by a stretch of seventeen adenine residues. This polyadenine stretch 
was also observed by Wise and co-workers in genes that underwent phase variation in Af. 
hyorhinis (256). A change in the number of adenine residues determined expression in that 
system. It could be speculated that M. hyopneumoniae also utilizes the same mechanism to 
control expression of P97, but in all strains that have been examined, P97 is constitutive. Since 
our hybridization studies suggest that there may be two copies of the P97 gene sequence in M. 
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hyopneumoniae, there may be random phase switching occurring in each copy, but a bias 
towards the ON phenotype would prevent identifying a clone lacking P97 completely by 
immimoblot analysis. M. hyopneumoniae may also contain more than a single cellular adhesin, 
and different stages in M. hyopneumoniae pathogenesis may involve the expression of 
different adhesin molecules. The possibility of phase switching of P97 warrants further 
investigation. 
Open reading frame 2 is 426 bp in length with a coding capacity for a 16.4-kDa protein 
with a pi of 10.52. It has no homology to any known sequence. It is located between ORF 1 
and the P97 structural gene with 534 bp and 411 bp of noncoding sequence, respectively, 
separating the genes. Two potential stem-loop structures were identified flanking ORF 2 inside 
these noncoding sequences. It is not uncommon for regulatory proteins to be found located 
upstream of the target promoter and transcribed separately. A stretch of 21 adenine residues 
was also found 340 bp upstream of ORF 2 possibly providing a recognition sequence for a 
recombinational event. This along with the high pi of ORF 2 suggests that ORF 2 may serve as 
a regulatory protein. To test this hypothesis, one must first establish the DNA binding ability of 
the protein product of ORF 2 followed by analysis of its sequence specificity. 
Copy Number of P97 Operon Sequences 
Zhang et al. demonstrated that Mab F1B6 recognized multiple proteins, including P97, in 
immunoblot analysis of Af. hyopneumoniae (264). The source of these multiple proteins can be 
explained as either the result of degradation of 124.9-kDa P97, the existence of multiple copies 
or partial copies of V91 gene sequences, or a combination of the two possibilities. 
Hybridization of M. hyopneumoniae 232A genomic DNA with probes derived from P97 
operon internal sequences showed that a second copy of P97 may be present in the Af. 
hyopneumoniae 232A genome (Figure 16). An additional 14 kb BgWL fragment was recognized 
by probes which spanned the entire P97 gene and the 5' half of PI02. However, when 
genomic DNA was digested with four other enzymes, EcoRI, EcoRV, HincU, and HindUL, no 
additional bands were observed. At least two explanations are possible. First, if P97 exists as 
two copies in the chromosome, the more frequent cutting enzymes were unable to identify the 
additional junction site of the duplicated sequence, and the BglO. site within the second copy of 
P97 was modified. A putative BglH site exists approximately 10.5 kb upstream of the BglH. 
site in P97 accounting for the 10.5 kb band in Figure 16; the second copy of P97 would 
account for the 14 kb band and both would be in equal concentration as suggested by the 
intensity of the bands in Figure 16. 
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If P97 exists in only a single copy, however, an alternative explanation would be necessary 
for the hybridization data. One possibility is a modification of the P97 internal BglQ. site in a 
subset of cells within the population which would result in a 14 kb BgUl fragment recognized 
by probes 1-4, but not by probe 5. This fragment would include sequences from the upstream 
BglQ. site to the first BgHi site downstream of the P97 operon. Modification would have to 
occur in about half of the cells to give approximately equal concentrations of the two fragments 
as suggested by the similar intensity of the two bands. Restriction-modification might account 
for this variability, but it is unclear what type of modification might account for inhibition of 
BglQ. digestion in half of the DNA molecules. 
It is not uncommon for mycoplasmal adhesins to be present in multiple copies in 
the genome (41,224). To resolve this issue, it might be necessary to clone the 14 kb 
BglQ. fragment and restriction digest the clone. If the P97 internal BglH. site in the 
single copy model is modified in M. hyopneumoniae by an unknown mechanism, this 
modification would be resolved in E. coli resulting in a restriction map identical to the 
restriction map already determined. This would be the first direct evidence of the 
presence of a restriction-modification system in M. hyopneumoniae, and help to explain 
the failure to transform M. hyopneumoniae 232A with foreign DNA. If there is a 
second copy and the BglQ. site has been permanently modified by mutation, the 
restriction map will reflect this change. Further analysis of this clone by restriction 
mapping and DNA sequencing would be necessary to determine the exact nature of this 
second copy. 
When the fi^/II-digested genomic DNA was analyzed with probes 4 and 5, the 14 kb 
fragment was recognized only by probe 4, but not by probe 5. In addition to the expected BgM 
fragments recognized by probe 4, two extra Augments of 7.5 kb and 2.8 kb were also 
recognized, indicating the presence of a second copy of the P102 gene in the genome of M. 
hyopneumoniae (Figure 16). Hybridization of genomic DNA digested with other enzymes by 
probes 4 and 5 also confirmed the presence of the second copy of the PI02 gene. 
Hybridization of EcoRI-digested DNA with probe 4 resulted in three bands of 3.8,4.2, and 
4.8 kb. One fragment, 4,2 kb was also recognized by probe 5. These fragments were cloned 
into the vector pSK- to derive plasmids pISM1232, pISM1233 and pISM1234 and restriction 
mapped. Preliminary results of restriction mapping and sequence analysis of the ends of these 
clones revealed that the 4.8 kb fragment was only partly homologous to the P102 sequence 
which resulted in the weak hybridization observed in hybridization analysis (Figure 16). The 
3.8 and 4.2 kb fragments shared significant homology to PI02 sequences with identical 
sequences spanning up to one third of the P102 gene sequence. Aligrmient of the sequences of 
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the 3.8 and 4.2 kb fragments to the P102 gene sequence suggested that the 3.8 kb fragment 
contains the 5' sequence of P102, the 4.2 kb fragment contains the 3' region of P102 and other 
downstream sequences, and that the two fragments are separated by a 0.5 kb gap (Figure 23). 
Sequence homology of the 3.8 kb fragment to the P102 sequence was found to terminate 
abruptly at the junction region between the P102 gene and P97, but it included the Neil site; the 
remaining sequence displayed no homology to known sequences in the database. Sequence 
analysis of the 4.2 kb fragment revealed about 500 bp which were almost identical to 
sequences surrounding the Sail site in PI02. Further sequencing of the 4.2 kb fragment 
downstream of the SaR site is needed to determine if the second copy of PI02 includes the 
entire PI02 sequence or only a portion of the sequence. The former possibility is more likely 
since probe 5 which included the 3' half of the P102 gene also recognized the 4.2 kb EcoRI 
fragment. When the 3.8 and 4.2 kb fragments were aligned to the corresponding P102 gene 
sequence and separated by 0.5 kb, the restriction map derived from the aligmnent revealed a 
pattern similar to the chromosomal region overlapped with the Lambda ZAP® n clones obtained 
by hybridization screening of the genomic library with pISM2i36-specific probes that did not 
align with the P97 operon (Figure 23). This restriction map is distinct from the P97 operon 
contig shown in Figures 10 and 23. The restriction map predicted the 5.4 kb Hindin and 5.5 
kb £coRV fragments which were both confirmed by hybridization with probes 4 and 5 (Figure 
16). 
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CONCLUSIONS 
The impact that M. hyopneumoniae has had and continues to have on the swine industry is 
significant. Vaccines have not proven satisfactory for a variety of reasons, but mainly they fail 
to prevent colonization of the organism. Since colonization of the swine trachea is the first step 
to infection, studies of the mechanisms utilized by M. hyopneumoniae to adhere to tracheal 
tissues are cmcial in dealing with this important disease. Previous studies by Zhang et al. 
demonstrated that the surface protein P97 seemed to be involved in adherence to swine 
epithelial cells, specifically to the cilia of those cells (263, 264,266). We have extended those 
studies and have shown that rP97 binds to swine cilia in vitro. This was accomplished by the 
cloning of the P97 gene and functional analysis of the recombinant P97 protein. It was also 
demonstrated that the p97 gene is part of a two gene operon, which also includes an ORF 
coding for a 102-kDa protein designated P102. This protein has characteristics of a membrane 
protein, but its function is not clear. Its DNA sequence has no homology with any known 
genes, and thus, we are unable to predict a possible function for P102. 
These studies represent the first molecular and genetic analysis of any M. hyopneumoniae 
adhesin. Through the use of novel opal suppressor strains of E. coli, it was possible to identify 
P97 expressing epitopes in a lambda genomic library. In the absence of opal suppression, these 
cloned fragments did not produce FlB6-reactive polypeptides in E. coli. Therefore, these 
strains made a critical contribution to this project; their use resulted in the initial identification of 
four clones, three of which contained the P97 gene sequence. The fourth clone, pISM2136, 
has been difficult to explain, but it appears to be derived from another region of the 
chromosome which contains a second copy of PI02. It is not clear why pISM2136 produces a 
product that is recognized by Mab F1B6 since its DNA or predicted protein sequence has no 
homology with the Mab binding site region in P97. 
Attempts to define the size variation observed in immunoblot analysis of Af. 
hyopneumoniae with Mab F1B6 have not been successful. Screening of the genomic library 
with F1B6 for additional copies of the P97 gene resulted only in clones that matched the 
restriction map of the P97 operon. Only the hybridization analysis of the flg/U-digested 
chromosomal DNA suggests that at least two copies of P97 exist in M. hyopneumoniae (Figure 
16). 
The P97 FlB6-reactive antigenic epitope and cilia binding site was localized to the carboxy 
terminus where two repeat sequences are found. The cilia binding site was localized to the R1 
repeat. This may allow the development of a subunit vaccine carrying this repeat sequence 
which would induce swine cilium adherence blocking antibodies. The Mab F1B6 binding 
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epitope defined by tiiese studies include the 5' end of R1 as well as additional upstream 
sequences. It is not yet clear if the upstream sequences define the epitope or if RI sequences 
are also involved. The resolution of the system did not allow further refinement of this 
problem. 
It is clear from these studies that there at least two copies of PI02 in the M. hyopneumoniae 
chromosome. The second copy has been partially cloned and analyzed. It has a high homology 
with the sequence in the P97 operon, but there are no P97 sequences associated with this copy 
of P102. It is not known why P102 is found in multiple copies in the chromosome since its 
function is not understood. We can only surmise that it is involved with adherence since one 
copy is found adjacent to the ciliary adhesin. If examples from other mycoplasmal systems are 
any indication, P102 will have a direct role in adherence. It is likely that a P102-specific 
antisera would help to resolve its function. 
It has not been possible to directly relate cilia binding activity of different M. 
hyopneumoniae strains with changes in the P97 gene sequence. It was hoped that changes in 
the R1 repeat region could be correlated with loss of adherence activity, but these results 
indicate that there is little change in this region of the protein. Nor has it been possible to 
correlate lack of P97 expression with loss of adherence activity (T. Young, personal 
communication). Therefore, it is not yet possible to directly Unk P97 with the ciliary adherence 
phenotype of M. hyopneumoniae in vivo. Undoubtedly there are other proteins and activities 
associated with ciliary adherence that have not yet been identified. Further analysis of PI02 
may shed some light on this complicated process. 
85 
REFERENCES 
1. Abiven, P., B. Blanchard, C. Saillard, M. Kobisch, and J. M. Bove. 1992. A specific 
DNA probe for detecting Mycoplasma hyopneumoniae in experimentally infected piglets. 
Mol. CeU. Probe 6:423-429. 
2. Akkan, M. L., L. Wong, and F. J. Silverblatt. 1986. Change in degree of type 1 piliation 
of Escherichia coli during experimental peritonitis in the mouse. Infect. Immun. 54:549-
554. 
3. Alting-Mees, M. A., and J. M. Short. 1989. pBIuescript IT: gene mapping vectors. Nucl. 
Acids Res. 17:9494. 
4. Arico, B., S. Nuti, V. Scarlato, and R. Rappuoli. 1993. Adhesion of Bordetella 
pertussis to eukaryotic cells requires a time-dependent export and maturation of 
filamentous hemagglutinin. Proc. Natl. Acad. Sci. USA 90:9204-9208. 
5. Artiushin, S., M. Duvall, and F. C. Minion. 1995. Phylogenetic analysis of mycoplasma 
strain ISM1499 and its assignment to the Acholeplasma oculi strain cluster. Int. J. Syst. 
Bacteriol. 45:104-109. 
6. Artiushin, S., L. Stipkovits, and F. C. Minion. 1993. Development of polymerase chain 
reaction primers to deX&ci Mycoplasma hyopneumoniae. Mol. Cell. Probes 7:381-385. 
7. Asai, T., M. Okada, M. Ono, T. Irisawa, Y. Mori, Y. Yokomizo, and S. Sato. 1993. 
Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage 
fluids from pigs infected with Mycoplasma hyopneumoniae. Vet. Immunol. 
Immunopathol. 38:253-260. 
8. Asai, T., M. Okada, M. Ono, Y. Mori, Y. Yokomizo, and S. Sato. 1994. Detection of 
interleukin-6 and prostaglandin E2 in bronchoalveolar lavage fluids of pigs 
experimentally infected with Mycoplasma hyopneumoniae. Vet. Immunol. 
Immunopathol. 44:97-102. 
9. Ashworth, L. A., A. B. Dowsett, L. 1. Irons, and A. robinson. 1985. The location of 
surface antigens of Bordetella pertussis by immunoelectron microscopy. Dev. Biol. 
Stand. 61:143-151. 
10. Baseman, J. B. 1993. The cytadhesins of Mycoplasma pneumoniae and Mycoplasma 
genitalium, p. 243-259. In S. Rottem and I. Kahane (ed.). Subcellular biochemistry, vol. 
20. Mycoplasma cell membranes. Plenum Press, New York. 
11. Baseman, J. B., R. M. Cole, D. C. Krause, and D. K. Leith. 1982. Molecular basis for 
cytoadsorption of Mycoplasma pneumoniae. J. Bacteriol. 151:1514-1522. 
86 
12. Baseman, J. B., J. Morrison-Plummer, D. Drouillard, B. Puleo-Scheppke, V. V. Tryon, 
and S. C. Holt. 1987. Identification of a 32 kilodalton protein of Mycoplasma 
pneumoniae associated with hemadsorption, isr. J. Med. Sci. 23:474-479. 
13. Beachey, E. H., and H. S. Courtney. 1987. Bacterial adherence: the attachment of group 
A streptococci to mucosal surfaces. Rev Infect Dis 5:s475-81. 
14. Beachey, E. H., and H. S. Courtney. 1989. Bacterial adherence of group A streptococci 
to mucosal surface. Respiration 55:33-40. 
15. Beachey, E. H., and I. Ofek. 1976. Epithelial cell binding of group A streptococci by 
lipoteichoic acid on fimbriae denuded of M protein. J. Exp. Med. 143:759-771. 
16. Bereiter, M., T. F. Young, H. S. Joo, and R. F. Ross. 1990. Evaluation of the ELISA, 
and comparison to the complement fixation test and radial immunodiffusion enzyme 
assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. 
Vet. Microbiol. 25:177-192. 
17. Bemhard, W., A. Gbarah, and N. Sharon. 1992. Lectinophagocytosis of type 1 
fimbriated (mannose-specific) Escherichia coli in the mouse peritoneum. J. Leukoc. Biol. 
52:343-348. 
18. Bimboim, H. 1983. A rapid alkaUne extraction method for the isolation of plasmid DNA. 
Methods Enzymol. 100:243-255. 
19. Blanchard, B., M. M. Vena, A. Cavalier, J. Le Lannic, J. Gouranton, and M. Kobisch. 
1992. Electron microscopic observation of the respiratory tract of SPF piglets inoculated 
with Mycoplasma hyopneumoniae. Vet. Microbiol. 30:329-341. 
20. Bloch, C. A., and P. E. Omdorff. 1990. Impaired colonization by and full invasiveness 
of Escherichia coli K12 bearing a site-directed mutation in the type 1 pilin gene. Infect. 
Immun. 58:275-278. 
21. Blomfield, I. C., P. J. Calie, K. J. Eberhardt, M. S. Mcclain, and B. I. Eisenstein. 
1993. Lpr stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J. 
Bacteriol. 175:27-36. 
22. Blomfield, I. C., M. S. Mcclain, J. A. Princ, P. J. Calie, and B. I. Eisenstein. 1991. 
Type-1 fimbriation andfimE mutants of Escherichia coli K-12. J. Bacteriol. 173:5298-
5307. 
23. Boner, G., A. M. Mhashilkar, M. Rodriguez-Ortega, and N. Sharon. 1989. Lectin-
mediated, nonopsonic phagocytosis of type 1 Escherichia coli by human peritoneal 
macrophages of uremic patients treated by peritoneal dialysis. J. Leukoc. Biol. 46:239-
245. 
87 
24. Bredt, W. 1979. Motility, p. 141-155. In M. F. Barile and S. Razin (ed.). The 
Mycoplasmas. I. Cell biology. Academic Press, New York. 
25. Brubaker, R. R. 1985. Mechanisms of bacterial virulence. Annu. Rev. Microbiol. 39:21-
50. 
26. Brunner, H., J. Feldner, and W. Bredt. 1984. Effect of monoclonal antibodies to the 
attachment-tip on experimental Mycoplasma pneumoniae infection of hamsters, a 
preliminary report. Is. J. Med. Sci. 20:878-881. 
27. Caparon, M. G., and J. R. Scott. 1987. Identification of a gene that regulates expression 
of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad 
Sci USA 84:8677-81. 
28. Carruthers, M. M., and W. J. Kabat. 1983. Mediation of staphylococcal adherence to 
mucosal cells by lipoteichoic acid. Infect. Immun. 40:444-446. 
29. Caurso, J. P., and R. F. Ross. 1990. Effects of Mycoplasma hyopneumoniae and 
Actinobacillus {Haemophilus) pleuropnewnoniae infections on alveolar macrophage 
functions in swine. Am. J. Vet. Res. 51:227-231. 
30. Chou, P. Y., and G. D. Fasman. 1978. Empirical predictions of protein conformations. 
Ann. Rev. Biochem. 47:251-276. 
31. Cole, B. C., and G. H. Cassell. 1979. Mycoplasma infections as models of chronic 
inflammation. Arth. Rheum. 22:1375-1381. 
32. Cooper, A. C., J. R. Fuller, M. K. Fuller, P. Whittlestone, and D. R. Wise. 1993. In 
vitro activity of danofloxacin, tylosin, and oxytetracycline against mycoplasmas of 
veterinary importance. Res. Vet. Sci. 54:329-334. 
33. Courtney, H. S., M. S. Bronze, J. B. Dale, and D. L. Hasty. 1994. Analysis of the role 
of M24 protein in group A streptococcal adhesion and colonization by use of omega-
interposon mutagenesis. Infect. Immun. 62:4868-4873. 
34. Courtney, H. S., Y. Li, J. B. Dale, and D. L. Hasty. 1994. Cloning, sequencing, and 
expression of a fibronectin/fibronogen-binding protein from group A streptococci. Infect. 
Inmiun. 62:3937-3946. 
35. Courtney, H. S., C. von Hunolstein, J. B. Dale, M. S. Bronze, E. H. Beachey, and D. 
L. Hasty. 1992. Lipoteichoic acid and M protein: dual adhesins of group-A streptococci. 
Microb. Pathog. 12:199-208. 
36. Dahlgren, U. I., S. Ahlstedt, and L. A. Hanson. 1987. The localization of the antibody 
response in milk or bile depends on the nature of the antigen. J. Inmiunol. 138:1397-
1402. 
88 
37. Dahlgren, U. L, A. E. Wold, L. A. Hanson, and T. Midtvedt. 1990. The secretory 
antibody response in milk and bile against fimbriae and LPS in rats monocolonized or 
immunized in the Peyer's patches with Escherichia coli. Immunology 71:295-300. 
38. Dal-Nogare, A. R. 1990. Type 1 pili mediate gram-negative bacterial adherence to intact 
tracheal epithelium. Am. J. Respir. Cell. Biol. 2:433-440. 
39. Dale, J. B., R. W. Baird, H. S. Courtney, D. L. Hasty, and M. S. Bronze. 1994. 
Passive protection of mice against group A streptococcal pharyngeal infection by 
lipoteichoic acid. J. Infect. Dis. 169:319-323. 
40. Dallo, S. F., and J. B. Baseman. 1990. Cross-hybridization between the cytadhesin 
genes of Mycoplasma pneumoniae and Mycoplasma genitalium and genomic DNA of 
Mycoplasma gallisepticum. Microb. Pathog. 8:371-375. 
41. Dallo, S. F., and J. B. Baseman. 1991. Adhesin gene of Mycoplasma genitalium exists 
as multiple copies. Microb. Pathog. 10:475-480. 
42. Dallo, S. F., A. Chavoya, and J. B. Baseman. 1990. Characterization of the gene for a 
30-kilodalton adhesin-related protein of Mycoplasma pneumoniae. Infect. Immun. 
58:4163-4165. 
43. Dallo, S. F., J. R. Horton, C. J. Su, and J. B. Baseman. 1990. Restriction fragment 
length polymorphism in the cytadhesin PI gene of human clinical isolates of Mycoplasma 
pneumoniae. Infect. Immun. 58:2017-2020. 
44. Dallo, S. F., A. L. Lazzell, A. Chavoya, S. P. Reddy, and J. B. Baseman. 1996. 
Biofimctional domains of the Mycoplasma pneumoniae P30 adhesin. Infect Immun 
64:2595-2601. 
45. DeBey, M. C., and R. F. Ross. 1994. Ciliostasis and loss of cilia induced by 
Mycoplasma hyopneumoniae in porcine tracheal organ cultures. Infect. Immun. 62:5312-
5318. 
46. DeBey, M. C., J. A. Roth, and R. F. Ross. 1993. Enhancement of the increase in 
intracelluar calcium concentration in stimulated neutrophils by Mycoplasma 
hyopneumoniae. Vet. Res. Commun. 17:249-257. 
47. DiRita, V. J., and J. J. Mekalanos. 1989. Genetic regulation of bacterial virulence. 
Annu. Rev. Genet. 23:455-482. 
48. Dirksen, L. B., T. Proft, H. Hilbert, H. Plagens, R. Herrmarm, and D. C. Krause. 
1996. Sequence analysis and characterization of the hmw gene cluster of Mycoplasma 
pneumoniae. Gene 171:19-25. 
89 
49. Djordjevic, S. P., G. J. Eamens, L. F. Romalis, and M. M. Saunders. 1994. An 
improved enzyme linked immunosorbent assay (ELISA) for the detection of porcine 
serum antibodies Mycoplasma hyopneumoniae. Vet. Microbiol. 39:261-273. 
50. Dominick, M. A., M. J. Schmerr, and A. E. Jensen. 1985. Expression of type 1 pili by 
Escherichia coli strains of high and low virulence in the intestinal tract of knotobiotic 
turkeys. Am. J. Vet. Res. 46:270-275. 
. 5 1 .  D o r m a n ,  C .  J . ,  a n d  C .  F .  H i g g i n s .  1 9 8 7 .  F i m b r i a l  p h a s e  v a r i a t i o n  i n  E s c h e r i c h i a  c o l i :  
dependence on integration host factor and homologies with other site-specific 
recombinases. J. Bacteriol. 169:3840-3843. 
52. Doster, A. R., and B. C. Lin. 1988. Identification of Mycoplasma hyopneumoniae in 
formalin-fixed porcine lung, using an indirect immunoperoxidase method. Am J Vet Res 
49:1719-21. 
53. Dozois, C. M., N. Chanteloup, M. D. Moulin, A. Bree, C. Desautels, and J. M. 
Fairbrother. 1994. Bacterial colonization and in vivo expression of F1 (type 1) fimbrial 
antigens in chickens experimentally infected with pathogenic Escherichia coli. Avian Dis. 
38:231-239. 
54. Dritz, S. S., M. M. Chengappa, J. L. Nelssen, M. D. Tokach, R. D. Goodband, J. C. 
Nietfeld, and J. J. Staats. 1996. Growth and microbial flora of notmiedicated segregated, 
early weaned pigs from a commercial swine operation. J. Am. Vet. Med. Assoc. 
208:711-715. 
55. Duguid, J. P., and R. R. Gillies. 1957. Fimbriae and adhesive properties in dysentery 
bacilli. J. Pathol. Bacteriol. 74:397-408. 
56. Eisenstein, B. I., D. S. Sweet, V. Vaughn, and D. I. Friedman. 1987. Integration host 
factor is required for the DNA inversion that controls phase variation in Escherichia coli. 
Proc. Natl. Acad. Sci. USA 84:6506-6510. 
57. Emsley, P., I. G. Charles, N. F. Fairweather, and N. W. Isaacs. 1996. Structure of 
Bordetella pertussis virulent factor P.69 pertactin. Nature 381:90-92. 
58. Ernst, S., R. Langer, C. L. Cooney, and R. Sasisekharan. 1995. Enzymatic degradation 
of glycoaminoglycans. Grit. Rev. Biochem. Mol. Biol. 30:387-444. 
59. Finlay, B. B., and S. Falkow. 1989. Common themes in microbial pathogenicity. 
Microbiol. Rev. 53:210-230. 
60. Firon, N., S. Ashkenazi, D. Mirelman, I. Ofek, and N. Sharon. 1987. Aromatic alpha-
glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated 
Escherichia coli to yeast and intestinal epithelial cells. Infect. Immun. 55:472-476. 
90 
61. Freeman, M. J., M. Lopez-Osuna, C. H. Armstrong, and L. Sanda-Freeman. 1984. 
Evaluation of the indirect hemagglutination assay as a practical serodiagnostic test for 
mycoplasmal pneumonia of swine. Vet. Microbiol. 9:259-270. 
62. Frey, J., A. Haldimann, M. Kobisch, and J. Nicolet. 1994. Immune response against 
the L-lactate dehydrogenase of Mycoplasma hyopneumoniae in enzootic pneumonia of 
swine. Microb. Pathog. 17:313-322. 
63. Friis, N. F. 1977. Mycoplasma suipneumoniae and Mycoplasma flocculare in the growth 
precipitation test. Acta Vet. Scand. 18:168-175. 
64. Fujita, K., T. Yamamoto, and R. Kitagawa. 1991. Binding sites for P and/or type 1-
piliated Escherichia coli in human ureter. J. Urol. 146:217-222. 
65. Funnell, S. G., and A. Robinson. 1993. A novel adherence assay for Bordetella 
pertussis using tracheal organ cultures. FEMS Microbiol. Lett. 110:197-203. 
66. Gaily, D. L., J. A. Bogan, B. I. Eisenstein, and 1. C. Blomfield. 1993. Environmental 
regulation of tticfim switch controlling type 1 fimbrial phase variation in Escherichia coli 
K-12: effects of temperature and media. J. Bacteriol. 175:6186-6193. 
67. Gamier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and 
implications of simple methods for predicting the secondary structure of globular 
proteins. J. Mol. Biol. 120:97-120. 
68. Gbarah, A., C. G. Gahmberg, G. Boner, and N. Sharon. 1993. The leukocyte surface 
antigens CDl lb and CD 18 mediate the oxidative burst activation of human peritoneal 
macrophages induced by type 1 fimbriated Escherichia coli. J. Leukoc. Biol. 54:111-
113. 
69. Gbarah, A., C. G. Gahmberg, I. Ofek, U. Jacobi, and N. Sharon. 1991. Identification 
of the leukocyte adhesion molecules CDl 1 and CD 18 as receptor for type 1-funbriated 
(mannose-specific) Escherichia coli. Infect. Immun. 59:4525-4530. 
70. Gbarah, A., A. M. Mhashilkar, G. Boner, and N. Sharon. 1989. Involvement of protein 
kinase C in activation of human granulocytes and peritoneal macrophage by type 1 
fimbriated (mannose-specific) Escherichia coli. Biochem. Biophys. Res. Commun. 
165:1243-1249. 
71. Geary, S. J., and E. M. Walczak. 1983. Cytopathic effect of whole cells and purified 
membranes of Mycoplasma hyopneumoniae. Infect. Immun. 41:132-136. 
72. Geuijen, C. A. W., R. J. L. Willems, and F. R. Mooi. 1996. The major fimbrial subunit 
of Bordetella pertussis binds to sulfated sugars. Infect. Immun. 64:2657-2665. 
91 
73. Giampapa, C. S., S. N. Abraham, and E. H. Beachey. 1988. Isolation and 
characterization of a receptor for type 1 fimbriae of Escherichia coli from guinea pig 
erythrocytes. J. Biol. Chem. 263:5362-5367. 
74. Goetz, M. B. 1989. Priming of polymorphonuclear neutrophilic leukocyte oxidative 
activity by type 1 pili from Escherichia coli. J. Infect. Dis. 159:533-542. 
75. Goetz, M. B., and F. J. Silverblatt. 1987. Stimulation of human polymorphonuclear 
leukocyte oxidative metaboUsm by type 1 pili from Escherichia coli. Infect. Immun. 
55:534-540. 
76. Goodwin, R. F. 1984. Apparent reinfection of enzootic-pneumonia-free pig herds: early 
signs and incubation period. Vet. Res. 115:320-324. 
77. Gullberg, D., and P. Ekblom. 1995. Extracellular matrix and its receptors during 
development. Int. J. Dev. Biol. 39:845-854. 
78. Hahn, T.-W., K. A. Krebes, and D. C. Krause. 1996. Expression in Mycoplasma 
pneumoniae of the recombinant gene encoding the cytadherence-associated protein 
HMWl and identification of HMW4 as a product. Mol. Microbiol. 19:1085-1093. 
79. Haldimann, A., J. Nicolet, and J. Frey. 1993. DNA sequence determination and 
biochemical analysis of the immunogenic protein P36, the lactate dehydrogenase (LDH) 
of Mycoplasma hyopneumoniae. J. Gen. Microbiol. 139:317-323. 
80. Harman, P. C., and R. F. Goodwin. 1990. Treatment of experimental enzootic 
pneumonia of the pig by norfloxacin or its 6-chloro analogue. Res. Vet. Sci. 49:203-210. 
81. Hannan, P. C., P. J. OHanlon, and N. H. Rogers. 1989. In vitro evaluation of various 
quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory 
bacterial pathogens. Res. Vet. Sci. 46:202-211. 
82. Hanski, E., and M. Caparon. 1992. Protein F, a fibronectin-binding protein, is an 
adhesin of the group A streptococcus Streptococcus pyogenes. Proc. Nati. Acad. Sci. 
USA 89:6172-6176. 
83. Hanski, E., P. A. Horwitz, and M. Caparon. 1992. Expression of protein F, the 
fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous 
streptococcal and enterococcal strains promotes their adherence to respiratory epithelial 
cells. Infect. Immun. 60:5119-5125. 
84. Harasawa, R., K. Koshimizu, O. Takeda, T. Uemori, K. Asada, and I. Kato. 1991. 
Detection of Mycoplasma hyopneumoniae DNA by the polymerase chain reaction. Mol. 
Cell. Probes 5:103-109. 
85. Hasty, D. L., I. Ofek, H. S. Courtney, and R. J. Doyle. 1992. Multiple adhesins of 
streptococci. Infect. Immun. 60:2147-2152. 
92 
86. Hazenbos, W. L., C. A. Geuijen, B. M. van den Berg, F. R. Mooi, and R. van Furth. 
1995. Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial 
subunit FimD. J. Infect. Dis. 171:924-929. 
87. Hazenbos, W. L., B. M. van den Berg, C. A. Geuijen, F. R. Mooi, and R. van Furth. 
1995. Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes 
activates complement receptor type 3 via protein tyrosme kinases. J. Immunol. 155:3972-
3978. 
88. Henderson, B., S. Poole, and M. Wilson. 1996. Bacterial modulins: a novel class of 
virulent factors which cause host tissue pathology by inducing cytokine synthesis. 
Microbiol. Rev. 60:316-341. 
89. Hofman, K., and W. Stoffel. 1993. TMbase - a database of membrane protein spanning 
segments. Biol. Chem. Hoppe-Seyler 347:166. 
90. Hu, P. C., R. M. Cole, Y. S. Huang, J. A. Graham, D. E. Gardner, A. M. Collier, and 
W. A. J. Clyde. 1982. Mycoplasma pneumoniae infection: role of a surface protein in the 
attachment organelle. Science 216:313-315. 
91. Hu, P. C., A. M. Collier, and J. B. Baseman. 1977. Surface parasitism by Mycoplasma 
pneumoniae of respiratory epithelium. J. Exp. Med. 145:1328-1343. 
92. Huang, Y., and G. W. Stemke. 1992. Construction of the physical maps of Mycoplasma 
hyopneumoniae and Mycoplasma flocculare and the location of rRNA genes on these 
maps. Can. J. Microbiol. 38:659-663. 
93. Hultgren, S. J., W. R. Schwan, A. J. Schaeffer, and J. L. Duncan. 1986. Regulation of 
production of type 1 pili among urinary tract isolates of Escherichia soli. Infect. Immun. 
54:613-620. 
94. Inamine, J. M., S. Loechel, and P. C. Hu. 1988. Analysis of the nucleotide sequence of 
the PI operon of Mycoplasma pneumoniae. Gene 73:175-183. 
95. Isenberg, H. 1988. Pathogenicity and virulence: Another view. Clin. Microbiol. Rev. 
1:40-53. 
96. Ishibashi, Y., S. Claus, and D. A. Relman. 1994. Bordetella pertussis filamentous 
hemaggultinin interacts with a leukocyte signal transduction complex and stimulates 
bacterial adherence to monocyte CR3 (CDllb/CD18). J. Exp. Med. 180:1225-1233. 
97. Jacobs, E., M. Drews, A. Stuhlert, C. Buttner, P. J. Klein, M. Kist, and W. Bredt. 
1988. Immunological reaction of guinea pigs following intranasal Mycoplasma 
pneumoniae infection and immunization with the 168 kDa adherence protein. J. Gen. 
Microbiol. 134:473-479. 
93 
98. Jacobs, E., A. Stuhlert, M. Drews, K. Pumpe, H. E. Schaefer, M. Kist, and W. Bredt. 
1988. Host reactions to Mycoplasma pneumoniae infections in guinea-pigs preimmunized 
systemically with the adhesin of this pathogen. Microb. Pathog. 5:259-265. 
99. Jayappa, H. G., R. A. Gooddow, and S. J. Geary. 1985. Role of Eschirichia coli type 1 
pilus in colonization of porcine ileum and its protective nature as a vaccine antigen in 
controlling colibacillosis. Infect. Immun. 48:350-354. 
100. Johansson, K. E., J. G. Mattsson, K. Jacobsson, C. Fernandez, K. Bergstrom, G. 
Bolske, P. Wallgren, and U. B. Gobel. 1992. Specificity of oligonucleotide probes 
complementary to evolutionarily variable regions of 16S rRNA from Mycoplasma 
hyopneumoniae and Mycoplasma hyorhinis. Res. Vet. Sci. 52:195-204. 
101. Jones, C. H., J. S. Pinkner, A. V. Nicholes, L. N. Slonim, S. N. Abraham, and S. J. 
Hultgren. 1993. FimC Is a periplasmic PapD-like chaperone that directs assembly of type 
1 pili in bacteria. Proc. Nad. Acad. Sci. USA 90:8397-8401. 
102. Jones, D. H., B. W. McBride, and G. H. Farrar. 1996. Poly(lactide-co-glycolide) 
microencapsulation of vaccine antigens. J. Biotechnol. 44:29-36. 
103. Kim, M. F., M. B. Heidari, S. J. StuU, M. A. Mcintosh, and K. S. Wise. 1990. 
Identification and mapping of an immunogenic region of Mycoplasma hyopneumoniae 
p65 surface lipoprotein expressed in Escherichia coli from a cloned genomic fragment. 
Infect. Immun. 58:2637-2643. 
104. Kishima, M., R. Ross, and C. Kuniyasu. 1985. Cell-mediated and humoral immune 
response to Mycoplasma hyopneumoniae in pigs enhanced by dextran sulfate. Am. J. 
Vet. Res. 46:456-462. 
105. Kishima, M., and R. F. Ross. 1985. Suppressive effect of nonviable Mycoplasma 
hyopneumoniae on phytohemagglutinin-induced transformation of swine lymphocytes. 
Am. J. Vet. Res. 46:2366-2368. 
106. Klemm, P. 1986. Two regulatorygenes, fimB and fimE, control the phase variation 
of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393. 
107. Klemm, P. 1992. FimC, a chaperone-like periplasmic protein of Escherichia coli 
Involved in biogenesis of type-1 fimbriae. Res. Microbiol. 143:831-838. 
108. Klemm, P., and G. Christiansen. 1990. The fimD gene is required for cell surface 
location of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 220:334-338. 
109. Klemm, P., K. A. Krogfelt, L. Hedegaard, and G. Christiansen. 1990. The major 
subunit of Escherichia coli type 1 fimbriae is not required for D-marmose-specific 
adhesion. Mol. Microbiol. 4:553-559. 
94 
110. Kobisch, M., L. Quillien, J. P. Tillon, and H. Wroblewski. 1987. The Mycoplasma 
hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia. 
Ann. Inst. Pasteur Immunol. 138:693-705. 
111. Krause, D. C. 1996. Mycoplasma pneumoniae cytadherence: uiu^velling the tie that 
binds. Mol. Microbiol. 20:247-253. 
112. Krause, D. C., and K. K. Lee. 1991. Juxtaposition of the genes encoding Mycoplasma 
pneumoniae cytadherence-accessory proteins HMWl and HMW3. Gene 107:83-89. 
113. Krause, D. C., D. K. Leith, R. M. Wilson, and J. B. Baseman. 1982. Identification of 
Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect. 
Immun. 35:809-817. 
114. Kristensen, B., P. Paroz, J. Nicolet, M. Wanner, and A. L. de Week. 1981. Cell-
mediated and humoral inmiune response in swine after vaccination and natural infection 
with Mycoplasma hyopneumoniae. Am. J. Vet. Res. 42:784-788. 
115. Krivan, H. C., L. D. Olson, M. F. Barile, V. Ginsburg, and D. D. Roberts. 1989. 
Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran 
sulfate. J. Biol. Chem. 264:9283-9288. 
116. Krivan, H. C., D. D. Roberts, and V. Ginsburg. 1988. Many pulmonary pathogenic 
bacteria bind specifically to the carbohydrate sequence GalNAc beta 1,4 Gal found in 
some glycolipids. Proc. Natl. Acad. Sci. USA 85:6157-6161. 
117. Krogfelt, K. A., H. Bergmans, and P. Klenrni. 1990. Direct evidence that the FimH 
protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect. 
Immun. 58:1995-1998. 
118. Krogfelt, K. A., and P. Klenmi. 1988. Investigation of minor components of 
Escherichia coli type 1 fimbriae: protein chemical and immunological aspects. Microb. 
pathog. 4:231-238. 
119. Krogfelt, K. A., B. A. McCormick, R. L. Burghoff, D. C. Laux, and P. S. Cohen. 
1991. Expression of Eschirichia coli F-18 type 1 fimbriae in the streptomycin-treated 
mouse large intestine. Infect. Immun. 59:1567-1568. 
120. Kukkonen, M., T. Raunio, R. Virkola, K. Lahteenmaki, P. H. Makela, P. Klemm, S. 
Clegg, and T. K. Korhonen. 1993. Basement membrane carbohydrate as a target for 
bacterial adhesion binding of type-I fimbriae of Salmonella enterica and Escherichia coli 
to laminin. Mol. Microbiol. 7:229-237. 
121. Kurono, Y., T. Fujiyoshi, and G. Mogi. 1989. Secretory IgA and bacterial adherence to 
nasal mucosal cells. Ann. Otol. Rhinol. Laryngol. 98:273-277. 
95 
122. Layh-Schmitt, G. 1993. The 0RF6 gene product of the PI operon of Mycoplasma 
pneumoniae. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278:287-295. 
123. Layh-Schmitt, G., and R. Herrmann. 1994. Spatial arragnement of gene product of the 
PI operon in the membrane of Mycoplasma pneumoniae. Infect. Immun. 62:974-979. 
124. Le Potier, M. F., P. Abiven, M. Kobisch, D. Crevat, and P. Desmettre. 1994. A 
blocking ELIS A using a monoclonal antibody for the serological detection of 
Mycoplasma hyopneumoniae. Res. Vet. Sci. 56:338-345. 
125. Leininger, E., C. A. Ewanowich, A. Bhargava, M. S. Peppier, J. G. Kenimer, and M. 
J. Brennan. 1992. Comparative roles of the Arg-Gly-Asp sequence present in the 
Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect. Immun. 
60:2380-2385. 
126. Leininger, E., M. Roberts, J. G. Kenimer, I. G. Charles, N. Fairweather, P. Novotny, 
and M. J. Brennan. 1991. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis 
surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA 
88:345-349. 
127. Livey, I., C. J. Duggleby, and A. Robinson. 1987. Cloning and nucleotide sequence 
analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Mol. Microbiol. 
1:203-209. 
128. Lloyd, L. C., G. S. Cottew, and D. A. Anderson. 1989. Protection against enzootic 
pneumonia of pigs: intraperitoneal inoculation with live LKR strain of Mycoplasma 
hyopneumoniae. Aust. Vet. J. 66:9-12. 
129. Locht, C., P. Bertin, F. D. Menozzi, and G. Renauld. 1993. The filamentous 
haemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp. Mol. 
Microbiol. 9:653-660. 
130. Loosmore, S. M., R. K. Yacoob, G. R. Zealey, G. E. Jackson, Y. P. Yang, P. S. 
Chong, J. M. Shortreed, D. C. Coleman, J. D. Cumiingham, L. Gisonni, and et al. 
1995. Hybrid genes over-express pertactin ftora. Bordetella pertussis. Vaccine 13:571-
80. 
131. Low, B., B. Braaten, and M. Van der Woude. 1996. Fimbriae, p. 146-157. In F. C. 
Neidhardt, R. Curtiss, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. 
Reznikoff, M. Riley, M. Schaechter and H. E. Umbarger (ed.), Escherichia coli and 
Salmonella cellular and molecular biology. AMerican Society for Microbiology, 
Washington, D.C. 
96 
132. Mahairas, G. G., and F. C. Minion. 1989. Random insertion of the gentamicin 
resistance transposon 1^4001 in Mycoplasma pulmonis. Plasmid 21:43-47 (Author's 
correction 30:177-178, 1993). 
133. Makhov, P. T., J. H. Hannah, M. J. Brennan, B. L. Trus, E. Kocsis, J. F. Conway, P. 
T. Wingdield, M. N. Simon, and A. C. Steven. 1994. Filamentous hemagglutinin of 
Bordetella pertussis. A bacterial adhesin formed as a 50 nm monomer rigid rod based on 
a 19-residual repeat motif rich in beta strands and turns. J. Mol. Biol. 241:110-24. 
134. Malaviya, R., T. Dceda, E. A. Ross, and S. N. Abraham. 1996. Mast cell modulation of 
neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 
381:77-80. 
135. Malaviya, R., E. A. Ross, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell 
degranulation induced by typel fimbriated Escherichia coli in mice. J. Clin. Invest. 
93:1645-1653. 
136. Malaviya, R., E. A. Ross, J. I. Macgregor, T. Dceda, J. R. Little, B. A. Jakschik, and 
S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. 
Immunol. 152:1907-1914. 
137. Markham, P. P., M. D. Glew, J. E. Sykes, T. R. Bowden, T. D. Pollacks, G. F. 
Browning, K. G. Whithear, and 1. D. Walker. 1994. The organisation of the multigene 
family which encodes the major cell surface protein, pMGA, of Mycoplasma 
gallisepticum. FEBS Lett 352:347-352. 
138. Mattingly, S. J., and B. P. Johnston. 1987. Comparative analysis of the localization of 
lipoteichoic acid in streptoccus agalactiae and Streptococcus pyogenes. Infect. Immun. 
55:2383-2386. 
139. Mattsson, J. G., K. Bergstrom, P. Wallgren, and K. E. Johansson. 1995. Detection of 
Mycoplasma hyopneumoniae in nose swabs from pigs by in vitro amplification of the 
16S rRNA gene. J. Clin. Microbiol. 33:893-897. 
140. Mcclain, M. S., I. C. Blomfield, and B. I. Eisenstein. 1991. Roles offimB and fimE in 
site specific DNA inversion associated with phase variation of type 1 fimbriae in 
Escherichia coli. J. Bacteriol. 173:5308-5314. 
141. McCormick, B. A., D. P. Franklin, D. C. Laux, and P. S. Cohen. 1989. Type 1 pili are 
not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-
piliated Escherichia coli F-18 and E. coli K-12. Infect. Immun. 57:3022-3029. 
142. McCormick, B. A., P. Klemm, K. A. Krogfelt, R. L. Burghoff, L. Pallesen, and D. C. 
Laux. 1993. Eschirichia coli F-18 phase locked "on" for expression of type 1 fimbriae is 
97 
a poor colonizer of the streptomycin-treated mouse large intestinae. Microb. Pathog. 
14:33-43. 
143. Mebus, C. A., and N. R. Underdahl. 1977. Scanning electron microscopy of trachea and 
bronchi from gnotobiotic pigs inoculated with Mycoplasma hyopneumoniae. Am. J. Vet. 
Res. 51:1249-1254. 
144. Mebus, C. A., and N. R. Underdahl. 1977. Scanning electron microscopy of trachea and 
bronchi from gnotobiotic pigs inoculated with Mycoplasma hyopneumoniae. Am. J. Vet. 
Res. 43:1249-1254. 
145. Menozzi, F. D., R. Mutombo, G. Renauld, C. Gantiez, J. H. Harmah, E. Leininger, M. 
J. Brennan, and C. Locht. 1994. Heparin-inhibitable lectin activity of the filamentous 
hemagglutinin adhesin of Bordetella pertussis. Infect. Immun. 62:769-778. 
146. Messier, S., and R. F. Ross. 1991. Interactions of Mycoplasma hyopneumoniae 
membranes with porcine lymphocytes. Am. J. Vet. Res. 52:1497-502. 
147. Messier, S., R. F. Ross, and P. S. Paul. 1990. Humoral and cellular immune responses 
of pigs inoculated with Mycoplasma hyopneumoniae. Am. J. Vet. Res. 51:52-58. 
148. Minion, F. C., C. VanDyk, and B. K. Smiley. 1995. Use of an Escherichia coli 
enhanced opal suppressor strain to screen a Mycoplasma hyopneumoniae library. FEMS 
Microbiol. Lett. 131:81-85. 
149. Monga, M., and J. A. Robert. 1994. Spermagglutination by bacteria: receptor-specific 
interaction. J. Androl. 15:151-156. 
150. Mooi, F. R., W. H. Jansen, H. Brunings, H. Gielen, H. G. J. van der Heide, H. C. 
Walvoort, and P. A. Guinee. 1992. Construction and analysis of Bordetella pertussis 
mutants defective in the production of fimbriae. Microb. Pathog. 12:127-135. 
151. Mooi, F. R., A. ter Avest, and H. G. van der Heide. 1990. Structure of the Bordetella 
pertussis gene coding for the serotype 3 fimbrial subunit. FEMS Microbiol. Lett. 54:327-
331. 
152. Mori, Y., Y. Yoshida, C. Kuniyasu, and K. Hashimoto. 1983. Improvement of 
complement fixation test antigen for the diagnosis of Mycoplasma hyopneumoniae 
infection. Natl. Inst. Anim. Health Q. Tokyo 23:111-116. 
153. Morrison-Plunmier, J., A. Laxxell, and J. B. Baseman. 1987. Shared epitope between 
Mycoplasma pneumoniae major adhesin protein PI and a 140 kilodalton protein of 
Mycoplasma genitalium. Infect. Immun. 55:49-56. 
154. Murphy, D., W. G. Van Alstine, L. K. Clark, S. Albregts, and K. Knox. 1993. Aerosol 
vaccination of pigs against Mycoplasma hyopneumoniae infection. Am. J. Vet. Res. 
54:1874-1880. 
98 
155. Nilsson, K., U. I. Dahlgren, and L. A. Hanson. 1988. Different origins of IgA 
antibodies with various antigen specificities appearing in rat bile. Scand. J. Inimunol. 
28:547-551. 
156. Ofek, I., W. A. Simpson, and E. H. Beachey. 1982. Formation of molecular complexes 
between a structurally defined M-protein and acylated or deacylated lipoteichoic acid of 
Streptococcus pyogenes. J. Bacteriol. 149:426-433. 
157. Ogle, K. F., K. K. Lee, and D. C. Krause. 1991. Cloning and analysis of the gene 
encoding ±e cytadherence phase-variable protein HMW3 from Mycoplasma pneumoniae. 
Gene 97:69-75. 
158. Ogle, K. F., K. K. Lee, and D. C. Krause. 1992. Nucleotide sequence analysis reveals 
novel features of the phase-variable cytadherence accessory protein HMW3 of 
Mycoplasma pneumoniae. Infect. Immun. 60:1633-1641. 
159. Okada, M., A. P. Pentland, P. Falk, and M. G. Caparon. 1994. M protein and protein F 
act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin 
tissue. J. Clin. Invest. 94:965-977. 
160. Okada, N., M. K. Liszewski, J. P. Atkinson, and M. Caparon. 1995. Membrane 
cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A 
streptococcus. Proc. Natl. Acad. Sci. USA 92:2489-2493. 
161. Olsen, P. B., and P. Klemm. 1994. Localization of promoters in the fim gene cluster and 
the effect of H-NS on the transcription offimB and fimE. FEMS Microbiol. Lett. 
116:95-100. 
162. Orskov, L, and F. Orskov. 1990. Serologic classification of fimbriae. Curr. Top. 
Microbiol. Immunol. 151:71-90. 
163. Oswald, E., J. de Rycke, P. Lintermans, K. van Muylem, J. Mainil, G. Daube, and P. 
Pohl. 1991. Virulent factors associated with cytotoxic necrotizing factor type two in 
bovine diarrheic and septicemic strains of Eschirichia coli. J. Clin. Microbiol. 29:2522-
2527. 
164. Ozeri, V., A. Tovi, 1. Burstein, S. Natanson-Yaron, M. G. Caparon, K. M. Yamada, S. 
K. Akiyama, I. Vlodavsky, and E. Hanski. 1996. A two-domain mechanism for group A 
streptococcal adherence through protein F to the extracellular matrix. EMBO J. 15:989-
998. 
165. Pakainathan, D. R. 1995. Extracellular matrix proteins and leukocyte function. J. Leuk. 
Biol. 57:699-702. 
99 
166. Paton, J. C., P. W. Andrew, G. J. Boulnois, and T. J. Mitchell. 1993. Molecular 
analysis of the pathogenicity of Streptococcus pneumoniae-, the role of pneumococcal 
proteins. Annu. Rev. Microbiol. 47:89-115. 
167. Patti, J. M., B. L. Allen, M. J. McGavin, and M. Hook. 1994. MSCRAMM-mediated 
adherence of microorganisms to host tissue. Annu. Rev. Microbiol. 48:585-617. 
168. Pedroni, P., B. Riboli, F. de Ferra, G. Grandi, S. Toma, B. Arico, and R. Rappuoli. 
1988. Qoning of a novel pilin-like gene firom Bordetella pertussis: homology to the fim2 
gene. Mol. Microbiol. 2:539-543. 
169. Perez-Casal, J., N. Okada, M. G. Caparon, and J. R. Scott. 1995. Role of the 
conserved C-repeat region of the M protem of Streptococcus pyogenes. Mol. Microbiol. 
15:907-916. 
170. Perry, A., 1. Ofek, and F. J. Silverblatt. 1983. Enhancement of mannose-mediated 
stimulation of human granulocytes by fimbriae aggregated with antibodies on Escherichia 
coli surfaces. Infect. Immun. 39:1334-1345. 
171. Plos, K., H. Lomberg, S. Hull, I. Johansson, and C. Svanborg. 1991. Escherichia coli 
in patients with renal scarring genotype and phenotype of Gal alphal-4 Gal beta-, 
Forssman- and mannose-specific adhesins. Pediatr. Infect. Dis. J. 10:15-19. 
172. Pointon, A. M., W. D. Hueston, and G. D. Dial. 1990. Disease surveillance: reducing 
the uncertainty of decision making. Minnesota Swine Conference for Veterinarians. 38-
57. 
173. Powell, D. A., P. C. Hu, M. Wilson, A. M. Collier, and J. B. Baseman. 1976. 
Attachment of Mycoplasma pneumoniae to respiratory epithelium. Infect. Immun. 
13:956-966. 
174. Prasad, S. M., Y. B. Yin, E. Rodzinski, E. I. Tuomanen, and H. R. Masure. 1993. 
Identification of a carbohydrate recognition domain in filamentous hemagglutinin from 
Bordetella pertussis. Infect. Inomun. 61:2780-2785. 
175. Razin, S., M. Banai, H. Gamliel, A. Pollack, and W. Bredt. 1980. Scanning electron 
microscopy of mycoplasmas adhering to erythrocytes. Infect. Immun. 30:538-546. 
176. Razin, S., and E. Jacobs. 1992. Mycoplasma adhesion. J. Gen. Microbiol. 138:407-
422. 
177. Razin, S., I. Kahane, M. Banai, and W. Bredt. 1981. Adhesion of mycoplasma to 
eukaryotic cells. Ciba Found symp. 80:98-118. 
178. Reddy, S. P., W. G. Rasmussen, and J. B. Baseman. 1995. Molecular cloning and 
characterisation of an adherence-related operon of Mycoplasma genitalium. J. Bacteriol 
177:5943-5951. 
100 
179. Relman, D., E. Tuomanen, S. Falkow, D, T. Golenbock, K. Saukkonen, and S. D. 
Wright. 1990. Recognition of a bacterial adhesion by an integrin: macrophage CR3 
(alpha M beta 2, CDl lb/CD 18) binds filamentous hemagglutinin of Bordetella pertussis. 
Cell 61:1375-1382. 
180. Relman, D. A., M. Domenighini, E. Tuomanen, R. Rappuoli, and S. Falkow. 1989. 
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role 
in adherence. Proc. Natl. Acad. Sci. USA 86:2637-2641. 
181. Reynolds, H. Y. 1987. Bacterial adherence to respiratory tract mucosa: a dynamic 
interaction leading to colonization. Semin. Respir. Infect. 2:8-19. 
182. Roberts, D. D., L. D. Olson, M. F. Barile, V. Ginsburg, and H. C. Krivan. 1989. Sialic 
acid-dependent adhesion of Mycoplasma pneumoniae to purified glycoproteins. J. Biol. 
Chem. 264:9289-9293. 
183. Roberts, M., N. F. Fairweather, E. Leininger, D. Pickard, E. L. Hewlett, A. Robinson, 
C. Hay ward, G. Dougan, and I. G. Charles. 1991. Construction and characterization of 
Bordetella pertussis mutants lacking the v/r-regulated P.69 outer membrane protein. Mol. 
Microbiol. 5:1393-1404. 
184. Rodriguez-Ortega, M., I. Ofek, and N. Sharon. 1987. Membrane glycoproteins of 
human polymorphonuclear leukocytes that act as receptors for mannose-specific 
Escherichia coli. Infect. Immun. 55:968-973. 
185. Ross, R. F. 1992. Mycoplasmal disease, p. 537-551. In A. D. Leman, B. E. Straw, W. 
L. Mengeling, S. D'Allaire and D. J. Taylor (ed.). Diseases of Swine. Iowa State 
University Press, Ames. 
186. Ross, R. F. 1993. Mycoplasma - animal pathogens, p. 69-109. In I. Kahane and A. 
Adoni (ed.). Rapid diagnosis of mycoplasmas. Plenum Press, New York. 
187. Ross, R. F., and D. F. Cox. 1988. Evaluation of tiamulin for treatment of mycoplasmal 
pneumonia in swine. J. Am. Vet. Med. Assoc. 193:441-446. 
188. Ross, R. F., and T. F. Young. 1993. The nature and detection of mycoplasmal 
immunogens. Vet. Microbiol. 37:369-380. 
189. Ross, R. F., B. J. Zimmerman-Erickson, and T. F. Young. 1984. Characteristics of 
protective activity of Mycoplasma hyopneumoniae vaccine. Am. J. Vet. Med. 45:1899-
1905. 
190. Ruland, K., R. Himmelreich, and R. Herrmann. 1994. Sequence divergence in the 
0RF6 gene of Mycoplasma pneumoniae. J. Bacteriol. 176:5202-5209. 
101 
191. Russell, P. W., and P. E. Omdorff. 1992. Lesions in two Escherichia coli type 1 pilus 
genes alter pilus number and length without affecting receptor binding. J. Bacterial. 
174:5923-5935. 
192. Rye, M., B. Wagner, M. Wagner, and R. Bicova. 1988. Electron microscopic 
localization of lipoteichoic acid on group A streptococci. Zentralbl. Bakteriol. Mikrobiol. 
Hyg. A. 269:168-178. 
193. Sajjan, S. U., and J. F. Forstner. 1990. Characteristics of binding of Escherichia coli 
serotype 0157:H7 strain CL-49 to purified intestinal mucin. Infect. Immun. 58:860-867. 
194. Sajjan, S. U., and J. F. Forstner. 1990. Role of the putative "link" glycopeptide of 
intestinal mucin in binding of piliated Escherichia coli serotype 0157:H7 strain CL-49. 
Infect. Immun. 58:868-873. 
195. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory 
manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y. 
196. Saukkonen, K., W. N. Bumette, V. L. Mar, H. R. Masure, and E. Tuomanen. 1992. 
Permssis toxin has eukaryotic-like carbohydrate recognition domains. Proc. Nad. Acad. 
Sci. USA 89:118-122. 
197. Sauter, S. L., S. M. Rutherfurd, C. Wagener, J. E. Shively, and S. A. Hefta. 1991. 
Binding of nonspecific cross-reacting antigen, a granulocyte membrane glycoprotein, to 
Escherichia coli expressing type 1 fimbriae. Infect. Immun. 59:2485-2493. 
198. Sauter, S. L., S. M. Rutherfurd, C. Wagener, J. E. Shively, and S. A. Hefta. 1993. 
Identification of the specific oligosaccharide sites recognized fimbriae from Escherichia 
coli on nonspecific cross-reacting antigen, a cluster granulocyte glycoprotein. J. Biol. 
Chem. 268:15510-15516. 
199. Schaeffer, A. J., W. R. Schwan, S. J. Hultgren, and J. L. Duncan. 1987. Relationship 
of type 1 pilus expression in Escherichia coli to ascending urinary Uract infections in mice. 
Infect. Immun. 55:373-380. 
200. Schuller, W., H. D. Lehmkuhl, and W. P. Switzer. 1976. A fluorescent antibody 
technique for identification of Mycoplasma hyopneumoniae colonies. Am. J. Vet. Res. 
37:477-478. 
201. Schwan, W. R., H. S. Seifert, and J. L. Duncan. 1992. Growth conditions mediate 
differential transcription of fim genes Involved in phase variation of type 1 pili. J. 
Bacteriol. 174:2367-2375. 
202. Sheldrake, R. F., I. A. Gardner, M. M. Saunders, and L. F. Romalis. 1990. Serum 
antibody response to Mycoplasma hyopneumoniae measured by enzyme-linked 
102 
immunosoibent assay after experimental and natural infection of pigs. Aust. Vet. J. 
67:39-42. 
203. Sheldrake, R. F., I. A. Gardner, M. M. Saunders, and L. F. Romalis. 1991. 
Intraperitoneal vaccination of pigs to control Mycoplasma hyopneumoniae. Res. Vet. Sci. 
51:285-291. 
204. Sheldrake, R. F., L. F. Romalis, and M. M. Saunders. 1993. Serum and mucosal 
antibody response against Mycoplasma hyopneumoniae following intraperitoneal 
vaccination and challenge of pigs with M. hyopneumoniae. Res. Vet. Sci. 55:371-376. 
205. Sherman, P., R. Soni, and E. Boedeker. 1988. Role of type 1 pili (fimbriae) in mucosal 
attachment of the enteroadherent Escherichia coli, strains RDEC-1, in rabbits. J. Pediatr. 
Gastroenterol. Nutr. 7:594-601. 
206. Sherman, P. M., and E. C. Boedeker. 1987. Pilus-mediated interactions of the 
Escherichia coli strain RDEC-1 with mucosal glycoproteins in the small intestine of 
rabbits. Gastroenterology 93:734-743. 
207. Short, J. M., J. M. Femandez, J. A. Sorge, and W. D. Huse. 1988. Lambda ZAP: a 
bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids 
Res. 16:7583-7600. 
208. Simpson, W. A., H. S. Courtney, J. C. Morrison, and E. H. Beachey. 1987. 
Interactions of fibronectin with streptococci: the role of fibronectin as a recptor for 
Streptococcus pyogenes. Rev. Infect. Dis. 9:S351-S359. 
209. Simpson, W. A., H. S. Courtney, and I. Ofek. 1987. Interaction of fibronectin with 
streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes. Rev. 
Infect. Dis. 9:351-359. 
210. Slender, R. K., T. K. Korhonen, V.-R. V., P. H. Williams, P. E. Pattison, and D. A. 
Caugant. 1986. Genetic relationships and clonal stracture of strains of Escherichia coli 
causing neonatal septicemia and meningitis. Infect. Immun. 52:213-222. 
211. Smiley, B. K., and F. C. Minion. 1993. Enhanced readthrough of opal (UGA) codons 
and production of Mycoplasma pneumoniae PI epitopes in Escherichia coli. Gene 
134:33-40. 
212. Smith, H. 1989. The mounting interest in bacterial and viral pathogenicity. Annu. Rev. 
Microbiol. 43:1-22. 
213. Smith, H. 1990. Pathogenicity and the microbe in vivo. J. Gen. Microbiol. 136:377-
383. 
103 
214. Smith, H. 1995. The state and future of studies on bacterial pathogenicity, p. 335-357. 
In J. A. Roth and e. al (ed.). Virulence mechanisms of bacterial pathogenes, 2nd ed. 
American society for Microbiology, Washington,D.C. 
215. Steadman, R., N. Matthews, M. Lichodziejewska, and J. D. Williams. 1991. Human 
neutrophil responses to pathogenic Escherichia coli are receptor-specific and selectively 
augmented by recombinant human tumor necrosis factor-alpha. J. Infect. Dis. 163:1033-
1039. 
216. Steadman, R., N. Topley, D. E. Jeimer, M. Davies, and J. D. Williams. 1988. Type 1 
fimbriated Escherichia coli stimulates a unique pattern of degranulation by human 
polymorphonuclear leukocytes. Infect. Immun. 56:815-822. 
217. Stemke, G. W. 1989. A gene probe to detect Mycoplasma hyopneumoniae, the 
etiological agent of enzootic pneumonia. Mol. Cell. Probes 3:255-232. 
218. Stevens, M. K., and D. C. Krause. 1990. Disulfide-linked protein associated with 
Mycoplasma pneumoniae cytadherence phase variation. Infect. Inmiun. 58:3430-3433. 
219. Stevens, M. K., and D. C. Krause. 1991. Localization of the Mycoplasma pneumoniae 
cytadherence-accessory proteins HMWl and HMW4 in the cytoskeletonlike triton shell. 
J. Bacteriol. 173:1041-1050. 
220. Stevens, M. K., and D. C. Krause. 1992. Mycoplasma pneumoniae cytadherence phase-
variable proteins HMW3 is a component of the attachment organelle. J. Bacteriol. 
174:4265-4274. 
221. Stjemquist-Desatnik, A., D. N. Kurl, and P. Christensen. 1986. Repeated passage of 
freshly isolated group A streptococci on blood agar. Acta. Pathol. Microbiol. Immunol. 
Scand. B. 94:405-408. 
222. Strasser, M., J. Frey, G. Bestetti, M. Kobisch, and J. Nicolet. 1991. Cloning and 
expression of a species-specific early inununogenic 36-kilodalton protein of Mycoplasma 
hyopneumoniae in Escherichia coli. Infect. Immun. 59:1217-1222. 
223. Strathmann, M., B. A. Hamilton, C. A. Mayeda, M. I. Simon, E. M. Meyerowitz, and 
M. J. Palazzolo. 1991. Transposon-facilitated DNA sequencing. Proc. Natl. Acad. Sci. 
USA 88:1247-1250. 
224. Su, C.-J., A. Chavoya, and J. B. Baseman. 1988. Regions of Mycoplasma pneumoniae 
cytadhesin PI structural gene exist as multiple copies. Infect. Immun. 56:3157-3161. 
225. Su, C. J., A. Chavoya, and J. B. Baseman. 1988. Regions of Mycoplasma pneumoniae 
cytadhesin PI structural gene exist as multiple copies. Infect. Immun. 56:3157-3161. 
226. Su, C. J., S. F. Dallo, and J. B. Baseman. 1990. Molecular distinctions among clinical 
isolates oiMycoplasma pneumoniae. J. Clin. Microbiol. 28:1538-1540. 
104 
227. Su, C. J., V. V. Tryon, and J. B. Baseman. 1987. Cloning and sequence analysis of 
cytadhesin PI gene from Mycoplasma pneumoniae. Infect. Immun. 55:3023-3029. 
228. Switzer, W. P., and R. F. Ross. 1975. Mycoplasmal disease, p. In H. W. Dunn and A. 
D. Leman (ed.). Diseases of swine. Iowa Stae University Press, Ames. 
229. Tajima, M., and T. Yagihashi. 1982. Interaction of Mycoplasma hyopneumoniae with 
the porcine respiratory epithelium as observed by electron microscopy. Infect. Immun. 
37:1162-1169. 
230. Talay, S. R., P. Valentin-Weigand, P. G. Jerlstrom, K. N. Timmis, and G. S. 
Chhatwal. 1992. Fibronectin-binding protein of Streptococcus pyogenes: sequence of the 
binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun. 
60:3837-3844. 
231. Tewari, R., J. I. Macgregor, T. Dceda, J. R. Little, S. J. Hultgren, and S. N. Abraham. 
1993. Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from 
the periplasm of Escherichia coli. J. Biol. Chem. 268:3009-3015. 
232. Topley, N., R. Steadman, R. Mackenzie, J. M. Knowlden, and J. D. Williams. 1989. 
Type 1 fimbriae strains of Eschirichia coli mitiate renal parenchymal scarring. Kidney Int. 
36:609-616. 
233. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins 
fi-om polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc. 
Natl. Acad. Sci. USA 76:4350-4354. 
234. Truszczynski, M., and J. Osek. 1987. Occurence of mannose resistant hemagglutinins in 
Escherichia coli strains isolated from porcine colibacillosis. Comp. Immunol. Microbiol. 
Infect. Dis. 10:117-124. 
235. Tullus, K., I. Kuhn, I. Orskov, and R. Mollby. 1992. The important of P and type 1 
fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol. Infect. 
108:415-421. 
236. Tully, J. G., J. M. Bove, F. Laigret, and R. F. Whitcomb. 1993. Revised taxonomy of 
the class Mollicutes - proposed elevation of a monophyletic cluster of arthropod-
associated moUicutes to ordinal rank {Entomoplasmatales ord-nov), with provision for 
familial rank to separate species with nonhelical morphology (Entomoplasmataceae fam-
nov) from helical species (Spiroplasmataceae), and emended descriptions of the order 
Mycoplasmatales, family Mycoplasmataceae. Int. J. Syst. Bacteriol. 43:378-385. 
237. Tuomanen, E., H. Towbin, G. Rosenfelder, D. Braun, G. Larson, G. C. Hanson, and 
R. HiU. 1988. Receptor analogs and monoclonal antibodies that inhibit adherence of 
105 
Bordetella pertussis to human ciliated respiratoiy epithelial cells. J. Exp. Med. 168:267-
277. 
238. Tuomanen, E., and A. Weiss. 1985. Characterization of two adhesins of Bordetella 
pertussis for human ciliated respiratory-epithelial cells. J. Infect. Dis. 152:118-125. 
239. Tylewska, S. K., V. Fischetti, and R. J. Gibbbons. 1988. Binding selectivity of 
Streptococcus pyogenes and M-protein to epithelial cells differ from that of lipoteichoic 
acid. Curr. Microbiol. 16:209-216. 
240. Valentin-Weogand, P., S. R. Talay, K. N. Timmis, and G. S. Chhatwal. 1993. 
Identification of a fibronectin-binding protein as adhesin of Streptococcus pyogenes. Int. 
J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278:238-245. 
241. van't Wout, J., W. N. Bumette, V. L. Mar, E. Rozdzinski, S. D. Wright, and E. I. 
Tuomanen. 1992. Role of carbohydrate recognition domains of pertussis toxin in 
adherence of Bordetella pertussis to human macrophages. Infect. Immun. 60:3303-3308. 
242. VanHeyningen, T., G. Fogg, D. Yates, E. Hanski, and M. Caparon. 1993. Adherence 
and fibronectin binding are environmentally regulated in the group A streptococci. Mol. 
Microbiol. 9:1213-1222. 
243. Wang, J. R., and M. W. Stinson. 1994. M protein mediates streptococcal adhesion to 
Hep-2 cells. Infect. Immun. 62:442-448. 
244. Wang, J. R., and M. W. Stinson. 1994. Streptococcal M6 protein binds to fucose-
containing glycoproteins on cultured human epithelial cells. Infect. Inrniun. 62:1268-
1274. 
245. Westerlund, B., and T. K. Korhonen. 1993. Bacterial proteins binding to the mammalian 
extracellular matrix. Mol. Microbiol. 9:687-694. 
246. Whittlestone, P. 1979. Porcine mycoplasmas, p. 133-176. In J. G. TuUy and R. F. 
Whitcomb (ed.). The mycoplasmas, volume n. Human and animal mycoplasmas. 
Academic Press, New York. 
247. Wiedermann, U., S. Ahlstedt, B. Andersson, and U. I. Dahlgren. 1993. Antibody 
response in bronchoalveolar lavage and bile in rats after aerosol inmiunization with an 
Escherichia coli strain producing ovalbumin. Int. Allergy Immunol. 101:254-259. 
248. Wieslander, A., M. J. Boyer, and H. Wroblewski. 1992. Membrane protein structure, p. 
93-112. In J. Maniloff, R. N. McElhaney, L. R. Finch and J. B. Baseman (ed.). 
Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, 
Washington, D.C. 
249. Willems, R. J., C. Geuijen, H. G. van der Heide, M. Matheson, A. Robinson, L. F. 
Versluis, R. Ebberink, J. Theelen, and F. R. Mooi. 1993. Isolation of a putative fimbrial 
106 
adhesin from Bordetella pertussis and the identification of its gene. Mol. Microbiol. 
9:623-634. 
250. Willems, R. J., H. G. van der Heide, and F. R. Mooi. 1992. Characterization of a 
Bordetella pertussis fimbrial gene cluster which is located direcdy downstream of the 
filamentous haemagglutinin gene. Mol. Microbiol. 6:2661-2671. 
251. Williams, P. P., and J. E. Gallagher. 1978. Cytopathogenicity of Mycoplasma 
hyopneumoniae in porcine tracheal ring and lung explant cultures alone and in 
combination with monolayers of fetal lung fibroblasts. Infect. Immun. 20:495-502. 
252. Wilson, M. H., and A. M. Collier. 1976. Ultrastructural study of Mycoplasma 
pneumoniae in organ culture. J. Bacteriol. 125:332-339. 
253. Wise, K. S., G. H. Cassell, and R. T. Acton. 1978. Selective association of murine T 
lymphoblastoid cell surface alloantigens with Mycoplasma hyorhinis. Proc. Nat. Acad. 
Sci. USA 75:4479-4483. 
254. Wise, K. S., and M. F. Kim. 1987. Identification of intrinsic and extrinsic membrane 
proteins bearing surface epitopes of Mycoplasma hyopneumoniae. Isr. J. Med. Sci. 
23:469-473. 
255. Wise, K. S., and M. F. Kim. 1987. Major membrane surface proteins of Mycoplasma 
hyopneumoniae selectively modified by covalently bound lipid. J. Bacteriol. 169:5546-
5555. 
256. Wise, K. S., D. Yogev, and R. Rosengarten. 1992. Antigenic variation, p. 473-489. In 
J. Maniloff, R. N. McElhaney, L. R. Finch and J. B. Baseman (ed.). Mycoplasmas: 
molecular biology and pathogenesis. American Society for Microbiology, Washington, 
D.C. 
257. Wold, A. E., J. Mestecky, M. Tomana, A. Kobata, H. Ohbayashi, T. Endo, and C. S. 
Eden. 1990 Sep. Secretory immunoglobulin A carries oligosaccharide receptors for 
Escherichia coli type 1 fimbrial lectin. Infect, and Lranun. 58:3073-3077. 
258. Wold, A. E., M. Thorssen, S. Hull, and C. S. Eden. 1988. Attachment of Escherichia 
coli via marmose- or Gal alpha 1-4 Gal beta-containing receptors to human colonic 
epithelial cells. Infect. Immun. 56:2531-2537. 
259. Yogev, D., R. Watson-McKown, R. Rosengarten, J. Im, and K. S. Wise. 1995. 
Increased structural and combinatorial diversity in an extended family of genes encoding 
Vlp surface proteins of Mycoplasma hyorhinis. J. Bacteriol. 177:5636-5643. 
260. Young, T. F., B. Z. Erickson, R. F. Ross, and Y. Wannemuehler. 1989. 
Hemagglutination and hemagglutination inhibition of turkey red blood cells with 
Mycoplasma hyopneumoniae. Am. J. Vet. Res. 50:1052-1055. 
107 
261. Young, T. F., and R. F. Ross. 1987. Assessment of antibody response of swine 
infected with Mycoplasma hyopneumoniae by immunoblotting. Am. J. Vet. Res. 48:651-
656. 
262. Young, T. F., R. F. Ross, and J. Drisko. 1983. Prevalence of antibodies to Mycoplasma 
hyopneumoniae in Iowa swine. Am. J. Vet. Res. 44:1946-1948. 
263. Zhang, Q., T. F. Young, and R. F. Ross. 1994. Glycolipid receptors for attachment of 
Mycoplasma hyopneumoniae to porcine respiratory ciliated cells. Infect. Immun. 
62:4367-4373. 
264. Zhang, Q., T. F. Young, and R. F. Ross. 1995. Identification and characterization of a 
Mycoplasma hyopneumoniae adhesin. Infect. Immun. 63:1013-1019. 
265. Zhang, Q. J., and K. S. Wise. 1996. Molecular basis of size and antigenic variation of a 
Mycoplasma hominis adhesin encoded by divergent vaa genes. Infect. Immun. 64:2737-
2744. 
266. Zhang, Q. J., T. F. Young, and R. F. Ross. 1994. Microtiter plate adherence assay and 
receptor analogs fox Mycoplasma hyopneumoniae. Infect. Immun. 62:1616-1622. 
267. Zielinski, G. C., and R. F. Ross. 1993. Adherence of Mycoplasma hyopneumoniae to 
porcine ciliated respiratory tract cells. Am. J. Vet. Res. 54:1262-1269. 
268. Zielinski, G. C., T. Young, and R. F. Ross. 1990. Adherence of Mycoplasma 
hyopneumoniae to ceU monolayers. Am. J. Vet. Res. 51:339-343. 
269. Zielinski, G. C., T. Young, R. F. Ross, and R. F. Rosenbusch. 1990. Adherence of 
Mycoplasma hyopneumoniae to ceU monolayers. Am. J. Vet. Res. 51:339-343. 
270. Zingler, G., G. Schmidt, I. Orskov, F. Orskov, U. Falkenhagen, and G. Naumarm. 
1990. K-antigen identification, hemolysin production, and hemagglutination types of 
Escherichia coli 06 strains isolated from patients with urinary tract indections. Int. J. 
Med. Microbiol. 274:372-381. 
108 
ACKNOWLEDGMENTS 
I would like to thank Drs. C. F. Ford, S. L. Carpenter, M. Nilsen-Hamilton, J. S. 
Haynes, and C. O. Thoen for serving on my examining committee. Their suggestions and 
especially, their patience will always be remembered. I would like to express my special 
thanks to my major advisor Dr. F. Chris Minion without whom the completion of this 
dissertation would have been impossible. I thank him for his advice, patience, encouragement, 
and support throughout this study. I am deeply indebted to his having faith in me and his 
willingness to let me join his laboratory at a most difficult time. I also like to thank Drs. P. A. 
Kapke, S. Artiushin, and 1. Morozov for helpful discussions and advice. 
I thank Mrs. T. F. Young, B. Z. Erickson, N. J. Upchurch, and Dr. R. F. Ross for 
providing me with the M. hyopneumoniae strains, swine cilia, and chemicals as well as their 
assistance in making Friis media and training in the adherence assay. 
I like to thank the following people with whom I have had the honor to work with in this 
laboratory. They are B. A. Esswein, S. Ambalakkat, and C. T. VanDyk. My special thanks 
go to C. T. VanDyk for her technical support in constructing and initial screening of the M. 
hyopneumoniae genomic library. I am fortunately enough to be part of VMRI where I have 
had the opportunity to work with so many intelligent and interesting people. I thank all of 
them. 
Finally, I would like to thank my family in Taiwan who have supported me throughout this 
degree process. Without that support I would have not been able to complete my studies. I 
would like to dedicate this dissertation to my father who did not live to see its completion. 
